tsawon lokacin da alamun suka fara bayyana?
kuma za a iya magance ciwon kirji ta wannan hanyar musamman a cikin tsufa
da kuma samun zazzabi
kuma kana bukatar a auna karfin jini da cholesterol yake samu a cikin jini
Shin kuna da zazzabi a yanzu?
Shin kana jin ciwon kirji a yanzu?
kuma a saman wannan kana da matsalar numfashi
kuma za ku iya gaya mani wasu alamun da kuke nunawa tare da wannan?
yaya zafin jikinka yake
kuma ina da wani abu da yake damuna
kuma ina da mura da ke sa ni tari
kuma ina da ciwon kirji mai tsanani
kuma wannan shine lokacin da za ku iya samun cutar mura mai saurin kamuwa da ƙura da kuma tsire-tsire masu tsire-tsire.
kuma yana sa ka ciwon kirji
kuma ina ganin ina da zazzabi kadan
kuma ina so ka bayyana inda kake jin ciwon kirji
kuma suna da kadan wuta
da kuma ciwon sukari
kuma ka sani ina jin kamar kirjina yana gab da fashewa
kuma ka san mutane suna yi min ba'a a koyaushe
kuma kana da ciwon kirji
kuma ka ce wannan yana sa ka cikin damuwa
wani a cikin danginku yana da ciwon zuciya? ciwon zuciya? bugun zuciya? hawan jini?
wani alamun ko kuma yanayin da kake da shi na ciwon jijiya?
Shin akwai wasu masu cutar a cikin iyali da ke nuna irin wannan alamun?
Shin kana da wasu alamun cutar?
Shin kana jin cewa ba ka da isashen isashen iska?
har yanzu kuna jin ciwon kirji
saboda wannan shine lokacin da mutane ke kamuwa da mura
amma kuma ba za mu iya watsi da ciwon kirji da ke haifar da cututtukan zuciya ba
amma babban abin damuwa a yanzu shine ciwon kirji
amma ina da matsalar numfashi
amma na san mutane da yawa sun yi imani da ni
amma muna bukatar mu bi da kowane irin ciwon kirji da tsananin tsananin
amma kana numfashi yadda ya kamata a yanzu?
'Domin wannan ciwon kirji na manta da duk abin da ya faru
kamar wani ya matsa maka a kirji
za ka ji kamar iska tana cikin ka
suna gunaguni cewa suna rashin lafiya suna nuna irin wannan alamun?
kuna da wani ciwo na kullum kamar hawan jini ko kuma wani irin ciwo?
kuna da wasu matsalolin kiwon lafiya da suka shafi cututtukan da kuka sha wahala a baya kamar su ciwon sukari?
Shin akwai wani abu da ya rage a cikin ruhun da wannan ciwon kirji?
kana da hawan jini?
ruhun zama kadan tare da wannan?
Shin ka san alamun da ke nuna hakan?
ka ga hoton?
sha da yawa a yau
amma ina yin gwajin ciwon sukari
amma yana da alamun da suka yi daidai da nawa
Yaya zafin jikinka yake?
yaya hawan jini yake?
idan zazzabi ya ci gaba
idan kuna da zazzabi na digiri talatin da takwas da takwas ko sama da haka
idan kana ganin alamun bayyanarka da kuma matsalolin da kake da su na nuna cewa kana da siffa mai kyau
na yi zazzabi jiya
na sami ɗan zazzabi
jiya ina da zazzabi
Ina da ciwo mai tsanani a nan cikin kirji
tare da ni ina da matsalar numfashi
Zan aiko muku da hoto
Ina da ciwon kirji a yau
yau kawai ina da ciwon kai da zazzabi
ina tsammanin mura ce
ina tsammanin ɗan mura ne
kamar wani mai nauyi yana zaune a kirjina?
duk ya fara ne da ciwon kai da kuma jin zafi a lokaci guda
Ina jin zafi a tsakiyar kirji
yana kwantar da hankali kuma yana kama da ciwon kirji
yana cikin kirjina
yana tsakiyar kirjina
yana tsakiyar kirjina
ina da ciwo a kirji
ina da matukar damuwa da ciwon kirji na yanzu
Ina so ku gaya mani game da wannan ciwon kirji
kamar hawan jini ko ciwon sukari
kusan tsakiyar daidai a cikin kirji
yanzu kana da zazzabi ka sha ruwan 'ya'yan itace mai daɗi
mary kwana nawa kake da alamun cutar
yanzu ka ce kana da ciwon kirji
wani lokacin ina jin zafi a kirji
lafiya akwai wasu alamun da kake nunawa tare da wannan banda kawai ciwo
ko kuma kana ganin mutum ne da ke zaune a kan kirjinka?
da kyau daidai yake da zafin jiki da ciwon kai da kuma ciwon jijiya
a tsakiya a cikin kirji
Ka nuna min a wannan hoton inda kake jin zafi
daga mai ƙone wuta
To, shin kana ganin wasu daga cikin wadannan alamun suna da alaka da ciki?
Shin yaranku suna da irin wannan alamar?
gaya mani game da ciwon kirjinka
Wuta ta yi ta ƙaruwa da dare
zazzabi na kwana biyu da suka gabata
zafin ya fara tashi a daren jiya
wannan shi ne Dr. Porter wanda ke aiki a wani asibiti da ke daukar marasa lafiya masu tsanani zuwa sashen gaggawa
za ku iya gaya mani dalla-dalla game da ciwon kirjin ku?
Ina jin zafi a cikin jikina a nan a cikin kirji
shi ne lokacin da ciwon kirji ya yi tsanani
haka ne idan ina da wannan ciwon kirji
wane irin ciwo kake da shi a kirjinka?
yaushe ne wannan ciwon kirji ya fara?
ina kake da ciwon kirji?
ina kake jin wannan ciwon kirji da ke ɓoye a cikin kirji t
kamar yana da wuya a kirjinka
uiko ina da ciwon sukari da dai sauransu
wanda ya ce kana jin wannan ciwon kirji
Adadin masu kamuwa da cutar coronavirus (COVID-19) ya karu cikin sauri a cikin EU/EEA da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Adadin masu kamuwa da cutar coronavirus (COVID-19) a cikin ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya ya nuna cewa, duk da bambancin da ke tsakanin ƙasashe, cutar ta COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Dangane da abin da ya faru a Italiya, jihohi, asibitoci da cibiyoyin kula da gaggawa dole ne su kasance cikin shiri don karɓar adadi mai yawa na masu cutar COVID-19 waɗanda za a buƙaci kulawa, musamman dangane da kula da marasa lafiya masu wahala.
A ranar 31 ga watan Disamba, 2019, an samu wasu mutane da suka kamu da cutar sankara da ba a san dalilin da ya sa ba a kai su birnin Wuhan, lardin Hubei, na kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta ba da sanarwar kamuwa da sabon coronavirus wanda yanzu ake kira SARS-CoV-2.
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
A halin yanzu, shaidar ta nuna cewa kusan kashi 80% na mutanen da ke dauke da COVID-19 suna da ƙananan cututtuka, ko kuma cututtukan numfashi da ke da alaƙa da cutar, kuma yawancin suna warkewa.
A cikin kashi 14 cikin dari na masu cutar, COVID-19 na haifar da rashin lafiya mai tsanani wanda ke buƙatar asibiti yayin da sauran kashi 6 cikin dari ke buƙatar kulawa a cikin ɗakunan gaggawa.
Yawan mutuwar asibiti na COVID-19 ya kai kashi 4%.
A cikin wannan binciken, mun bincika yanayin yawan mutanen da ke kamuwa da cutar COVID-19 a kowace ƙasa a cikin Tarayyar Turai/EEA da Burtaniya (UK) kuma mun kwatanta shi da lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a cikin EU/EEA da UK da Italiya daga 31 ga Janairu zuwa 15 ga Maris 2020.
Masu cutar COVID-19 a EU/EEA da UK
Bayan kasar Sin, COVID-19 ya ci gaba da yaduwa zuwa wasu kasashe kuma cutar ta COVID-19 ta bazu a duk duniya kamar yadda ta faru a kasar nan.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar Eurosurveillance 2020 na 5 ga Maris, Spiteri da abokan aikinsa sun sanar da adadin mutanen da suka fara tabbatar da cutar COVID-19 a Turai bisa ga ma'anar WHO.
A cikin EU/EEA, Faransa ta gano mutane uku na farko da suka kamu da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
Ya zuwa ranar 15 ga Maris, 2020, an samu karuwar cutar COVID-19 a kasashe 30 na EU/EEA da kuma Birtaniya, wanda ya kai ga samun karuwar cutar ta COVID-19 39,768 da mutuwar 1,727, wanda 17,750 da mutuwar 1,441 a Italiya kadai.
Gano yawan masu kamuwa da cutar COVID-19 da kuma yadda take yaduwa a duniya
A Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Turai (ECDC), an ba da bayanan COVID-19 na kasashe a duniya daga tushen amintacce kamar Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, wanda ake sabuntawa kowace rana da karfe 8:00.
An yi amfani da wannan bayanin don nazarin yanayin COVID-19 a cikin EU/EEA da Burtaniya, da kuma kwatanta shi da Italiya.
Don nuna halin da ake ciki na COVID-19, mun tattara adadin COVID-19 na kwanaki 14, don haka muna mai da hankali kan yanayin yaduwar COVID-19 a cikin kowace ƙasa ta EU / EEA da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma nuna adadin masu kamuwa da cutar a kowace kasa a ranar 15 ga Maris 2020 da karfe 8:00 na safe idan aka kwatanta da Italiya tsakanin 31 ga Janairu da 15 ga Maris 2020.
Matsayi na COVID-19 a cikin EU/EEA da UK
Gabaɗaya, jimlar adadin COVID-19 a cikin EU/EEA da Burtaniya sun kasance iri ɗaya a cikin kwanaki 14 kamar yadda yake a lardin Hubei na China (Hoto 1).
Gabaɗaya a cikin EU/EEA da Burtaniya, adadin waɗanda suka kamu da COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu sannan ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (Sarin bayani).
Wannan ya samo asali ne daga karuwar adadin wadanda suka kamu da cutar a Italiya, amma duk sauran kasashen EU/EEA da Burtaniya sun sami karuwar adadin wadanda suka kamu da cutar ta COVID-19 (Sarin bayani).
Shafi na 2 ya nuna kimanin adadin masu kamuwa da cutar COVID-19, a cikin EU/EEA da UK da Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa, a ranar 15 ga Maris, karfe 8:00, sauran ƙasashe 15 na EU/EEA da Burtaniya sun riga sun nuna jimillar adadin waɗanda suka kamu da cutar kamar Italiya a cikin makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da suka kamu da cutar COVID-19 zai tashi nan ba da jimawa ba a EU/EEA da kuma Burtaniya.
Canje-canje a cikin adadin mutanen da ke kamuwa da cutar COVID-19 ya nuna cewa cutar tana yaduwa a cikin sauri a duk ƙasashe.
Wannan duk da cewa akwai matakan gwaji daban-daban a cikin kasashe, matakan kiwon lafiya na canzawa, ma'anar kamuwa da cuta na iya bambanta daga ƙasa zuwa ƙasa, da kuma ka'idoji daban-daban don zaɓar waɗanda za a gwada su don tabbatar da cutar ta COVID-19, gami da gwajin waɗanda ba su iya yin gwajin ba.
A farkon watan Maris na shekarar 2020, likitocin da ke yankunan da cutar ta addabi a Italiya sun bayyana cewa kusan kashi 10 cikin 100 na masu fama da COVID-19 na bukatar kulawar gaggawa, kuma kafofin yada labarai sun ce asibitocin gaggawa da ke yankunan sun riga sun karɓi adadin da ba za a iya wucewa ba.
Bayanai kan marasa lafiya da suka kamu da COVID-19 da aka kwantar a asibiti ko kuma a cibiyoyin kula da gaggawa a halin yanzu suna samuwa a matakin EU/EEA a halin yanzu kashi 6% da 1% na marasa lafiya ne (bayanai ba a bayyana su ba).
Duk da haka, dole ne a tattara shi sosai don tattara bayanai game da marasa lafiya da ake bi a halin yanzu ta hanyar mai da hankali kan adadin waɗanda suka kamu da cutar da kuma adadin waɗanda suka mutu.
Wani bincike na 2010/11 ya nuna cewa dakunan kula da gaggawa da dakunan kula da marasa lafiya masu saurin zuwa sun bambanta a Turai, daga gado 29.2 a Jamus zuwa 4.2 a kowace mutane 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da kayan aiki fiye da Italiya (suna da gadajen asibiti da marasa lafiya 12.5 ga mutane 100,000 a 2010).
A cikin sabon bayani na shida na saurin binciken ECDC game da COVID-19, an ba da misalai na yawan marasa lafiya da suka wuce matakin kulawa, tare da kimantawa ga kowace EU / EEA da Burtaniya na marasa lafiya na COVID-19 da ke asibiti da kuma kusan kashi 90% na marasa lafiya da suka wuce gado a cikin asibiti.
Tun da yake a yanzu wasu yankuna a cikin EU/EEA da UK suna da yawan masu kamuwa da cutar, kuma asibitoci da cibiyoyin kula da gaggawa suna karɓar mutane daga wani yanki, ya kamata a sami bayanai game da marasa lafiya da gadajen gaggawa a cikin ƙididdigar yanki na 2 (NUTS-2).
Misali na Italiya da kuma yanayin da ke faruwa a wasu ƙasashe ya nuna cewa annobar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da Burtaniya.
Saboda haka, ƙasashe, asibitoci da cibiyoyin kula da gaggawa dole ne su shirya don magance ci gaba da kamuwa da cutar SARS-CoV-2 a cikin al'umma tare da karuwar adadin masu cutar COVID-19 da ke buƙatar kulawa, musamman dangane da kula da marasa lafiya masu tsanani, kamar yadda yake faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin wani bincike na gaggawa na ECDC, yana da mahimmanci a yi amfani da gaggawa da kuma matakan gaggawa na gaggawa don hana yaduwar SARS-COV-2, saboda haka maye gurbin matakan rigakafi da kewaye da zaman gida, saboda hauhawar da ake tsammani na yawan masu kamuwa da cutar na iya hana masu yanke shawara da ma'aikatan asibiti isasshen lokaci don yin nazari, yarda da matakan da ya kamata su ɗauka da kuma aiwatar da su idan ba a dauki matakin farko ba.
Binciken gaggawa na al'amuran zai kuma nuna matakan kiwon lafiyar jama'a da ake ɗauka don rage tasirin cutar.
Akwai wasu 'yan hanyoyi da kasashe za su iya amfani da su don kara inganta matakan da suke dauka don rage yaduwar SARS-CoV-2 da kuma tasirinsa ga bangarorin kiwon lafiya.
Idan ba a yi haka ba, akwai yiwuwar cewa hukumomin kiwon lafiya na sauran ƙasashen EU/EEA za su fuskanci matsalar yawan masu fama da cutar a cikin kwanaki ko makonni masu zuwa.
Cutar cutar kwayar cutar korona ta 2019 (COVID-19), wacce ta haifar da cutar sankarar rai mai saurin kamuwa da cuta ta numfashi (SARS) SARS-CoV-2, ta kashe sama da mutane 3,000 tare da kamuwa da mutane sama da 80,000 a China da sauran kasashen duniya, kuma ta zama bala'i ga al'umma.
Kamar sauran kwayar cutar, SARS-CoV, wanda ya haifar da cutar sankarar bargo (SARS) a dubban mutane a 2003, SARS-CoV-2 na iya yaduwa ta hanyar ƙwayoyin cuta kuma yana da alamun bayyanar cututtuka iri ɗaya.
Amma COVID-19 ba shi da tsanani sosai kuma yana kashe mutane da yawa fiye da SARS duk da cewa yana yaduwa da sauri kuma yana shafar tsofaffi fiye da matasa da kuma maza fiye da mata.
Saboda yawan labaran da ake yi game da wannan sabon cutar, wannan takarda tana ƙoƙari ta samar da cikakken bayani game da wannan batun da ake ci gaba da bincike.
Muna mai da hankali kan mahimman bayanai kamar su ilimin cutar, abin da ke haifar da ita, kwayar cutar da ke haifar da ita, yadda ake ganewa, yadda ake bi da ita, yadda take yaduwa da kuma yadda za a hana ta.
Duk da cewa har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan cewa wannan binciken zai taimaka wajen gano da kuma kawar da wannan cuta mai barazana.
Bikin bazara na ranar 25 ga Janairu, 2020 ya kafa tarihi mai ban mamaki a cikin duk Sinawa waɗanda aka nemi su zauna a gida a duk lokacin hutu da makonni masu zuwa saboda annobar cutar ta sabon kwayar cutar.
Kwayar cutar tana da alaƙa da kwayar cutar korona (CoV) da ta haifar da annobar cutar zazzabin cizon sauro (SARS) a shekara ta 2003; saboda haka Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2 a ranar 11 ga Fabrairu 2020, kuma yanzu ana kiran cutar da ta haifar da cutar cutar CoV 19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu zuwa kasar da kuma kasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, sama da mutane 80,000 ne suka tabbatar da kamuwa da cutar COVID-19, fiye da 40,000 daga cikinsu an warke, kuma sama da mutane 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine "magabcin duniya na 1" kuma yana iya haifar da tasiri fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu, an buga sama da takardu 200 kan COVID-19 da suka hada da abubuwan da suka shafi kwayar cutar, cutar, asalinta, yadda ake bincikar ta da kuma yadda ake magance ta tun bayan da aka fitar da rahoton farko a ranar 7 ga Janairu 2020 wanda ya bayyana yanayin kwayar cutar da aka gano a cikin marasa lafiya daban-daban.
Wannan bita yana ƙoƙarin taƙaita binciken da aka riga aka yi akan wannan sabon batun kuma ana ci gaba da bincike sosai.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da sauran cututtukan da ke haifar da CoV, kamar su mura ta Gabas ta Tsakiya (MERS, wanda aka gano a shekarar 2012).
Za mu kuma duba darussan da muka koya har zuwa yanzu game da hana yaduwar cutar da kuma gano tushen cutar da kuma wasu tambayoyi masu gaggawa da ba a amsa ba.
Kwayoyin cuta na CoVs, waɗanda aka fi ɗauka a matsayin ƙwayoyin cuta masu saurin kashewa, suna haifar da nau'ikan 4 na mura na yau da kullun a kusan kashi 15%.
Amma, a wannan karni, mun fuskanci nau'ikan CoVs masu saurin kamuwa da cutar sau biyu, SARS-CoV da MERS-CoV, wadanda suka haifar da barkewar cutar a China a 2003 da Saudi Arabia a 2012, sannan suka bazu zuwa wasu kasashe da dama inda mutane da dama suka kamu da cutar.
Wannan shine dalilin da ya sa COVID-19 na zamani shine annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, an fara gano cutar da ba a san dalilin da ta haifar ba a Wuhan a ranar 31 ga Disamba, 2019, wanda kuma aka sanar da Hukumar Lafiya ta China.
Bayan kwana bakwai ne aka fitar da takardar bayanin cutar ta CoV.
An samu mutuwar farko a Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu cutar ta bazu cikin sauri zuwa wasu birane, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an bayar da rahoton cewa wasu likitoci sun kamu da cutar, wanda a bayyane yake cewa mutane na iya kamuwa da cutar.
A ranar 23 ga watan Janairu, an sanya birnin Wuhan a cikin kwanton bauna kuma an dakatar da dukkan hanyoyin sufuri.
A ranar 24 ga watan Janairu ne aka fara gudanar da binciken asibiti kan cutar, inda aka gano cewa daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka kai kasuwar ruwa ta Wuhan inda ake zargin cewa cutar ta samo asali ne daga wani dabba da ba a san ko wane irin kwayar cutar ba.
A ranar 30 ga watan Janairu, WHO ta ayyana annobar a matsayin bala'in da ke damun lafiyar duniya.
A lokacin da aka buga wannan rahoton, cutar ta riga ta bazu a duk ƙasar Sin da kuma wasu ƙasashe 50 a duniya (Hoto (Hoto 2).2).
Saboda yadda cutar ke yaduwa cikin sauri, ba shi da sauƙi a san yadda za ta sake dawowa da kuma sakamakon da za ta haifar.
A ranar 11 ga watan Fabrairun 2020, binciken da aka gudanar a cibiyoyi daban-daban kan marasa lafiya 8,866 da suka hada da marasa lafiya 4,021 da aka tabbatar da cutar COVID-19 ya ba da hoto mafi inganci game da yadda annobar ta kasance a shafin yanar gizon (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Mutane da ke kamuwa da cutar SARS-CoV-2 suna da shekaru daban-daban, amma sun fi yawa a tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na masu kamuwa da cutar sun haura shekaru 50, kuma kaɗan ne a ƙarƙashin shekaru 20, kuma kawai 14 daga cikinsu suna ƙasa da shekaru 10.
Maza sun fi kamuwa da cutar SARS-CoV-2 (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya yadu sosai a Hubei da yankuna da ke kewaye da shi.
A matsakaita, daga bayyanar COVID-19 zuwa ganowar cutar ya wuce kwanaki 5 (2-9).
A matsakaita, ya ɗauki kwanaki 4.8 (3,0-7,2) kafin ya nuna alamun cutar.
A matsakaici, mutum na farko da ya mutu ya kasance a cikin shekaru 9,5 (4,8-13) bayan bayyanar cutar.
Matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin.
Yawan masu kamuwa da cutar ya yi tashin gwauron zabi kafin 23 ga Janairu, 2020, wanda ya zo daidai da lokacin da mutane ke tafiya kafin bikin bazara a kasar Sin.
Adadin tabbataccen kamuwa da cutar ya kasance 1.44% (95% CI: 1.10-1.86%), kuma yawan mutuwar a cikin dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku da suka fi damuwa game da COVID-19 sune jinsi (maza), shekaru (≥60), da kuma tsananin zazzabi.
CoVs wani rukuni ne na manyan ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta.
Ana iya rarraba su zuwa nau'i huɗu, wato alpha, beta, gamma da delta, wanda a cikin su ne nau'in alpha da beta na CoVs ke iya cutar da mutane.
Glycoprotein (S) na kai tsaye yana kama ACE2 da DPP4 a cikin SARS-CoV da MERS-CoV, kuma sakamakon ya daidaita.
An gano kwayar RNA ta kwayar cutar zuwa kwayar halitta; bayan an kwafe kwayar cutar, RNA ta kwayar halitta tare da glycoproteins da kuma nucleocapsid proteins suna samar da kwayar halitta da ke haɗuwa da kwayar cutar plasma don samar da kwayar cutar.
An gano asalin kwayar cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV wanda ya yi daidai da kashi 99,98% na kwayoyin halittar kwayoyin halittar 10 da aka kama a wurin da cutar ta barke, a kasuwar kayan kiwon lafiya na Huanan a Wuhan.
A cikin wannan labarin, an nuna cewa SARS-CoV-2 yana da kwayoyin halittar da suka fi kama da SARS-CoV fiye da MERS-CoV.
A cikin microscopes na lantarki na bincike, an gano SARS-CoV-2 a cikin ƙananan ɓangarorin epithelium na numfashi na mutum.
An gano ACE2 a cikin mutum a cikin SARS-CoV-2 da SARS-CoV.
Amma kwayar cutar SARS-CoV-2 S tana da alaƙa da kwayar cutar ACE2 ta ɗan adam a ƙasa fiye da SARS-CoV, wanda ya dace da shawarar cewa SARS-CoV-2 ba ya cutar da marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya zama sabon ƙaramin kwayar halitta da aka gano wanda aka yi da kwayar halitta orf3b da kuma kwayar halitta da aka gano da aka yi da kwayar halitta orf8.
Kwayar cutar orf3b a cikin SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cutar da kuma hana IFNβ bayyana; amma kwayar cutar orf8 ba ta da wani nau'i ko yanayi da aka sani.
A ranar 18 ga Fabrairu, 2020, Zhou da abokan aikinsa sun sanar da tsarin microscopic na lantarki mai amfani da ƙananan zafin jiki (cryo-EM) na gano cikakken ACE2 na mutum a cikin kauri na 2.9 Å a cikin hanyar haɗin amino acid B0AT1.
Sun gano cewa wannan mahaɗin, wanda yake da tsari mai buɗe da rufe, ya haɗu a matsayin ƙwayoyin cuta biyu kuma mahaɗin ACE2-B0AT1 na iya haɗuwa da sunadarai biyu na S, wanda shine alamar bayyanar cutar ta CoV.
B0AT1 na iya zama mai amfani wajen gwajin maganin cutar SARS-CoV-2.
Dabbobi da suka fara kamuwa da cutar
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga kwari kuma ana iya daukarsu daga mutane zuwa dabbobi da raƙuma.
Ta hanyar yin amfani da kwayar cutar SARS-CoV-2 da sauran CoVs, an gano cewa cutar SARS-CoV-2 ce ta asali saboda sabon kwayar cutar tana da kamanceceniya da kashi 96% da nau'ikan CoVs guda biyu masu kama da SARS waɗanda aka samo daga kwari bat-SL-CoVZX45 da bat-SL-CoVZX21 .
Amma ba a san dabbar da ta fara kamuwa da cutar ba, wadda ta taimaka wa kwayar cutar ta iya yaduwa zuwa mutane, kuma ba a san yadda ake yaduwa ba.
Ji da abokan aikinsa sun ce macizai na iya zama masu cutar da kwayar cutar ta hanyar kwayar cutar da ta shafi kwayar S.
A cewar binciken, masu bincike a Guangzhou, China, sun ce dabbobi masu shayarwa, dabbobi masu shayarwa masu dogon baki da ake amfani da su a fannin kiwon lafiya a kasar Sin, na iya zama farkon wadanda suka kamu da cutar SARS-CoV-2 saboda kamannin kwayoyin halitta kashi 99% da aka gano a cikin kwayar cutar CoV da SARS-CoV-2.
Duk da haka, bambancin 1% da aka gano a cikin kwayoyin halittar biyu har yanzu yana da girma; don haka ana jiran sakamakon da zai ba da tabbaci (Figure (Figure 33).
Yawancin abubuwan da ke haifar da cutar SARS-CoV-2 ba a san su ba.
Kwayoyin cutar SARS-CoV da MERS-CoV na iya rayuwa na tsawon sa'o'i 48 a waje a yanayin zafi, har zuwa kwanaki 5 a yanayin zafi da ke ƙasa da 20 °C da yanayin zafi tsakanin 40% da 50%.
SARS-CoV-2 na iya samun halaye iri daya.
SARS-CoV-2 ya nuna rashin jurewa ga hasken rana da zafin jiki na 56 °C na tsawon mintuna 30; ether, 75% ethanol, kayan wankewa da ke dauke da corals, perastic acid, choroform, da sauran mai narkewa, amma ba chorionic acid ba, wanda zai iya kashe kwayar cutar sosai.
A cikin al'ada, mutane ba su da kariya ga SARS-CoV-2 kuma suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken bincike game da yadda jiki ke amsa cutar SARS-CoV-2.
Saboda haka, muna amfani da binciken da aka yi a baya game da wasu ƙwayoyin cuta na CoV, musamman SARS-CoV da MERS-CoV (Hoto (Hoto 4).4).
A cikin al'ada, bayan kamuwa da cutar, ana iya gano kwayar cutar ta hanyar rigakafin halitta ta hanyar masu rarrabe kwayar halitta (PRR) wanda ya ƙunshi masu karɓa irin na C-type, masu karɓa na TLR, masu karɓa na NLR da masu karɓa na RLR.
A cikin hanyoyi daban-daban, kwayar cutar ta haifar da zafin jiki, kumburi a cikin kwayoyin cutar, da kuma tarin furotin mai nau'in I (IFN) da aka kirkira don yaƙi da kwayar cutar wanda ke rage yaduwar kwayar cutar kuma yana sake cinye kwayar cutar.
Amma, kwayar N na SARS-CoV na iya taimakawa kwayar cutar ta zama mai kariya ga cutar.
Bayan wani lokaci, tsarin garkuwar jiki zai fara yaki da kwayar cutar.
Kwayoyin T sun ƙunshi CD4+ da CD8+ T kwayoyin da suke da muhimmiyar rawa a cikin rigakafi.
CD4+ T sun karawa kwayoyin B karfi don samar da kwayoyin cuta masu kare jiki, kuma CD8+ T sun kashe kwayoyin cutar.
T-cell masu taimako suna samar da sinadarin cytokines wanda ke taimakawa wajen rage zafin jiki don taimakawa wajen kare kwayoyin.
Amma CoVs na iya hana aikin kwayar T wanda ke haifar da mutuwar kwayar T.
Tsaron ruwa wanda ya ƙunshi masu hanawa kamar C3a da C5a da kuma rigakafi na jiki ma yana da mahimmanci wajen yaƙar kamuwa da kwayar cutar.
Misali, rigakafin da aka cire daga mai cutar da ya warke ya hana MERS-CoV.
Bugu da ƙari, yawan rigakafin jiki yana haifar da yawan ƙwayoyin cuta da ba su da kyau wanda zai iya haifar da lalacewar huhu da sauran gabobin, kuma, a sakamakon rashin aiki, rashin aiki da kuma mutuwa.
An gano cutar SARS-CoV-2 a cikin wadanda suka kamu da cutar, wanda ya fi shafar tsofaffi da ke fama da cututtuka daban-daban da kuma mata masu juna biyu.
Mutane da ke da kwayar cutar da yawa ko kuma waɗanda ke da ƙarancin garkuwar jiki suna da haɗarin kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin da SARS-CoV-2 ke rayuwa a cikin jiki kafin bayyanar cututtuka yana tsakanin kwanaki 1 zuwa 14, yawanci tsakanin kwanaki 3 zuwa 7 bisa ga binciken farko na marasa lafiya 425 a Wuhan.
Koyaya, nazarin marasa lafiya 1,099 ya nuna cewa lokacin bayyanar cututtuka shine kwanaki 3 gabaɗaya kuma yana tsakanin kwanaki 0 zuwa 24.
Binciken da aka yi kwanan nan, kamar yadda aka ambata a sama, ya nuna cewa lokaci da ake bukata don bayyanar cututtuka ya kai kwanaki 4.8 (3.0-7.2) bisa ga adadin marasa lafiya 8,866.
Yana da mahimmanci hukumomin kiwon lafiya su tsara lokacin keɓewa bisa ga ainihin lokacin da ake ɗauka don bayyanar cututtuka, don haka hana mutane masu kamuwa da cutar amma marasa alamun cutar daga yaduwa.
A yadda aka saba, ana bukatar a killace mutane da suka kamu da cutar ko kuma suka kamu da cutar na tsawon kwanaki 14.
Idan an tsawaita lokacin killacewar zuwa kwanaki 24?
Yawanci zazzabi shine farkon bayyanar cutar ta COVID-19, wanda ba ya tare da wata alama ko kuma tare da wasu alamun kamar tari mai zafi, wahalar numfashi, ciwon zuciya, ciwon kai, ciwon hanci, yawan zazzabi, ciwon kirji, tari, amai da amai.
Wasu marasa lafiya sun sami wahalar numfashi ko kuma rashin isashshen iskar oxygen a cikin jini bayan mako guda bayan kamuwa da cutar.
Marasa lafiya masu tsanani sun fara fuskantar matsalolin numfashi, hawan jini, matsalolin acid da kuma maganin jini.
Ya kamata a yi gwajin cutar a farkon lokacin da marasa lafiya ke da zazzabi ko alamun cututtukan numfashi da zazzabi, koda kuwa ba su nuna alamun cutar huhu ba.
Binciken da aka gudanar a ƙarshen Disamba na 2019 ya nuna cewa yawan alamun cutar ya kai kashi 98% na zazzabi, kashi 76% na tari, kashi 55% na matsalar iskar oxygen da kashi 3% na tari; kashi 8% na marasa lafiya da suka nemi na'urar taimakawa numfashi.
An yanke irin wannan shawarar ne a cikin binciken da aka yi kwanan nan na mutanen da suka kamu da cutar a cikin iyali da kuma wadanda ba su da alamun cutar.
Kamar wannan binciken, binciken da aka yi a shekarar 2012 na masu kamuwa da cutar ya nuna cewa masu kamuwa da cutar MERS-CoV sun kuma nuna zazzabi (98%), tari (47%) da kuma matsalar rashin iskar oxygen (55%) a matsayin alamun farko.
Amma kashi 80 cikin dari na masu cutar sun bukaci na'urar numfashi fiye da wadanda ke fama da COVID-19 kuma yawan mutuwar MERS ya fi na COVID-19.
An kuma lura da fitsari (26%) da ciwon makogwaro (21%) a cikin masu fama da cutar MERS.
A cikin marasa lafiya da ke fama da cutar SARS, zazzabi (99%-100%), tari mai saurin tashi (29%-75%), matsalolin iskar oxygen (40%-42%), tari (20-25%) da ciwon hanci (13-25%) sun kasance manyan alamun cutar kuma marasa lafiya da suka nemi na'urar taimakawa numfashi sun kai kimanin kashi 14%-20%.
A ranar 14 ga watan Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin dari yayin da aka tabbatar da cewa akwai mutane 66,576 a duniya.
Kamar yadda yake da kwayar cutar, adadin mutuwar SARS ya kai kashi 10% na 8,096 da aka tabbatar a watan Nuwamba na 2002.
A cikin cutar MERS, bisa ga binciken kamuwa da cutar na Yuni 2012, adadin mutuwar ya kai kashi 37% na 2,494 da aka tabbatar da cutar.
Binciken da aka yi a baya ya nuna cewa matsakaicin adadin kamuwa da cutar (R0) na SARS-CoV-2 ya kasance 6.47, matsakaicin kamuwa da cutar 95% (CI) ya kasance 5.71-7.23, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4 kawai.
Ana iya ganin kwatancen SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, yawan mutuwar da R0 a cikin tebur Table 1.1.
A cikin wannan labarin, an bayyana cewa, cutar SARS-CoV-2 tana da cutar da ke iya yaduwa fiye da MERS-CoV da SARS-CoV, amma tana da cutar da ke kashe mutane da yawa.
Wannan shine dalilin da ya sa cutar SARS-CoV-2 ta fi MERS-CoV da SARS-CoV ƙarfi.
Sau da yawa, ana ganin masu bautar gumaka a cikin iyali ɗaya ko a cikin ikilisiya ɗaya ko kuma a cikin jirgin ruwa ɗaya.
Yawancin lokaci marasa lafiya sun kasance sun ziyarci ko sun zauna a Wuhan ko wasu yankuna da ke fama da cutar ko kuma sun yi hulɗa da mutane masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu kafin kama su.
Koyaya, an gano cewa mutane na iya zama tare da kwayar cutar ba tare da wata alama ba fiye da makonni biyu kuma waɗanda suka warke kuma aka sallame su daga asibiti na iya kasancewa tare da kwayar cutar, wanda ke ba da shawarar tsawaita keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini (musamman ƙwayoyin jini) a cikin kwanakin farko.
Misali, mafi ƙarancin kwayar halitta a cikin ƙwayoyin jini shine 4×109/L tare da kwayar halitta 1×109/L, kuma an gano ƙimar aminotransferase (AST) da kwayar cutar a cikin jini a cikin marasa lafiya 1,099 na COVID-19.
An samu karuwar matakan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
A cikin marasa lafiya masu tsanani, matakin D-dima, wanda shine ƙwayoyin cuta da ke haifar da lalacewar fibrin da ke cikin jini, ya kasance mai girma, kuma yawan kwayoyin sun ragu.
Rashin daidaituwa na bugun jini na cikin zuciya yana faruwa a yawancin masu cutar COVID-19 kuma ana nuna shi ta hanyar ƙuƙwalwar ƙuƙwalwa ko kuma ƙarancin ƙuƙwalwar ƙuƙwalwa (GGO).
Sau da yawa marasa lafiya suna samun ciwon hauka, ciwon huhu da kuma matsalar numfashi mai tsanani (ARDS).
A lokacin da ake fama da matsalar numfashi mai tsanani (ARDS), zafin jiki, tarin ruwa da kuma kumburi na huhu suna da matukar tasiri ga isar da iska.
Rashin aiki na nau'ikan pinemosites na I da II yana rage yawan kwayar halitta wanda ke rage sararin samaniya tsakanin ruwa da kuma sa jijiyoyin su ninka, don haka rage ikon numfashi na huhu kuma yana kara haɗarin rashin aikin huhu.
Saboda haka, mummunan tasirin radiyo mai saurin motsa jiki sau da yawa yana haifar da mummunan cutar.
A ranar 18 ga watan Fabrairun 2020, bincike na farko na COVID-19 ya nuna ciwon hauka, kumburi a cikin ƙwayoyin huhu, ƙwayoyin cuta na ƙwayoyin cuta, da ƙwayoyin cuta masu haɗuwa da ƙwayoyin cuta a cikin huhu na marasa lafiya da suka mutu, wanda ya dace da asalin kamuwa da cutar ta ARDS, wanda ya yi daidai da na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar tsarin RT-PCR na dakin gwaje-gwaje a matsayin babban abin da aka yi amfani da shi wajen gwajin COVID-19.
Koyaya, saboda yawan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙ
Haka lamarin yake da gwajin SARS.
Saboda haka, tattara bayanan cututtuka, alamun cututtuka, gwaje-gwajen gwaje-gwaje da kuma sakamakon gwajin sun zama da mahimmanci kuma dole ne don samar da ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, wata ƙungiya karkashin jagorancin Feng Zhang ta bayyana wata yarjejeniya ta amfani da tsarin SHERLOCK mai tushen CRISPR don gano SARS-CoV-2, wanda ke gano nau'ikan  RNA na SARS-CoV-2 a cikin 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 a kowace microliter da aka shigar) ta amfani da  volts a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai rikitarwa ba.
Ana fatan cewa wannan sabon tsarin zai iya inganta ingancin idan aka gwada shi a gwajin asibiti.
Saboda rashin sanin sabon CoV, likitoci na iya zama kusa da marasa lafiya na COVID-19 a farkon lokacin da suke gwada magungunan da aka bayar ko aka yi niyya kafin magance wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan da ke haifar da kwayar cuta (Table (Table 2).2).
Wadannan sun hada da magungunan da ake amfani da su da kuma wadanda za a iya amfani da su tare da magungunan rigakafi, magungunan hana kamuwa da cuta, magungunan hana kumburi, plasma da aka samu daga marasa lafiya da suka warke, magungunan gargajiya na kasar Sin, da kuma taimakon zuciya.
An yi niyyar amfani da plasma da aka samu daga marasa lafiya da suka warke don magance cutar.
Kamfanonin samar da magunguna suna samar da kwayoyin cuta da kuma alluran rigakafi da ke yaki da cutar.
SARS-CoV-2 yana da tasiri sosai a cikin huhu kuma yana iya yin tasiri, a ƙananan matakan, ga sauran abubuwan da ke samar da ACE2 kamar su ƙwayoyin cuta da koda.
Duk da haka, rashin aiki da rashin aiki na tsarin numfashi sune manyan matsalolin lafiyar marasa lafiya da kuma babban dalilin mutuwa.
Saboda haka taimakon numfashi yana da mahimmanci wajen rage alamun cutar da kuma ceton rayuka kuma ya hada da samun iskar oxygen gaba daya, samun iskar oxygen mai yawa, sanya na'urar numfashi mai sauki da kuma numfashin na'urar numfashi saboda cutar.
Ya kamata a hana marasa lafiya da ke da alamun ciwon numfashi mai tsanani maganin ECMO, wanda shine maganin maye gurbin numfashi na zuciya da na huhu wanda ake amfani dashi wajen kula da wadanda ke da ciwon zuciya ko na numfashi.
Bugu da ƙari, kulawa da aikin koda, rigakafi da magani na cututtuka da hawan jini, da kuma kula da aiki na kwayoyin halitta na da amfani ga marasa lafiya da SARS-CoV-2.
An san cewa yawan sitokin yana faruwa ne saboda yawan rigakafin da ke tattare da cutar SARS da MERS.
Cytokine yana da yawa a cikin tsarin amsawar rigakafi wanda aka nuna ta hanyar gano wasu cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Wadannan kwayoyin suna sa kwayoyin rigakafi su saki kwayoyin da ba su da wuri da yawa kuma suna haifar da ARDS da kuma rashin aiki na kwayoyin.
Rage rigakafi yana da amfani wajen magance yawan cytokines, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da maganin corticosteroid da tosilismab, wanda shine kwayar cutar corona guda daya da ke yaki da IL6, wajen maganin yawan cytokines.
Sauran magungunan rage rigakafi na maganin cytokine sun hada da rage karfin kwayar cutar T; hana IFN-γ, IL-1, da TNF; hana JAK; maganin hana yaduwa; rage alamun cytokine 4; da kuma maganin hana HDAC.
Magungunan hana kumburi, kamar su maganin hana kamuwa da cuta, an yi amfani da su sosai wajen maganin SARS domin rage yawan cutar da cutar ke haifarwa.
Koyaya, shan magungunan anti-inflammatory da yawa bai yi tasiri ba a cikin cututtukan huhu masu rauni a cikin marasa lafiya da SARS da COVID-19.
Maimakon haka, zai iya haifar da matsaloli masu tsanani, musamman cutar osteoporosis (AVN), wanda ke da tasiri mai tsanani a kan maganin cututtuka.
Koyaya, an ba da shawarar cewa a ba da ƙananan allurai na corticosteroids ga marasa lafiya masu cutar COVID-19 a cikin ɗan gajeren lokaci kuma a hankali.
A lokacin rubuta wannan rahoto, an gano kwayar cutar a cikin mutum mai lafiya.
Amma allurar remdesivir, wacce take kama da nucleotide, ta tabbatar da tasiri ga Amurkawa da ke fama da COVID-19.
Remdesivir wani sabon maganin rigakafi ne da Gilead ta samar don maganin cututtukan Ebola da Marlburg.
Daga baya, an nuna cewa remdesivir yana iya kashe wasu ƙwayoyin cuta masu amfani da RNA, ciki har da MERS da SARS.
Bisa ga abin da aka ambata, Gilead ta ba da maganin ga China don yin bincike biyu a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana jiran sakamakon.
Bugu da kari, baricitinb, interferon-α, lopinavir/ritonavir da ribavirin sun nuna cewa suna da tasiri wajen magance marasa lafiya da ke fama da alamun rashin numfashi mai tsanani.
Ciki, amai, kumburi, kumburi da sauran matsaloli masu tsanani na iya faruwa sakamakon hada maganin lopinavir/ritonavir.
Ya kamata a lura da hulɗar wannan magani da sauran magunguna da ake amfani da su a cikin marasa lafiya.
An cire plasma daga marasa lafiya da suka warke ta hanyar aikin antibody
Ana yin amfani da jinin mutanen da suka warke daga kamuwa da cuta don magance wasu cututtuka ko kuma hana mutane marasa lafiya kamuwa da cutar.
Gaskiya ne, marasa lafiya da suka warke suna da yawan ƙwayoyin cuta masu guba da ke yaki da kwayar cutar a cikin jinin su.
Kwayoyin rigakafi na jiki sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaki da kwayar cutar da kuma wasu kwayoyin da ke gano kwayoyin cutar kuma suna kashe su.
Bisa ga abin da aka ambata, za a cire plasma daga jinin wani rukuni na marasa lafiya da suka warke daga COVID-19 sannan a yi allurar a cikin marasa lafiya 10 masu tsanani.
Alamomin sun fara samun sauki cikin awa 24, tare da raguwar kumburi da yawan kwayar cutar da kuma karuwar iskar oxygen a cikin jini.
Amma ana bukatar bincike da kuma bayani don a iya amfani da shi a cikin marasa lafiya da yawa kafin a samar da magunguna na musamman.
Bugu da ƙari, saboda tasirin maganin, wasu daga cikin tasirin plasma ya kamata a bincika su da kyau.
Alal misali, ƙwayoyin cuta na iya ƙaruwa sosai kuma su sa a yi sinadarin cytokines, waɗanda za su iya zama guba mai haɗari.
Yawancin lokaci, ana samun ƙananan ƙwayoyin rigakafi a cikin jini kuma ana buƙatar ƙarin plasma don kula da marasa lafiya masu tsanani.
Ba shi da sauƙi a samar da takamaiman rigakafi a cikin lokaci mai sauri don yaƙi da annobar duniya.
Saboda haka, yana da mahimmanci kuma mai mahimmanci a cire kwayoyin B daga marasa lafiya da suka warke sannan a gano kwayar cutar ta rigakafi ko kuma a gwada rigakafin rigakafi da suka dace da sunadarai masu mahimmanci na kwayar cutar.
Ta haka, za mu iya ƙara yawan ƙwayar jikinmu.
An yi amfani da maganin gargajiya na kasar Sin (TCM) don magance cututtuka daban-daban a cikin Sin shekaru dubbai.
Amma aikinsa ya dogara ne da haɗuwa da magunguna daban-daban a cikin yanayin da ya dace don gano cutar bisa ga tsarin da ake amfani da shi a TCM.
Yawancin magunguna masu tasiri ba a san su ba ko kuma ba a san su sosai ba saboda wahalar sarrafawa da kuma kula da magungunan ko abubuwan da aka haɗa su.
A halin yanzu, saboda rashin takamaiman maganin COVID-19, TCM ya zama ɗayan magungunan magani mafi mahimmanci ga marasa lafiya masu saurin bayyanar cututtuka ko marasa lafiya da suka warke.
Misali, an gano cewa shu Feng Jie Du da Lian Hua Qing Wen sun iya taimakawa wajen maganin COVID-19.
An samu gagarumar farfadowa daga cutar COVID-19 a larduna da dama na kasar Sin da suka yi amfani da maganin TCM a kashi 87% na marasa lafiya na gida, kamar su Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da a lardin Hubei, wanda ya yi amfani da maganin TCM a kashi 30% na marasa lafiya na COVID-19, an samu raguwar farfadowa (13%).
Amma wannan kwatancen bai kai na'urar ba saboda akwai wasu abubuwan da ke da tasiri kamar yawan marasa lafiya da rashin lafiya da ya kamata a yi la'akari da su a cikin binciken.
A ranar 18 ga watan Fabrairun 2020, Boli Zhang da abokan aikinsa sun buga wani bincike da ke kwatanta maganin da ake yi a Turai da Amurka da kuma maganin da ake yi ta hanyar hada WM da TCM.
Sun gano cewa lokaci da ake bukata don dawo da zafin jiki, bayyanar cututtuka da kuma asibiti ya fi guntu a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Abin sha'awa, an ga raguwar yanayin tsananin bayyanar cututtuka (daga mai sauƙi zuwa mai tsanani) a cikin rukunin WM + TCM fiye da rukunin WM kawai (7.4% zuwa 46.2%) kuma ƙananan mutuwar a cikin rukunin WM + TCM fiye da rukunin WM kawai (8.8% zuwa 39%).
Duk da haka, amfanin da kuma ingancin TCM har yanzu suna jiran ƙarin bincike a kan mutane da kuma cibiyoyi da yawa.
Zai kuma zama da kyau a nuna yadda maganin yake aiki kuma a bayyana abubuwan da ke cikin TCM da ke da amfani a cikin shi kaɗai ko a hade tare da wasu idan ya yiwu.
Marasa lafiya da ake zargi ko kuma aka tabbatar da cutar COVID-19 suna da matukar tsoron kamuwa da cutar, kuma waɗanda aka keɓe su ba sa jin daɗi, suna jin kadaici da haushi.
Hakanan, alamun cututtuka kamar zazzabi, rashin numfashi, tari da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan da cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
A farkon barkewar cutar SARS, an gano wasu cututtukan kwakwalwa da suka hada da damuwa mai tsawo, damuwa, fargaba, tashin hankali, rashin hankali, rashin nutsuwa, da kuma tunanin kashe kansa.
Binciken da aka yi na tuntuɓar mutum da kuma keɓewa na doka a matsayin wani ɓangare na matakan COVID-19 da hukumomin kiwon lafiya na jihar ke ɗauka na iya haifar da ƙarin damuwa da laifi game da tasirin kamuwa da cuta, keɓewa da nuna bambanci ga dangi da abokai.
Saboda haka, ya kamata a samar da sabis na kiwon lafiya na hankali ga waɗanda ke da cutar COVID-19, waɗanda ake zargi da kamuwa da cutar, waɗanda suka sadu da su, da kuma sauran mutanen da ke buƙatar taimako gaba ɗaya.
Taimakon jin kai ya kamata ya kasance tare da kafa ƙungiyoyin kula da lafiyar kwakwalwa na ƙungiyoyi daban-daban, ingantaccen tsarin don ci gaba da sabuntawa game da cutar SARS-CoV-2 da kuma kula da marasa lafiya da kuma amfani da kayan aiki da aikace-aikacen fasaha don hana mutane kusanci.
Ingantattun alluran rigakafi suna da mahimmanci don hana kamuwa tsakanin dabbobi masu kamuwa da cutar da mutane masu kamuwa da cutar da sauran dabbobi ko mutane waɗanda ke iya kamuwa da cutar kuma galibi suna haɗuwa da maganin antiviral don yaƙi da kamuwa da cutar ta sabon kwayar cutar.
An yi ƙoƙari wajen samar da alluran rigakafin da aka yi amfani da su a kan furotin S don samar da rigakafin cutar na dogon lokaci ko kuma inganta ƙarfin jiki na SARS-CoV.
An gwada allurar rigakafi da ke amfani da kwayar cutar SARS a kan dabbobi.
Amma ba za a iya sanin amfanin wannan maganin a cikin dabbobi ko kuma a cikin tsofaffi da marasa lafiya masu rai ba kuma a cikin rigakafin kamuwa da kwayar cutar da ke da alaƙa da dabbobi ba har sai an gudanar da binciken asibiti.
Wannan na iya kasancewa saboda shekaru 17 da barkewar cutar SARS, babu wanda ya kamu da cutar.
A gefe guda, an ci gaba da samun karamin adadin mutane da suka kamu da cutar MERS a Gabas ta Tsakiya, kuma cutar ta yadu zuwa wasu yankuna saboda yawan dabbobi da ke yaduwa a yankunan da cutar ta fi yawa.
An tsara hanyoyin rigakafin MERS ta amfani da kwayar cutar da aka lalata, DNA purasimides, kwayar cutar mai tsiro, ƙananan ƙwayoyin cuta, ƙwayoyin cuta masu kama da kwayar cuta da ƙwayoyin cuta masu ƙyalli kuma an gwada wasu daga cikin waɗannan hanyoyin a cikin dabbobi.
Samar da ingantacciyar allurar rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafin cutar da ke hana su kamuwa da cutar, abu ne da ake bukata da kuma gaggawa don magance cutar.
Amma yana da wahala a warware wannan matsalar saboda tsawon lokacin da ake buƙata (kamar watanni 18) don samar da allurar rigakafi tare da bambance-bambancen CoVs.
A matsayin sabon cuta, COVID-19 ya fara nuna hanyoyin warkarwa ga dubban masu kamuwa da cutar.
Sau da yawa, marasa lafiya suna iya samun sauƙi.
Amma, kamar SARS da MERS, COVID-19 na da tasiri sosai kuma yana haifar da mutuwar marasa lafiya.
Saboda haka, samar da hanyoyin magance cutar na da muhimmanci domin asibitoci da asibitoci su iya amfani da su yadda ya kamata ko kuma a wuraren da ba su da isassun kayan aiki.
Dangane da binciken asibiti da aka gudanar zuwa yanzu, abubuwan da ke biyo baya na iya shafar ko kuma haifar da cutar COVID-19 (Table (Table 33):
Shekaru: Shekaru shine babban abin da aka yi la'akari da shi wajen tantance cutar SARS, haka kuma COVID-19.
COVID-19 ya fi rinjayar mutanen da ke tsakanin shekaru 30 zuwa 65 wanda kashi 47.7% na su sun haura shekaru 50 a cikin binciken da aka gudanar kan marasa lafiya 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da suka nemi shiga sashen gaggawa sun fi yawan samun wasu cututtuka da matsaloli kuma sun fi tsofaffi fiye da waɗanda ba su nemi ba (yawan shekaru 66 zuwa 51), wanda ke nuna cewa shekaru na da tasiri sosai a cikin cutar COVID-19.
Jima'i: Maza sun fi kamuwa da cutar SARS-CoV-2 (0.31/100,000) fiye da mata (0.27/100,000), kamar yadda aka bayyana.
Cutar cututtuka: Marasa lafiya na COVID-19 da ke buƙatar shiga sashen gaggawa suna da cututtukan zuciya da suka fi tsanani da kuma ciwon zuciya.
Rashin aikin zuciya kuma ya kasance babban dalilin mutuwar masu cutar SARS.
An nuna cewa SARS-CoV-2 na iya kama kwayar cutar ACE2 a kan kwayar cutar, wanda hakan zai iya haifar da rikice-rikice a cikin marasa lafiya na COVID-19.
Ya kamata a ce shekarun da mutum yake da shi na rashin lafiya suna da nasaba sosai kuma suna iya shafan juna.
Sakamakon gwaji na musamman: Matsakaicin sinadarin da ake kira CRP a cikin jini yana nuna tsananin kumburi ko ciwon jijiya kuma an nuna cewa yana iya zama ɗayan abubuwan da ke da tasiri a cikin maganin cutar, maganin magani da kuma dawowar mai haƙuri.
An kuma gano alaƙa tsakanin CRP da tsufa da kuma kamuwa da COVID-19.
Bugu da ƙari, yawan ƙwayoyin cuta na LDH, AST, ALT, da CK na iya nuna sakamakon maganin.
Wadannan cututtuka suna da yawa a cikin kwayoyin halitta, musamman a cikin zuciya da kuma a cikin duhu, kuma ana fitar da su lokacin da aka lalata sassan jiki.
Saboda haka, su ne alamun cututtukan zuciya ko kuma duhu.
Alamun farko: Yin amfani da abin kwantar da hankula da kuma bayyanar cututtukan da ke faruwa na ɗan lokaci ya kamata a kula da su da kuma sauran batutuwa a cikin shirin rigakafin COVID-19.
Amfani da maganin hana kumburi: Kamar yadda aka ambata a sama, maganin hana kumburi shine maganin hana kumburi wanda aka fi amfani dashi azaman magani na taimako don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Saboda yawan maganin corticosteroid da aka yi amfani da shi a cikin marasa lafiya masu cutar SARS, yawancin marasa lafiya sun sami nasarar warkewa daga cututtukan ƙashi da ke haifar da nakasa da rashin lafiya.
Saboda haka, idan ya zama dole, masu fama da COVID-19 ya kamata su sha magungunan hana kumburi a cikin ƙarancin lokaci.
Rashin ƙarfi: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19, marasa lafiya da yawa sun sami rauni na musamman saboda tsawan keɓewa da matsanancin damuwa da kuma asarar dangi.
Yana da mahimmanci a ba wa waɗannan marasa lafiya shawara ta zuciya da tallafi na dogon lokaci don taimaka musu su warke daga gajiya da dawowa cikin rayuwar yau da kullun.
Dangane da binciken da aka yi a kan marasa lafiya zuwa yanzu, COVID-19 ya bayyana yana da halaye daban-daban da SARS.
Baya ga kamuwa da cutar ta numfashi ta zuciya, SARS-CoV-2 na iya shiga cikin hanci da hanci cikin sauƙi kuma ya haifar da ƙananan ko babu alamun cutar a farkon kwanakin kamuwa da cutar, kamar yadda yake tare da sauran ƙwayoyin cuta na mura.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon kwanakin ko kuma lokacin da suka fara nuna alamun cutar na iya samun adadin kwayar cutar da ke aiki a cikin jiki, wanda hakan ke sa ya zama da wuya a magance cutar.
Amma an nuna cewa SARS-CoV yana yaduwa ne a lokacin da marasa lafiya suka kamu, saboda yawancin masu kamuwa da cutar ba su da lafiya a farkon kwanakin.
Saboda haka, cutar COVID-19 ta fi SARS tsanani da kuma wahalar sarrafawa.
A halin yanzu akwai matakan tsaro da yawa a kasar Sin kamar dokar hana fita a Wuhan da garuruwan da ke kewaye da ita da kuma ci gaba da keɓewar kusan dukkan jama'a don hana yaduwar SARS-CoV-2.
Duk da cewa matakan sun yi matukar tasiri ga tattalin arziki da sauran bangarorin kasar, yawan sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa annobar ta koma baya.
Wani kwatanci mai ban sha'awa shine cewa cutar za ta ƙare a watan Maris, sa'annan lokacin dawowa cikin al'ada zai kasance tsakanin watanni 3 zuwa 4.
Amma wasu masana ba su da irin wannan tabbacin.
Paul Hunter da abokan aikinsa sun gano cewa COVID-19, wanda ya fi SARS yaduwa, ba zai kare ba har zuwa 2020.
Ira Longini da abokan aikinsa sun tsara tsarin tsinkaya na ƙarshen annobar kuma sun yi hasashen cewa SARS-CoV-2 na iya shafar kashi biyu bisa uku na yawan mutanen duniya.
Wani rukuni na mutanen Kanada sun sanar da cewa an gano SARS-CoV-2 a cikin kwayar cutar ta zuciya da hanci na marasa lafiya da suka warke makonni 2 bayan an sallame su daga asibiti, wanda ke nuna cewa sabon kwayar cutar na iya dawowa kamar yadda cutar ta kamu da ita.
Amma akwai alamun da ke nuna cewa kasar Sin tana da kyakkyawan sakamako dangane da raguwar adadin sabbin masu kamuwa da cutar, wanda ke nuna cewa matakan da aka dauka na iya zama masu tasiri.
A baya an yi hasashen cewa mutane miliyan daya ne za su kamu da cutar Ebola kuma dubu dari biyar za su mutu.
Amma saboda tsauraran matakan killace mutane, an sami nasarar shawo kan cutar.
Kamar SARS-CoV, akwai yiwuwar cewa SARS-CoV-2 zai iya zama ɗan ƙaramin ƙwayoyin cuta da ke iya ɓacewa ko kuma ya zama ƙwayoyin cuta masu ƙarancin kisa a cikin mutane.
Ana iya ganin kwatancen cutar COVID-19 da SARS da MERS a cikin wannan labarin (Hoto 55).
SARS-CoV-2 yafi yaduwa ta hanyar tari ko fitsari, kuma mutum na iya kamuwa da cutar ta hanyar taɓawa da abubuwan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin fitsari, wanda ke nuna cewa akwai yiwuwar samun sabon hanyar yaduwar cutar ta hanyar taɓawa ta bakin mutum.
Wani binciken da aka yi kwanan nan a kan marasa lafiya 138 ya nuna cewa kashi 41% na masu cutar na iya kamuwa da cutar ta hanyar kamuwa da cuta a asibiti, gami da marasa lafiya 17 da suka riga sun kamu da cutar da kuma likitoci 40.
Saboda haka, ana bukatar kulawa sosai don kare mutane, musamman likitoci, ma'aikatan kiwon lafiya, dangin marasa lafiya, abokan aiki, har ma da matafiya waɗanda zasu iya haɗuwa da marasa lafiya ko kuma mutanen da ke da cutar.
Hanyar farko da za a iya amfani da ita don rage haɗarin kamuwa da cutar ita ce sanya abin rufe fuska; amfani da kayan rufe fuska na likita da N95 (matakin # 1860s) yana taimakawa wajen hana yaduwar kwayar cutar.
Takunkumin likita yana hana ƙanshin da zai iya shiga cikin iska ko kuma ya taɓa abubuwa daga wanda ya kamu da cutar.
Amma N95 (matakin # 1860s) shine kawai zai iya kare mutum daga kamuwa da kwayar cutar da ke tafiya a iska mai nisa daga 10 zuwa 80 nm, wanda kashi 5% na kwayar cutar ke iya wucewa; SARS-CoV-2 yayi daidai da SARS-CoV a girma kuma duka suna da nisan 85 nm.
Saboda wasu yankuna na iya shiga cikin masks na asibiti guda biyar a jere, likitoci da ke tuntuɓar marasa lafiya a kai a kai dole ne su sanya N95 (matakin # 1860s) maimakon masks na asibiti.
Baya ga sanya abin rufe fuska, likitoci dole ne su sanya riguna na musamman don rage haɗarin kamuwa da kwayar cutar.
Ƙwayoyin cuta na iya kamuwa da mutum ta fuska.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; wanda ke nuna cewa kwayar cutar ta shiga jikinsa ta fuskarsa.
Saboda haka, likitoci suna bukatar su saka abin rufe fuska ko kuma tabarau masu gani sa'ad da suke kula da marasa lafiya.
Ga mutanen da ke zaune a yankunan da cutar ta kamu da su ko kuma waɗanda ke da saurin kamuwa da cutar, yana da matukar muhimmanci kowa ya wanke hannayensa da sabulu mai tsabta, ya yi ƙoƙarin ware kansa, ya zauna a gida, kuma ya guji hulɗa da mutanen da ke da cutar.
Ya kamata mutane su kasance nesa da mai haƙuri na tsawon mita ɗaya da rabi.
Waɗannan ayyuka hanya ce mai mahimmanci don rage haɗarin kamuwa da cutar da hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya shigo cikin mutane a matsayin sabon kwayar cuta, yawancin abubuwan da ke tattare da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020 ya kamata ya haifar da babban damuwa a cikin China, wanda ke tunawa da barkewar cutar SARS a 2003.
Amma, a ranar 19 ga Janairu, 2020, shugaban Wuhan Center for Disease Control ya tabbatar da cewa sabon kwayar cutar ba ta da yaduwa sosai kuma mutane ba su da yaduwa sosai don haka magance cutar ba matsala.
Wannan sakon ya rage yawan damuwa a cikin jama'a, musamman a lokacin da kasar ke shirin bikin bazara, kuma damar da za a iya hana cutar a Wuhan ta ragu.
Cibiyoyin rigakafin cutar na kasar Sin na iya koyon darasi daga wannan babban labarin kuma suyi manyan canje-canje a nan gaba.
Misali, waɗannan cibiyoyin suna buƙatar (1) kasancewa masu hankali sosai wajen ba da sanarwar jama'a saboda jama'a suna la'akari da kowane kalma kuma suna canza halayensu da shawarwarinsu; (2) bin ƙarin bayanan da ba su dace ba daga asibitoci da yanke shawara mai dacewa maimakon jiran rahotanni daga likitoci ko hukumomi a cikin tsari; (3) ɗaukar ƙarin matakan da ke nufin hana barkewar cutar gaba ɗaya maimakon ƙoƙarin sauƙaƙa jama'a; da (4) shirya taron karawa juna sani na musamman akai-akai don taimakawa jama'a su sami ƙarin sani game da cututtukan cututtukan cututtuka da kuma gwadawa da inganta matakan magance su a yanayi daban-daban.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya yaɗu ko'ina a ƙasar Sin da kuma wasu ƙasashe 50 a dukan duniya a lokacin da muke rubuta wannan rahoto.
Saboda kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, cutar ta COVID-19 ta haifar da tunanin cewa SARS ta dawo.
Amma akwai wasu abubuwa masu banbanci tsakanin COVID-19 da SARS, wadanda suke da mahimmanci wajen hana barkewar cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa kuma ya fi rinjayar maza fiye da mata, kuma tsufa da yawan mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS ya fi COVID-19 mutuwa (10.91% zuwa 1.44%).
Masu cutar COVID-19 suna yada kwayar cutar ko da ba su da alamun cutar, kuma masu cutar SARS suna iya yada cutar a lokacin da suka kamu, wanda hakan ya sa ya fi ƙarfin hana yaduwar COVID-19 fiye da SARS.
Wannan yana daga cikin dalilan da yasa SARS-CoV-2 ke yaduwa cikin sauri da kuma fadin kasa fiye da SARS-CoV.
Gwajin RNA da aka amince da shi don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya da COVID-19.
A wani bangare kuma, marasa lafiya da suka warke na iya sake kamuwa da kwayar cutar.
Duk wannan yana ƙara haɗarin yaduwar kwayar cutar.
Duk da wannan matakin da aka dauka na binciken COVID-19, akwai wasu muhimman tambayoyi da yawa da har yanzu ba a amsa ba:
Daga ina SARS-CoV-2 ya fito?
Duk da cewa akwai daidaituwa na kashi 96% tsakanin SARS-CoV-2 da kuma wasu nau'ikan CoVs guda biyu masu kama da SARS da suka samo asali daga kwari, ba za mu iya tabbatar da cewa SARS-CoV-2 ya samo asali daga kwari ba.
Wanne dabba ce ta fara kamuwa da kwayar cutar daga kwayar cutar da ta samo asali, alal misali, daga kwari, kuma ta kamu da ita ga mutane?
Idan ba mu san amsoshin tambayoyi 1 da 2 ba, ba za mu iya dakatar da yaduwar kwayar cutar ba, kuma za a iya sake barkewar cutar a kowane lokaci.
Ko da yake gwajin kwayoyin halitta da kwayoyin halitta sun nuna cewa SARS-CoV-2 yana da tasiri akan ACE2, ta yaya kwayar cutar ta shiga cikin kwayoyin halittar iska kuma ta haifar da canje-canje na cututtuka na gaba?
Shin kwayar cutar tana kama kwayoyin da ke samar da ACE2 a wasu sassan jikin mutum?
Har sai mun sami amsoshi na gaskiya ga waɗannan tambayoyin, ba za mu iya gano cutar da sauri ba kuma mu iya magance ta yadda ya kamata.
Har yaushe za a ci gaba da wannan annobar?
Ta yaya kwayar cutar ke canzawa yayin da take yaduwa tsakanin mutane?
Shin za ta zama annoba ta duniya, za ta zama kamar SARS ko kuma za ta sake dawowa kamar mura?
Neman amsoshin waɗannan da wasu tambayoyi masu yawa yana da muhimmanci amma zai iya ɗaukan lokaci.
Amma, duk abin da ya faru, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mutane su koma rayuwarsu ta yau da kullun.
Dabbobi sun kamu da kwayar cutar korona
A cikin shekaru dubu da suka gabata, kwayar cutar coronavirus (CoVs) ta canza daga mutum zuwa dabba.
Kafin 2003, an san cewa CoVs biyu (HCoVs) masu kamuwa da mutane suna haifar da rashin lafiya mai sauƙi, kamar yadda cutar mura ta al'ada take.
Cutar cutar sankara (SARS) da cutar sankara ta Gabas ta Tsakiya (MERS) sun kawo sauyi a yanayin da cutar HCoV za ta iya zama mai tsanani da kuma barazana ga rayuwa.
Cutar SARS-CoV-2 da ta barke a tsakiyar shekarar 2019 a tsakiyar kasar Sin ta sake jan hankalin kafofin yada labarai game da CoVs kuma ta yi mamakin yadda suke da yaduwar cutar amma kuma rashin cutarwa idan aka kwatanta da SARS-CoV.
A cikin wannan labarin, an bayyana cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin.
Yawancin HCoVs sun fito ne daga ƙwayoyin cuta da ba su da cututtuka.
An kuma gano cewa dabbobi da suka kamu da wasu daga cikin HCoVs a baya ba su da lafiya.
Sanin dabbobin da ke tare da su yana da tasiri kai tsaye wajen hana mutane kamuwa da cututtuka.
Binciken hulɗar dabbobi da CoVs na iya zama da amfani wajen gano yadda CoVs ke haifar da cutar a cikin mutane.
A cikin wannan bita, mun taƙaita ilimin da ake da shi game da kwayar cutar HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin su da kuma yadda suke yaduwa tsakanin nau'ikan.
A cikin wannan binciken, an gano cewa cutar HCoVs tana da tasiri sosai a kan kwayoyin halitta.
A halin yanzu ana nazarin cutar CoV 2019 (COVID-19) a wannan matakin.
Bugu da ƙari, an kuma bayyana takardun da ake buƙata don cutar ta iya ɗaukar nauyin kwayar cutar da kuma sauye-sauyen kwayar cutar.
Kwayar cuta ta corona (CoVs) tana cikin Coronaviridae, wanda ya ƙunshi ƙungiyoyin ƙwayoyin cuta masu karɓa na RNA masu ƙyama.
An kira wadannan ƙwayoyin cuta masu girman 26 zuwa 32 kilobytes na RNA CoVs saboda suna kama da kambi a cikin microscope.
A cikin tsarin halittar, CoVs suna da kwayoyin halittar da ba a raba su ba.
Kusan kashi biyu bisa uku na kwayoyin halitta suna dauke da manyan takunkumi biyu (ORF1a da ORF1b), wanda ke haifar da pp1a da pp1ab na aiki daban-daban.
Ana kuma gyara sunadarai masu bambancin ra'ayi zuwa sunadarai 16 da ba su da daidaituwa, waɗanda ake kira nsp1~16.
Sauran ɓangaren kwayoyin halitta suna ɗauke da ORFs na sunadarai da ke da daidaito a ko'ina, ciki har da kai (S), ƙuƙwalwa (E), ƙuƙwalwa (M), da kuma ƙwayoyin ƙwayoyin cuta (N).
An kuma gano cewa, cutar ta kamu da cutar ta hanyar kwayar cutar korona.
Dangane da bambancin tsarin sunadarai, an rarraba CoVs zuwa nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'ikan nau'in nau'ikan nau'in nau'in nau'ikan nau'in nau'ikan nau'in nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
A cikin wannan binciken, an gano cewa cutar ta kamu da cutar beta-CoVs da kuma alpha-CoVs, kuma an gano cewa cutar ta kamu da cutar beta-CoVs da kuma gamma-CoVs.
A cikin shekaru dubbai, CoVs sun kamu da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan
A halin yanzu, an gano CoVs guda bakwai (HCoVs) da ke kamuwa da mutane.
A cikin su, HCoV-229E da HCoV-NL63 suna cikin jerin alpha-CoVs.
An gano cewa cutar ta cutar ta COVID-19 ta haifar da cutar sankara a cikin mutane da dama.
A cikin wannan yanayin, ana iya samun cutar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 a cikin yanayin rashin lafiya, kamar mura ko kuma tari.
A gefe guda, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan sun fi cutarwa, suna haifar da cututtukan numfashi na numfashi a cikin marasa lafiya da yawa waɗanda ke da haɗarin haɗarin kamuwa da cutar numfashi mai tsanani (ARDS) da kuma cututtukan da ke waje da huhu.
An gano asalin asalin HCoV-229E, B814, a cikin hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin sani daga binciken da aka yi kan HCoV-229E da HCoV-OC43, waɗanda duka biyu ke haifar da cututtukan cututtuka.
A gaskiya, an yarda da cewa cutar HCoVs ba ta da cutar har sai da barkewar cutar SARS.
Cutar SARS ta 2003 na daga cikin cututtukan da suka fi muni a tarihin zamani, inda ta shafi mutane 8,000 tare da mutuwar kusan kashi 10%.
Shekaru goma bayan haka, cutar MERS ta haifar da wata annoba da ta mamaye yankin Larabawa kuma a wasu lokutan ta kai ga sauran sassan duniya.
Sabuwar kwayar cutar HCoV 2019 (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine asalin cutar coronavirus ta 2019 (COVID-19) ta yanzu, wacce ta kashe mutane 3,120 kuma ta kamu da fiye da 91,000 a ranar 2 ga Maris, 2020.
An daɗe ana faɗakar da duniya game da yadda za ta shirya don barkewar cutar SARS-CoV-2.
An gano cewa cutar HCoVs guda bakwai daga ƙudaje, beraye, ko dabbobin gida ne.
An kuma gano cewa, cutar HCoVs ta fito ne daga kwayar cuta, wadda ta fi yawan zama tare da kwayar cuta, amma ba ta haifar da cututtuka ba.
Cutar COVID-19 ta haifar da mummunan tasiri a fannin kiwon lafiya, ilimi, zamantakewa da halayya a China da duniya.
A cikin wannan labarin, an bayyana cewa, cutar HCoVs tana da cutar da ke saurin kamuwa da cutar.
Wannan zai iya taimakawa ko sauƙaƙa gano kwayar cutar SARS-CoV-2, wanda ya fara kamuwa da cutar kuma ya haifar da yaduwar cutar, wanda zai iya zama mai tasiri wajen hana yaduwar cutar a nan gaba.
A cikin wannan bita, mun ba da taƙaitaccen bayani game da asalin HCoVs na dabbobi, yadda suke yaduwa tsakanin nau'ikan da kuma hanyoyin kamuwa da cuta.
Musamman, muna nunawa da kuma bincika ra'ayin da aka saba da shi cewa kwayar cutar HCoVs ba ta haifar da cutar a cikin dabbobi masu rai amma ta haifar da cutar a cikin mutane ko kuma a cikin sababbin dabbobi bayan yaduwar su zuwa nau'ikan daban-daban.
Mun kuma bincika yadda HCoVs ke canzawa inda yawan yaduwar cutar ke haifar da raguwar iyawar kamuwa da cuta.
A cikin wannan rukunin muna kuma nazarin sakamakon cutar SARS-CoV-2 ta yanzu.
An san cewa CoVs suna kamuwa da dabbobi tun daga ƙarshen 1930.
Kafin gano asalin HCoV-229E, B814, a cikin hanci na marasa lafiya da ke fama da mura, an gano CoVs daban-daban daga nau'ikan dabbobin da suka kamu da cutar, kamar su namomin kaza, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekaru goma da suka gabata, an gano HCoVs bakwai.
A cikin wannan labarin, an nuna cewa an yi amfani da maganin HCoVs a cikin nau'ikan da aka saba da su.
An gano kwayar cutar HCoV-229E ta farko a cikin kwayar numfashi na marasa lafiya da ke fama da cutar ta hanci da hanci a 1966, sannan daga baya ta fara girma a cikin ƙwayoyin WI-38 na huhu.
An gano cewa, cutar HCoV-229E ta haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A shekara ta 1967, an gano HCoV-OC43 a cikin kwayar halitta kuma an gano shi a cikin kwakwalwar beraye masu shayarwa.
Alamomin asibiti na HCoV-OC43 sun yi kama da na HCoV-229E, wanda ba za a iya rarrabe shi daga cututtukan da ke haifar da wasu ƙwayoyin cuta na numfashi kamar su ƙwayoyin cuta na mura da ƙwayoyin cuta na mura.
An gano cewa cutar HCoV-229E da HCoV-OC43 sun fi yawa a duniya, kuma suna da saurin yaduwa a lokacin bazara.
A matsakaici, lokacin da kwayar cutar ta bayyana a cikin kwayar cutar bai kai mako guda ba, sannan kuma a yi kusan makonni biyu ana kamuwa da cutar.
A cewar binciken da aka yi a kan masu son kai, mutanen da ba su kamu da cutar HCoV-229E ba sun kamu da cutar mura mai saurin kamuwa da cuta.
A cikin marasa lafiya da ke da matsalar rigakafi, an sami cutar numfashi mai tsanani.
SARS, wanda kuma aka sani da "muguwar mura", shine farkon cutar HCoV da aka bincika a cikin tarihin ɗan adam wanda ya haifar da SARS-CoV, HCoV na uku da aka gano.
An fara gano cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta kai mutane 8,096 da suka kamu da cutar tare da mutuwar mutane 774, ta kuma bazu a kasashe da nahiyoyi da dama.
Sai dai ga waɗanda suka kamu da cutar sosai, an nuna cewa kowane mai cutar yana iya kamuwa da cutar kamar sauran mutane biyu, lokacin bayyanar cututtuka yana tsakanin kwanaki 4 zuwa 7 sannan cutar ta zama mai tsanani a ranar 10 na kamuwa da cutar.
Marasa lafiya da ke dauke da cutar SARS-CoV sun fara fuskantar ciwon gwiwa, ciwon kai, zazzabi, rashin jin daɗi da kuma tashin hankali, sannan kuma wahalar numfashi, tari da kuma tsananin wahalar numfashi a matsayin alamun da suka bayyana daga baya.
Rage kwayar halitta, gwajin duhu mara kyau da kuma karuwar yawan kereatin sune matsalolin da SARS ke nunawa a cikin dakin gwaje-gwaje.
An kuma lura da mummunar lalacewar tsarin numfashi (DAD), yaduwar kwayar epithelium da kuma raguwar kwayar cutar ta rigakafi a cikin masu cutar SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa a cikin ɗakunan gaggawa da kuma sanya su a kan na'urar numfashi.
Baya ga cututtukan numfashi na cikin zuciya, wasu cututtukan jiki kamar su ciwon hanci, ciwon daji da kuma ciwon koda na iya faruwa a cikin waɗannan marasa lafiya masu tsanani, sau da yawa yana haifar da ƙaruwar cytokines, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya da ke da rashin lafiyar jiki.
An fara gano kwayar cutar ne a wani wuri da aka yi wa cutar a cikin huhu na wani mai cutar da aka fara ganowa wanda ya shigo Hong Kong daga Guangzhou.
A cikin wannan labarin, an nuna cewa an yi amfani da maganin HCoV a cikin nau'ikan kwayoyin halitta.
An gano HCoV-NL63 a cikin jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An fara gano shi a cikin yara ƙanana, tsofaffi da kuma marasa lafiya masu ƙarancin rigakafi da ke fama da cututtukan numfashi.
Rashin jin daɗi, jin zafi, da kuma ciwon ƙugu na HCoV-NL63 sune sanadin cutar.
Wani bincike mai zaman kansa ya gano kwayar cutar a cikin gwajin hanci na jariri mai wata 8 da ke fama da cutar sankara a Netherlands.
Ko da yake an samo shi ne a ƙasar Netherlands, amma a gaskiya ana samunsa a dukan duniya.
An yi hasashen cewa HCoV-NL63 yana haifar da kimanin kashi 4.7% na cututtukan numfashi na yau da kullun, kuma ya fi faruwa a farkon watan Mayu, hunturu da bazara.
HCoV-NL63 yana da alaƙa da kwayar cutar da ke haifar da kumburi a hanci da hanci.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da ke asibiti da ciwon kumburi da kuma cutar ta boronheuritis a Hong Kong.
A cikin wannan labarin, an gano cewa cutar HCoV-HKU1 tana da tasiri sosai a kan masu cutar da cutar.
A cikin wannan labarin, an bayyana cewa, a cikin wani rahoto da aka bayar, an gano cewa, a cikin wani rahoto da aka bayar, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin wannan rahoto, an gano cewa, a cikin rahoto, a cikin rahoto, a cikin rahoto, a cikin rahoto.
Dukkanin HCoVs guda huɗu suna da nau'ikan halittar yanayi kuma galibi ba su da damar canzawa zuwa cututtukan ƙwayoyin cuta masu yaduwa, duk da cewa an sami haɗari da ba a san dalilin su ba kamar yadda aka yi a cikin wani sabon misali na kwayar cutar HCoV-NL63, wanda kwanan nan aka ba da rahoton cewa yana haifar da mummunar cutar numfashi a cikin China.
A cikin mahallin, idan HCoVs sun sami damar yaduwa da kuma tsayawa a cikin mutane, suna da ƙarancin ƙarfi ko ƙarancin cutar.
An fara gano kwayar cutar MERS-CoV a cikin huhu na wani mutum mai shekaru 60 da ke fama da cutar sankarar bargo a Saudiyya a shekarar 2012.
Yayin da yawancin masu cutar da aka gano ta hanyar gwajin gwaji sun fito ne daga Gabas ta Tsakiya, an gano wasu masu cutar da suka zo daga wasu ƙasashe a Turai da Tunisia.
Wani ƙaramin ɓarkewar cutar ya faru a Koriya ta Kudu a cikin 2015 tare da tabbatar da kamuwa da cutar 186.
Alamomin asibiti na MERS suna kama da na SARS, wanda ke nuna ciwon hauka mai tsanani.
Bugu da ƙari ga SARS, waɗanda ke da cutar MERS sun sami mummunan ciwon koda, wanda ya zama na musamman na MERS a cikin cututtukan HCoVs.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtukan ƙanshi na yau da kullun, kamar su rashin jin daɗi da kumburi.
Ya zuwa ranar 14 ga watan Fabrairu, 2020, an gano marasa lafiya sama da 2500 a gwaje-gwajen dakin gwaje-gwaje tare da mutuwar kashi 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi kowa mutuwa a duniya.
Daga tsakiyar 2019 zuwa ƙarshen Disamba, an gano mutane da ke da cutar da aka saba da ita tare da SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta bayyana annobar cutar SARS-CoV-2 a matsayin babbar matsalar lafiyar jama'a da ke damun duniya, wanda ake kira COVID-19.
A ranar 3 ga watan Maris na shekarar 2020, an samu mutane 90,053 da suka kamu da cutar a duniya, tare da yawan mutuwar mutane 3,4%.
A wannan yanayin, yawan mutuwar a Hubei, China, ya kai kashi 4.2%, kuma a waje da lardin, ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan mura masu tsanani kamar SARS-CoV da MERS-CoV, wanda ke haifar da zazzabi, tari da kuma wahalar numfashi.
Wasu marasa lafiya suna da ciwon daji.
Cutar kumburi na daga cikin alamun cutar da ke da matukar tsanani kuma mai cutar na iya yin rashin lafiya da sauri wanda hakan zai haifar da mummunar matsalar numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan kamanceceniya a tsarin nucleotide wanda ya kai kashi 82%, suna da rassa daban-daban a cikin asalin.
A cikin wannan labarin, an bayyana cewa, cutar SARS-CoV-2 ta fi cutar SARS-CoV da MERS-CoV yawa.
An gano mutane da ke dauke da cutar SARS-CoV-2 da ba su nuna alamun cutar ba kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
A cikin wannan labarin, an bayyana cewa, cutar SARS-CoV-2 ta kamu da cutar HCoVs guda shida, kuma an gano cewa cutar ta kamu da cutar a cikin wani yanayi mai tsanani.
A cikin wannan labarin, an nuna cewa akwai wasu abubuwa da yawa da suka faru a cikin wannan cutar.
A wannan yanayin, SARS-CoV-2 yana bin tsarin HCoVs shida.
Na biyu, yawan bayyanar cututtukan COVID-19 ya kasance tsakanin SARS-CoV da HCoVs guda huɗu masu rarrabuwa (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, cutar SARS-CoV-2 tana nuna alamun da suka fi yawa a lokacin kamuwa da kwayar cutar HCoVs wanda ke ɗaukar nau'in yanayi, wanda ke nufin rashin bayyanar cututtuka, rashin bayyanar cututtuka ko kuma rashin bayyanar cututtuka.
Hakanan, ana iya gano ƙananan ƙarancin mutane masu cutar COVID-19 a lokacin cutar SARS-CoV, kodayake a ƙananan ƙarancin.
A karo na uku, yaduwar SARS-CoV-2 kuma yana nuna alamun da ya kamata a kula da su don gano nau'in HCoVs wanda ke ɗaukar nau'in SARS-CoV.
A gefe guda, hanyar yaduwar SARS-CoV-2 tana da akalla irin wannan matsayi kamar yadda HCoVs masu ɗaukar hoto suke da shi dangane da yanayin da suke ciki.
A gefe guda, har yanzu ana bukatar a bincika ko hanyar yaduwar SARS-CoV-2 ta ragu bayan shigar mutum kamar yadda yake tare da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin gwajin kwayar cutar.
Binciken na gaba ya kamata ya nuna ko yaduwar SARS-CoV-2 a cikin hanci da kuma magudanar baki yana da tasiri kamar yadda yake a SARS-CoV a cikin akalla wasu yankuna.
Hakanan yana da mahimmanci a bincika musamman ko SARS-CoV-2 na iya bayyana a cikin yanayi daban-daban kamar yadda yake a cikin nau'in HCoVs masu ɗaukar hoto.
Koyaya, halayen SARS-CoV-2 ciki har da yanayin yaduwa, iyawar kamuwa da cuta da kuma ci gaba da yaduwa bayan shiga cikin mutane zai ba da gudummawa ga ƙarshen cutar ta COVID-19.
An yi amfani da maganin HCoVs a cikin nau'ikan da aka tsara don ƙwarewa a cikin yanayin da ke da alaƙa da ƙwayoyin cuta.
A gefe guda, yana yiwuwa cewa mutane ne suka iya daidaitawa da wadannan HCoVs guda hudu.
A wasu kalmomi, duka biyun na iya tsira daga barkewar cutar HCoV a baya.
An kuma gano cewa cutar HCoVs tana da tasiri sosai a kan mutane, kuma an sami mutuwar mutane da ke fama da cutar HCoVs.
Don ci gaba da rayuwa, kwayar cutar korona mai dauke da cutar mutum (HCoV) tana samar da isassun kwayoyin halittar da zasu iya canzawa ta hanyar lalata kwayar cutar da ke hana kwayar cutar ta sake haifuwa.
A sakamakon haka, yayin da cutar SARS-CoV-2 ke ci gaba da yaduwa da kuma kamuwa da mutane da yawa, akwai babban haɗarin cewa za ta iya daidaitawa da jikin mutum.
Idan ya daidaita, zai zama da wahala a hana yaduwar cutar a cikin al'umma ta hanyar keɓewa ko wasu matakan.
A cikin shekaru da yawa, nau'ikan CoV guda huɗu da ke yaduwa daga asibiti zuwa cikin mutane, suna haifar da rashin lafiyar mutane da ke da rigakafi.
Ba lallai ne irin wannan kwayar cutar ta kasance a cikin dabbobi ba.
A gefe guda, ƙwayoyin cuta masu saurin kamuwa da cuta na SARS-CoV da MERS-CoV ba su da cikakkiyar daidaituwa a jikin mutum, wanda ke haifar da rashin saurin kamuwa da cuta a cikin mutane.
Ya kamata su ci gaba da ƙaruwa a cikin dabbobi masu cutar da ke jiran isar da su ga mutane da ke da ƙarancin rigakafi ta hanyar ɗaya ko fiye da masu cin abinci da masu shayarwa.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV/MERS-CoV da kuma kwayar HCoV guda hudu da ke iya yaduwa a waje da asibiti.
Yana da yaduwar kamuwa da cuta kamar kwayar cutar HCoVs a waje da asibiti, aƙalla har zuwa yanzu.
Amma, yana da cutarwa fiye da ƙwayoyin cuta na HCoVs da ke yaduwa a waje da asibiti kuma ba su da cutarwa kamar SARS-CoV ko MERS-CoV.
Har yanzu ba a san ko za ta iya zama da kyau a cikin mutane ba kuma ta iya tafiya tsakanin mutane ba tare da wata dabba ba.
Kafin mu tattauna game da asalin dabbobi na HCoV, yana da kyau mu tattauna game da ma'anar da kuma halaye na dabbobi da HCoVs ke canzawa, rayuwa tare da, girma, girma, da kuma yawan haifuwa.
A cikin wannan labarin, an bayyana cewa, a cikin wani labarin da aka wallafa, an gano cewa, cutar HCoVs tana da tasiri sosai a kan kwayoyin halitta.
Kwayar cutar dabba ta saba da ita kuma ba ta haifar da cutar ga dabbar da ta kamu da ita ba.
A cikin wannan yanayin, dabba da aka yi wa kwalliya ta zama mai ɗaukar kwayar cutar HCoV kuma ta kasance a cikin dogon lokaci.
A cikin waɗannan dalilai, dabbobi masu kamuwa da cutar sun kamu da cutar HCoV ko kuma kwayar cutar da ke haifar da ita.
A gefe guda, idan HCoV ya shiga cikin sabon hali a cikin dabba a lokacin da yake kusa ko kuma kafin ya iya cutar da mutane, ba ya iya daidaitawa da kuma haifar da cutar.
Wannan dabbar mai ci tana iya zama mai saurin kamuwa da cutar a cikin mutane kuma ta zama mai saurin kamuwa da cutar da sauri kuma ta iya kamuwa da ita a cikin mutane ta hanyar kara yawan kamuwa da cutar.
HCoVs na iya zama marasa cutarwa idan ba su iya canzawa a cikin dabba ba.
A gefe guda, HCoVs na iya zama mai amfani da kuma zama a cikin dabba mai ci gaba na dogon lokaci.
A wannan yanayin, dabbar da take girma a cikinsa tana zama dabbar da aka yi amfani da ita a zahiri.
Rahotanni na cutar sun nuna cewa wanda ya fara kamuwa da cutar SARS ya kamu da ita ne a lokacin farautar dabbobi.
An kuma gano cewa, a cikin wannan yanayin, ana iya samun cutar ta SARS-CoV-2 a cikin mutane da yawa.
An gano cewa ana iya samun kwayar cutar SARS-CoV a cikin karnuka da karnuka a kasuwar dabbobi.
Wannan ya tabbatar kai tsaye da cewa SARS ya ci gaba da yin magana bayan ya kashe dukkan ƙwayoyin cuta a kasuwa.
Koyaya, an ba da rahoton cewa jarirai a cikin daji ko filayen da ba su taɓa haɗuwa da dabbobi a cikin kasuwa ba sun sami SARS-CoV-free, wanda ke nufin cewa jarirai na iya zama masu ci gaba da ci gaba da SARS-CoV amma ba za su iya rayuwa tare da su ba.
Musamman, yayin da kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da kwayar cutar SARS-CoV, babu shakka cewa yawancin nau'ikan ƙananan dabbobi masu shayarwa suna da damar kamuwa da SARS-CoV.
Dukkanin su ba su da wata hanyar kamuwa da cutar SARS-CoV.
Binciken da aka yi a kan dabbobi da ke dauke da kwayar cutar SARS-CoV da ba ta girma ba ya nuna cewa kwayar cutar CoV tana da kamanceceniya da kwayar cutar CoV na bat, wanda aka sani da SARS-Rh-BatCoV HKU3 (SARSr-BatCoV HKU3), wanda ke faruwa a cikin bat a kasar Sin.
An gano cewa, cutar ta SARS-CoV-2 ta haifar da cutar da ke saurin kamuwa da cutar.
Wannan nau'in kwayar cutar ta SARS-CoV tana da kashi 88 zuwa 92 cikin dari na kwayar cutar SARS-CoV.
Binciken ya tabbatar da sabon ra'ayi cewa ƙwayoyin cuta masu ƙwayoyin cuta suna cutar da mutane.
An gano SARS-like CoVs (SL-CoVs) da yawa a cikin kwari, amma babu wanda aka ɗauka mai cutar sai WIV1.
An yi amfani da kwayar halitta mai sauya kwayar halitta ta mutum (ACE2) don karɓar SARS-CoV.
WIV1 an samo shi ne daga kwayoyin cutar da ke amfani da ACE2 a cikin kwayoyin halitta, da kuma a cikin mutane.
Abin mamaki, maganin SARS ya iya hana kwayar cutar WIV1.
Ya zuwa yanzu, WIV1 ya nuna cewa ya samo asali ne daga SARS-CoV na kwari, wanda ya kasance kashi 95% na kowa a cikin kwari.
Ko da yake kwayar cutar biyu suna da alaƙa da juna, ana tunanin cewa WIV1 ba shine mai ɗaukar kwayar cutar SARS-CoV ba kuma ƙwayoyin cuta ba su da nau'ikan nau'ikan SARS-CoV.
An gano cewa cutar MERS-CoV tana da alaƙa da CoV-HKU4 da CoV-HKU5 na namomin kaza.
An gano cewa, cutar ta cutar ta MERS-CoV ta kamu da cutar ta COVID-19 ta hanyar kwayar cutar DPP4.
Kwayar RNA polymerase protein a cikin MERS-CoV tana da kamanceceniya da kwayar cutar beta-CoV da aka gano a Turai da Afirka.
A halin yanzu, babu kwayar cutar MERS-CoV mai rai a cikin namomin kaza.
MERS-CoV da wani kwayar cutar CoV-HKU25 mai kama da juna sun yi daidai da kashi 87% na kwayoyin halittar.
Saboda haka, ƙwayoyin cuta na iya zama ba ainihin kwayar cutar MERS-CoV ba.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuma suna da ƙwayoyin cuta masu rauni musamman don cutar MERS-CoV, kamar yadda raƙuman da ke Gabas ta Tsakiya a ƙasashe da yawa na Afirka suke.
Kwayar cutar MERS-CoV mai rai tana kama da kwayar cutar da aka gano a cikin mutane daga gwajin hanci na raƙumi, wanda ya nuna cewa raƙumi shine ainihin kwayar cutar MERS-CoV.
Ya kamata a yi magana a kan ƙananan alamun cutar da aka gano a cikin raƙuman da aka bincika da cutar MERS-CoV.
Musamman, raƙuman da suka kamu da cutar sun fitar da kwayar ba ta hanyar numfashi kawai ba har ma ta hanyar fitsari, wanda shine babban hanyar watsa kwayar daga kwari.
Koyaya, akwai wasu tambayoyi saboda yawancin waɗanda aka tabbatar da kamuwa da cutar MERS ba su taɓa haɗuwa da raƙuma ba kafin bayyanar cututtuka, ana iya cewa sun kamu da cutar daga mutane ko kuma ba a san asalin cutar ba kuma yana iya yiwuwa wasu nau'ikan dabbobi da ba a san su ba suna da cutar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayar halitta da kuma CoV RaTG13 na kwayar halitta wanda aka samo daga kwayar halitta.
A cikin yanayin SARS-CoV da MERS-CoV, bambancin hali tsakanin SARS-CoV-2 da RaTG13 ya yi yawa sosai don a ce ba su da asalin juna.
Cutar da ke haifar da cutar SARS-CoV-2 ba za ta iya zama a cikin ƙwayoyin cuta ba sai dai idan an gano wani nau'in CoV mai girma a cikin ƙwayoyin cuta a cikin kwanaki masu zuwa.
Wataƙila dabbobi masu amfani da SARS-CoV-2 sun kasance daga cikin dabbobin da aka manta da su a kasuwar Huanan Seafood Wholesale, inda yawancin masu kamuwa da cutar COVID-19 suka fito, wanda ke nuna yiwuwar cewa dabbobi sun kamu da cutar ga mutane.
Yawancin binciken da aka yi kwanan nan dangane da tsarin tsarin metagenome sun nuna cewa wani rukuni na ƙananan halittu masu haɗari da aka sani da "kwararrun ƙwayoyin cuta" na iya zama asalin kwayar cutar beta-CoV mai alaƙa da SARS-CoV-2.
Wannan sabon kwayar cutar ta SARS-CoV-2 tana dauke da kashi 85 zuwa 92 cikin dari na kwayar cutar SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 wanda ya kai kashi 90% a matakin ilimin kimiya.
Suna cikin ƙananan ƙwayoyin cuta guda biyu masu kama da SARS-CoV-2 a cikin juyin halitta na kwayar cuta, ɗayan wanda ke da ƙwayoyin cuta masu kama da kwayar cuta (RBD) wanda ya yi kama da SARS-CoV-2 a kashi 97.4% na tsarin amino acid.
A cikin bambancin, SARS-CoV-2 da RaTG13 RBDs sun bambanta sosai, kodayake suna da kamanceceniya sosai dangane da alaƙar kwayoyin halitta.
A baya, binciken da aka yi kan cututtukan da ke dauke da cutar SARS-CoV-2 ya nuna cewa an gano wasu kwayoyin cutar a cikin kwayar cutar huhu.
Wannan binciken ya yi amfani da tsarin rarrabuwa da kuma rarraba daya daga cikin nau'ikan kwayoyin halitta wanda ya kai kashi 86.3% na kwayar cutar.
A cikin wannan labarin, mun tattauna game da yiwuwar cewa wani nau'in SARS-CoV-2 mai yiwuwa ne.
Amma, a halin yanzu babu wata hujja da ta nuna cewa SARS-CoV-2 ya samo asali ne kai tsaye daga kwayar cutar saboda bambancin halittar tsakanin SARS-CoV-2 da SARS-CoV-2 dangane da beta-CoV da ke kama kwayar cutar.
A cikin wannan, an yi amfani da maganin maganin rigakafi na SARS-CoV-2 da kuma maganin rigakafi na SARS-CoV-2 don magance cutar.
Dole ne a bayyana hanyar canza kwayar cutar SARS-CoV-2 a cikin kwari, dabbobi masu rarrafe da sauran dabbobi.
A cikin wannan binciken, an gano cewa cutar SARS-CoV-2 tana da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
An yi hasashen cewa babban matakin RBD tsakanin kwayar cutar SARS-CoV-2 mai dauke da beta-CoV da SARS-CoV-2 ya samo asali ne daga canjin da aka samu a cikin zabin.
Wani aikin kuma yana neman sauya fasalin SARS-CoV-2 zuwa beta-CoV mai kama da dabbar daji da RaTG13 zuwa nau'in dabbobi na uku.
A cikin yanayin juyin halitta, ana yin sauyawar kwayar halitta a cikin beta-CoVs.
Har yanzu ana gudanar da bincike kan kwayar cutar SARS-CoV-2 a cikin dabbobi.
A cikin wannan labarin, an yi bayanin cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wannan labarin, kuma a cikin wannan labarin.
A cikin wannan binciken, an gano cewa cutar HCoV-NL63 da HCoV-229E sun samo asali ne daga CoVs na namomin kaza, yayin da aka gano kwayoyin HCoV-OC43 da HCoV-HKU1 a cikin namomin kaza.
An gano wani kwayar cutar CoV mai suna ARCoV.2 (Appalachian Mountain CoV) a cikin kwayar cuta mai launin uku a Arewacin Amurka wanda ya nuna alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa ta hanyar kwayar halitta tare da wani CoV na raƙuman ruwa, wanda aka gano a matsayin Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da aka yi zargin cewa nau'in raƙumi yana da cutar.
A cikin wannan yanayin, ana iya samun bayanai game da dabbobi da aka sani da kawo kwayar cutar HCoVs a cikin hoto na 1 da kuma tebur na 2.
Binciken juyin halittar kwayar cutar ya ba da tabbacin cewa akwai tarihin watsawa tsakanin nau'in HCoV.
A lokacin da aka gano HCoV-OC43 daga wasu nau'ikan da suka kamu da cutar daga dabbobi masu kiwo a cikin shekarun 1890, an gano annoba ta cutar numfashi.
Tarihin watsawa tsakanin nau'in kwayar cutar HCoV-229E ba shi da tabbas.
An gano alpha-CoV na kwayar cutar da ke kama da HCoV-229E.
Daga cikinsu akwai alpha-CoV wanda ke daukar kwayar cutar.
Yawancin shaidu sun goyi bayan cewa kwayar cutar ta wuce daga kwari zuwa mutum.
Na farko, mutane da yawa da ba masu haya ba ne suke haɗuwa da ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwarar ƙwarƙwararru.
Amma, mutane ne suke fuskantar arugula sosai.
A karo na biyu, HCoV-229E wanda ya danganci alpha-CoV na arupa ba ya kashe kuma ba ya cutar da arupa, inda alpha-CoV na arupa ya haifar da annoba ta numfashi a cikin dabbobi.
A ƙarshe, an gano alpha-CoV na arupaga a cikin daji.
A cikin wannan, an gano cewa akwai yiwuwar kamuwa da cutar HCoV-229E ta alpha-CoV a cikin mutane.
A taƙaice, ƙudaje ne suke yaɗa ƙwayoyin cuta na zazzabin cizon sauro, Ebola, Nipah, da kuma Hendra.
A cikin wannan yanayin, ba abin mamaki bane cewa ƙwayoyin cuta na iya kaiwa ga mutane tare da kwayar cutar HCoV-229E.
A gefe guda, inda alpha-CoVs ke da alaƙa da kwayar HCoV-229E, ana iya samun kwayar cutar daga arupaga da raƙuma, kuma ta iya kamuwa da mutane, kamar yadda yake tare da MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar kwayar cutar tsakanin jinsuna daga kwari zuwa raƙumi da kuma daga raƙumi zuwa mutum.
An san canjin asalin MERS-CoV a cikin kwari lokacin da aka fara gano shi kuma an tabbatar da shi ta hanyar binciken da aka yi daga baya.
An gano cewa ƙwayoyin cuta na dabbobi suna da tasiri sosai a cikin watsa kwayar halitta da kuma yaduwar cutar tsakanin dabbobi.
Tsawon rayuwa, zama a wuri guda, kasancewa tare da kuma iyawar tashi da ke da kyau sune abubuwan da suka sanya kwari su zama manyan dabbobi masu 'rarraba kwayar cutar'.
A gefe guda, an yi shekaru da yawa da samun kwayar cutar MERS-CoV a cikin raƙuma.
Ya yi amfani da su sosai don su zama masu zaman kansu da kuma masu zaman kansu.
An gano cewa cutar MERS-CoV ba ta da cutarwa sosai kuma tana canzawa a hankali a cikin waɗannan dabbobi.
Cutar MERS-CoV tana da haɗari kuma mutane ba sa kamuwa da ita saboda ba ta da saurin yaduwa.
A cikin wannan labarin, an bayyana cewa, a cikin wani hadisin da aka rubuta, an gano cewa, a cikin wannan hadisin, an gano cewa, a cikin wannan hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, a cikin hadisin, an gano cewa, kuma an gano cewa, a cikin hadisin, an gano cewa, an gano cewa, an yi.
A cikin wannan yanayin, ana iya samun cutar beta-CoV a cikin dabbobi masu shayarwa.
Ana iya samun su a cikin kwayar cutar SARS-CoV-2 mai kama da beta-CoV amma ba tare da kamuwa da cutar ba kamar yadda ake samu a cikin kwayar cutar SARS-CoV.
Akwai yiwuwar cewa za a iya tabbatar da cutar SARS-CoV-2 daga dabbobi, ko kuma a tabbatar da ita a cikin binciken da za a yi nan gaba.
Na farko, ƙwayoyin cuta na iya zama kwayar cutar da ke da alaƙa da SARS-CoV-2 wanda ya zama daidai da kwayar cutar SARS-CoV-2.
Mutane suna iya zama tare da ƙwarƙwarar ƙasa ta wajen yin haƙa da kuma haƙa kwal.
Na biyu, dabbobi masu shayarwa na iya kasancewa daga cikin dabbobi masu yawan kwayar cutar da suka kamu da cutar SARS-CoV-2 da wuri.
Mutane suna kamuwa da kwayar cutar ta hanyar cin nama da cin naman dabbobin daji.
Ana iya zargin cewa yawancin dabbobi masu shayarwa ciki har da dabbobin gida suna da cutar SARS-CoV-2.
Bincike kan dabbobin gida da na daji ya gano cewa suna da rigakafin cutar.
A karo na uku, ana iya samun bambancin kwayar halitta da kuma daidaitawa na SARS-CoV-2 a cikin nau'in dabbobi na uku da suka fuskanci kwari da raƙuma.
Ana ci gaba da binciken kwayar cutar SARS-CoV-2.
Baya ga nau'ikan dabbobi masu amfani da kwayar cutar, abubuwa uku a cikin kwayar cutar suna da mahimmanci wajen sauƙaƙe CoV zuwa wasu nau'ikan dabbobi.
Da farko, yana da muhimmanci sosai a yi amfani da RNA a wasu wurare.
Idan aka kwatanta da sauran ƙwayoyin cuta masu kwayar RNA guda ɗaya, sauyin CoV na matsakaici ko sama da matsakaicin canjin kwayar halitta shine ~10-4 a kowace shekara don kowane kwayar halitta 2, dangane da matakin daidaitawa na CoV a cikin sabon kwayar halitta.
CoVs suna da enzymes masu canza RNA, wanda ke rufe sassansa wanda ke haifar da sauye-sauye da yawa zuwa rashin ƙarfi ko rashin wanzuwar.
Abin mamaki, a cikin ɓangaren tsakiya, Remdesivir an san shi da hana yin amfani da wasu nau'ikan CoV ta hanyar enzyme wanda ke hana aikin RNA polymerase.
Remdesivir yana daya daga cikin magungunan da aka yi nazari akan su a kan cutar SARS-CoV-2.
Duk da haka, bambancin CoVs kusan miliyan ne fiye da na dabbobi da cutar ke girma a cikinsu.
Kuma, sauyin yanayi yana da yawa idan CoVs ba su dace da yanayin dabbobin da ke girma ba.
A cikin kwatancen SARS-CoV mai sauyawa, ana iya ganin sauyin SARS-CoV-2 a ƙasa, wanda ke sa ya zama mafi dacewa ga mutane.
An ce ya riga ya saba da wani dabba da ke kusa da 'yan Adam.
A cikin wannan labarin, an bayyana cewa, a cikin wani labarin da aka wallafa, an gano cewa, cutar SARS-CoV-2 ta kamu da cutar MERS-CoV, wadda ta fi dacewa da raƙuma.
Saboda haka, ba zai yiwu ba cewa canjin kwayar halitta zai iya sa rigakafin SARS-CoV-2 da magungunan rigakafi su yi rauni nan da nan.
Na biyu, babban kwayar RNA a cikin CoVs yana amfani da wasu hanyoyin canzawa a cikin kwayar halitta wanda ke canzawa da kuma canza asalin; don haka, yana ƙara yiwuwar canzawa zuwa cikin gida, wanda shine fa'ida ga ci gaban sabbin ƙwayoyin cuta na CoV lokacin da ya dace.
Wannan ya tabbatar da tsarin RNA mai gina jiki da kuma yadda yake aiki a ƙarshen 3 na kwayar halitta.
Na uku, CoVs suna canzawa kuma sau da yawa suna samar da wasu ɓangarorin RNA ta hanyar  gyaran kwayar halitta .
A cikin dabba mai ciki, sauye-sauyen kwayoyin halitta suna faruwa sau da yawa yayin da RNA na CoV ke tafiya zuwa kwayar halitta.
RNAs masu kama da juna da ke da ƙarin ƙwayoyin halitta na iya canza ƙwayoyin cuta don samar da sabon CoV.
An gano bambance-bambancen kwayar cutar a cikin HCoV-HKU1 da HCoV-OC43, kuma CoVs masu cutar dabbobi kamar SL-CoV da batCoV-HKU9 suna rayuwa a cikin kwari.
Hadin kan kwayar cutar da dabbobi a cikin kamuwa da cuta
Baya ga ƙwayoyin cuta guda uku da aka ambata a sama, hulɗar kwayar cuta da dabbobi masu ci gaba wani abu ne da ke haifar da yaduwar kamuwa tsakanin nau'ikan.
A sakamakon haka, an dauki kwayar cutar SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna cewa kwayar cutar tana da zaɓi sosai wajen yaduwa tsakanin dabbobi.
Dangane da kwatancen bincike tsakanin SARS-CoV na mutum da na dabbobi, an yi imanin cewa SARS-CoV yana da saurin daidaitawa da kwayoyin da ke cikin gida, musamman ma canjin RBD na furotin S.
A cikin al'ada, RBD na kwayar cutar S na CoV tana da alaƙa da mai karɓar mai karɓa kuma an zaɓi ta ta hanyar rigakafin rigakafin da ta shiga.
A cikin SARS-CoV, RBD yana cikin matsayi na 318 zuwa 510 na amino acid a cikin S1 subunit, wanda ke ba shi damar ɗaukar ACE2 na mutum kuma shine tushen shigar da kwayar cutar.
RBD na SARS-CoV na iya gano kwayar cutar ACE2 a cikin dabbobi daban-daban, ciki har da farji, dabbobin daji, beraye, dabbobin daji, wanda ke haifar da kwayar cutar a cikin dabbobi.
A takaice, an gano ragowar amino acid 6 ne kawai a cikin RBD wanda ya bambanta da na mutane da kuma beraye masu kamuwa da cutar kuma 4 daga cikinsu suna da wani bangare wanda ke haɗuwa da mai karɓar kwayar cutar ACE2.
SARS-CoV na tagwaye yana da sauye-sauyen K479N da S487T a cikin RBD, wanda zai iya haɓaka alaƙar S-protein da kuma mai karɓar kwayar cutar ACE2.
A wasu kalmomi, canza waɗannan amino acid guda biyu na iya zama mahimmanci don daidaita kwayar cutar ga jikin mutum.
A cikin wannan labarin, an bayyana cewa, cutar SARS-CoV-2 tana da kwayar cutar da ke saurin kamuwa da cutar.
A cikin kashi 30 cikin dari na bambancin da ke tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S2 yana nuna cewa dangantakar S2 da ACE2 na ɗan adam na iya canzawa.
A zahiri, nazarin cryo-EM ya nuna sau 10 - 20 na haɗuwa mai ƙarfi tsakanin ACE2 na ɗan adam da furotin S na SARS-CoV.
Hakanan yana da ban sha'awa don tabbatar da ko akwai wani kwayar cutar da ke amfani da kwayar cutar SARS-CoV-2.
A cikin wannan labarin, an gano cewa cutar HCoV-NL63 tana da alaƙa da ACE2 amma a wani ɓangaren S.
Akwai wasu masu karɓar HCoV, kamar aminopeptidase N na HCoV-229E da sialic acid tare da acetyl 9-O na HCoV-OC43.
Wannan na iya bayyana yadda kwayar cutar CoV ke daidaitawa da jikin mutum ko kuma dabba da ta kamu da ita.
A cikin wannan labarin, an bayyana cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, a cikin wani labarin da aka wallafa, an gano cewa, an gano cewa, a cikin wani labarin da aka rubuta, an rubuta, an rubuta, an rubuta, kuma an rubuta.
Bambancin da ke tsakanin kwayar cutar da ke girma tsakanin mutane da dabbobi da ke haifar da kwayar cutar HCoVs kamar su kwari, raƙumi da kuma ƙuda zai iya hana yaduwar kwayar cutar tsakanin nau'ikan.
HCoVs suna canza kwayoyin halitta na gida kuma suna lalata sunadarai masu rigakafin cutar don su iya cutar da sauran dabbobi.
Saboda haka, dole ne a ci gaba da ganowa da kuma bayyana abubuwan da ke cikin kwayoyin a cikin wannan dangantaka mai zurfi tsakanin kwayar cutar da kuma mai ciwon.
Binciken kwayar halitta na kwayar cutar da kuma kwayar cutar SARS-CoV-2 ta hanyar fasahar CRISPR na zamani na iya samar da sakamako.
Bayyanar sabon kwayar cutar HCoV: Tushen
Yawancin nau'ikan CoV na kwari suna ba da babbar dama ga bayyanar sabon kwayar cutar HCoV.
A cikin wannan yanayin, an gano cewa an gano cewa an gano cutar HCoV a cikin kwayar cuta.
Kuma sauyawa da sauyawar kwayoyin halitta da ke haifar da HCoVs sune manyan matakai biyu a cikin wannan tsari.
Alal misali: Samun ko rasa kwayoyin da ke samar da sunadarai na iya canja wani ɓangare na kwayar cutar sosai.
A cikin kwayar cutar SARS-CoV, ana ganin ORF8 tana da mahimmanci wajen daidaitawa ga jikin mutum, kuma an gano ƙwayoyin cuta masu alaƙa da SARS-CoV waɗanda ke da alaƙa da ORF8.
An gano kwayar cutar SARS-CoV ta 29 a cikin kwayoyin halitta a farkon annobar.
Wannan kwayar tana rarraba ORF8 zuwa ORF8a da ORF8b kuma ana ganin tana iya daidaitawa da canjin da ke haifar da canjin halittar dabbobi.
Kuma SARS-CoV ya san cewa yana da bambancin kwayar halitta a cikin kwayar cutar alpha da gamma-CoV, inda yawancin kwayar halitta da aka canza ta zama RNA polymerase.
An kuma gano wasu canje-canje a cikin nsp9, da yawa a cikin nsp10, da kuma sassan nsp14.
A wani bangare kuma, MERS-CoV ya canza yanayin tsakanin nau'ikan kwayar cutar guda biyu, wanda ya faru a cikin raƙuman Saudi Arabiya.
A cikin wannan labarin, an gano cewa cutar coronavirus ta kamu da cutar coronavirus a cikin mutane da dama.
Ya kamata a lura cewa zabin da ba na halitta ba na iya haifar da canje-canje a cikin kwayar cutar, wanda zai iya haifar da fitowar kwayar cutar daga yankin da aka zaɓa, misali, tsarin rigakafin kwayar cutar.
Misali na wannan yanayin shine rashin kwayar ORF4 a cikin HCoV-229E wanda ke haifar da kawar da kwayar halittar.
A cikin wannan labarin, an gano cewa, a cikin wani labarin da aka yi a cikin littafin, an gano cewa, a cikin wannan labarin, an gano cewa, a cikin wani labarin da aka yi a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, an gano cewa, a cikin littafin, kuma a cikin littafin, an gano cewa, a cikin littafin, kuma a cikin littafin, an rubuta cewa, kuma a cikin littafin.
A ƙarshe, canjin sabon kwayar cutar HCoV ya haifar da matsalolin rashin rayuwa a cikin dabbobi masu yawa.
An gano rashin bayyanar cututtuka ko kuma alamu masu sauƙi lokacin da ƙwayoyin cuta suka kamu da cutar CoV, wanda ke nuna daidaituwa tsakanin CoV da ƙwayoyin cuta.
A bayyane yake cewa ƙwayoyin cuta suna da ƙwarewa sosai ga CoVs ta hanyar tsarin halittar jiki.
Misali: rashin ingancin kwayoyin cuta a cikin kwari yana rage cutar CoV sosai.
Kuma kwayoyin kashe kwayar cuta a cikin kwari sun daina aiki saboda karuwar kwayar cutar NKG2/CD94 da kuma rashin bayyanar kwayar cutar mai aiki da nau'in I.
Kuma, yawan sinadarin oxygen (ROS) wanda ke haifar da ayyukan kwayar halitta da yawa na iya hana CoV daga yin aiki a wasu wurare kuma yana da tasiri wajen gyara ayyukan enzymes masu canza kwayar halitta, don haka zaɓin kwayar cutar ta kwayar cuta mai saurin kamuwa da cuta lokacin da aka shigar da ita cikin sabon nau'in.
Sauran kwayoyin cutar CoV suna canzawa, suna haifar da sabon furotin ko sassan da ke ba da damar dabba ta saba da kwayar cutar.
Saboda haka, ba daidaituwa ba ce cewa an gano sabbin ƙwayoyin cuta guda uku na HCoV a cikin shekaru ashirin da suka gabata.
CoVs ba sa haifar da rashin lafiya ko kuma alamun rashin lafiya a cikin dabbobi masu yawan yawa kamar su kwari da raƙuma.
Suna yin canje-canje sosai ba tare da tsayayya da rigakafin jiki ba.
Wannan shine asirin da yasa dabbobi masu dauke da kwayar cutar ba su nuna alamun cutar ba kuma suna haifar da rashin lafiya ga mutane.
Alamun cutar sun fi yawa saboda yawan aikin rigakafi da kuma yawan sakin cytokines, saboda haka yawan rigakafin da ake samu yana kara lalacewar huhu.
Wannan ya bambanta da dabbobi marasa alamun cutar, inda kwayoyin rigakafi ke samar da kwayar cutar CoV mai sauyawa.
An yi amfani da maganin rigakafi na SARS-CoV-2 a cikin maganin cutar.
Kwayar cutar anti-virus tana da ƙarfi a cikin kwari.
Saboda haka, bayar da kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cutar kwayar cuta.
Har ila yau, kwayar cutar NLRP3 ba ta aiki a cikin kwari.
Bisa ga wannan ka'idar, hana kwayar NLRP3 tare da MCC950 zai iya zama da amfani wajen maganin COVID-19.
An gano cutar SARS-CoV-2 ne bayan bayyanar cutar SARS-CoV da MERS-CoV.
A cikin wannan binciken, an gano cewa beta-CoV na tururuwa yana da kashi 95% na SARS-CoV, kuma yana da kashi 96% na SARS-CoV-2.
A cikin wannan labarin, an gano cewa cutar SARS-CoV-2 ta kamu da cutar SARS-CoV-2 a cikin kwayar halitta.
An gano beta-CoV na dabbar daji wanda yayi kama da SARS-CoV-2, wanda ke nuna cewa dabbar daji na iya zama mai cin nama ko kuma beta-CoV na dabbar daji wanda ke cikin wani ɓangaren kwayar cutar SARS-CoV-2.
Duk da shakku, babu wata hujja da ta nuna cewa SARS-CoV-2 ya samo asali ne ta hanyar ganganci ko kuma ba da gangan ba.
An sake gabatar da CoVs saboda sabon fashewar SARS-CoV-2.
Binciken CoVs a cikin kwari da sauran dabbobi ya canza tunaninmu game da yadda dabbobi masu dauke da HCoVs ke cutar da mutane.
Akwai tabbaci mai ƙarfi cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga cutar sankarar bargo kuma sun kamu da mutane ta hanyar dabbobi masu shayarwa.
Halin SARS-CoV wanda ya samo asali ne daga haɗuwa tsakanin mutane da dabbobi a cikin kasuwar dabbobi, rufe su da kashe dabbobi da ke ciki zai iya hana barkewar cutar SARS.
Hakanan ya kamata a cire dabbobi masu shayarwa daga wuraren sayar da dabbobi don hana su cutar da sauran dabbobi, bisa ga binciken asalin beta-CoV na dabbobi masu shayarwa wanda ke da alaƙa da SARS-CoV-2.
Amma yadda cutar SARS-CoV-2 ke yaduwa a cikin mutane daga dabbobi masu shayarwa da sauran dabbobi masu shayarwa har yanzu ana bukatar a bayyana su a cikin binciken da za a yi nan gaba.
A gefe guda, kwayar cutar MERS-CoV ta daɗe tana cikin raƙuma.
Waɗannan raƙuman suna da muhimmanci wajen sufuri da kuma samar da nama, madara, ulu da kuma tufafi ga mazaunan yankin.
Sun yaɗu sosai a Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya kashe dukkan raƙuma ba don magance cutar MERS, kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake barkewar cutar MERS, dole ne a yi aiki mai ƙarfi tare da sauran matakan rigakafi da kuma samar da allurar rigakafin cutar MERS-CoV.
Idan ba mu iya kawar da wannan kwayar cutar ba, za a iya samun sabon nau'in kwayoyin halitta da zai iya haifar da annoba.
An yi amfani da nau'ikan CoVs daban-daban don kama dabbobi da ke yawo a cikin gandun daji.
Musamman, CoVs na kwayar cuta suna da iyawa daban-daban.
A nan gaba, yana da matukar yuwuwar cewa CoV na dabbobi zai iya canzawa, wanda zai haifar da sabon nau'in CoV mai saurin yaduwa ko kuma kisa.
Dole ne a daina cin naman daji a wasu sassan kasar Sin don kaucewa hulda da dabbobi ba dole ba.
Dangane da ci gaba da rikice-rikicen SARS, MERS da COVID-19, ana buƙatar ingantaccen tsarin magance ƙwayoyin cuta.
A taƙaice, ƙwayoyin cuta sun kasance a duniya tun da daɗewa.
Suna zama a cikin gidajen su har sai sun sami damar fita.
Ko da yake kwari suna da halaye da yawa da ke ba da damar yaduwar kwayar cutar, ana iya rage haɗarin haɗuwa da kwari da sauran nau'ikan namun daji idan aka koya wa mutane su guje su.
Kulawa da dabbobi masu shayarwa yana da mahimmanci don fahimtar yanayin CoV da kuma yanayin da yake ci, wanda ke da amfani wajen hana mutane kamuwa da cutar daga dabbobi da kuma hana barkewar cutar nan gaba.
A ƙarshe, mafi kyawun hanyar hana kwayar cutar daga dabbobi ita ce fahimtar ƙarancin kwayar cutar da kuma dabbobi da ke girma a ciki.
Har yanzu akwai nau'ikan dabbobi da yawa da ba a san asalin cutar SARS-CoV-2 ba.
Na farko, idan kwari ya kamu da cutar SARS-CoV-2 ga masu rarrafe, yana da ban sha'awa a ga dalilin da yasa kwari da kwari suke rayuwa a wuri guda.
Na biyu, idan kwari ke kaiwa mutane kwayar cutar kai tsaye, ya kamata a nuna yadda mutane ke hulɗa da kwari.
Na uku, idan dabba ta uku tana aiki ne a matsayin dabba mai cin nama, to yaya ta ke hulɗa da nau'ikan dabbobi kamar mutane, da namomin kaza da dabbobi masu rarrafe.
A ƙarshe, idan yawancin dabbobi masu shayarwa da dabbobi masu kiwo suna iya kamuwa da SARS-CoV-2, ya kamata a yi bincike da kuma gano yadda suke kamuwa da cutar.
Ko dai a cikin dabbobi masu shayarwa, dabbobi masu shayarwa ko wasu dabbobi masu shayarwa, ana sa ran cewa SARS-CoV-2 ko kuma kwayoyin cutar da ke dauke da shi za su bayyana a cikin dabbobi masu shayarwa a nan gaba.
Binciken da aka ci gaba a kan waɗannan dabbobi zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, wanda zai taka rawa sosai wajen hanawa da kuma magance COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin gwajin COVID-19  waɗanda ake zargi da cutar  waɗanda aka tabbatar da su 
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagororin gaggawa waɗanda suka ƙunshi shawarwari don ganowa da maganin cutar coronavirus ta 2019 (2019-nCoV), kuma jagororin sun ba mu kwarewa da kuma samar da kyakkyawan bayani game da yadda za a magance cutar a duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma fahimtarmu da iliminmu game da ita suna ƙaruwa a hankali bisa ga bincike da aikin asibiti; don haka hanyoyin bincike da magani suna ci gaba da sabuntawa.
A cikin wannan wasika, mun mayar da martani ga ka'idodinmu kuma mun gabatar da sabbin hanyoyin da za a bi don tantance mai yiwuwa  da wanda aka tabbatar da cutar  bisa ga sabon jagorar bincike da magani na COVID-19 (mataki na bakwai) da kwamitin kiwon lafiya na Jiha na kasar Sin ya fitar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta haifar da barkewar cutar, wanda yanzu ana kiranta da sunan cutar coronavirus ta 2019 (COVID-19) kuma an sanya wa kwayar cutar sunan cutar coronavirus mai saurin numfashi ta 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta kafa ƙa'idodin shawarwari na gaggawa kuma an buga su a shafin yanar gizon Cibiyar Nazarin Kiwon Lafiya ta Soja a ranar 06 ga Fabrairu 2020.
Tun da aka fitar da shi, ya burge mutane da yawa.
Amma yana da mahimmanci a fahimci cewa COVID-19 sabon cuta ne, fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga bincike da aikin likita; saboda haka, hanyoyin bincike da magani suna ci gaba da sabuntawa.
Misali, Jagororin Bincike da Kula da COVID-19 da Kwamitin Lafiya na Jiha na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar, tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, ya fitar da littattafai bakwai da suka hada da wasu sassan da aka gyara.
Yanzu tsarinmu ya karɓi shawarar Zhou da sauransu, waɗanda suka ƙirƙiri tsari mai sauƙi na ƙididdigar ƙwarewar likita.
Aikin su ya kara sabbin hujjoji na zahiri ga manufofinmu kuma ya ba da haske mai amfani game da wannan annoba ta duniya.
Muna goyon bayan waɗannan 'yan'uwa masu ƙwazo kuma muna godiya.
Koyaya, ya kamata a sake sabunta su bisa ga sabbin ka'idoji don ganowa da maganin COVID-19 (Gwaji na bakwai) da kuma sabon bincike.
Kamar yadda aka nuna a littafin na bakwai (3 Maris 2020) tabbatar da cutar da ake zargi dole ne ya dace da ɗayan alamun tarihin cutar da alamun cutar guda biyu don yin cikakken bincike, ko kuma dole ne ya haɗu da alamun cutar guda uku idan tarihin cutar bai bayyana ba:
Tarihin cutar: (1) Tafiya ko zama a Wuhan da kewayenta, ko kuma wasu wuraren da aka gano cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Haɗuwa da cutar SARS-CoV-2 (tare da gwajin da ke nuna cewa tana da kwayar nucleic acid); (3) Haɗuwa da masu zazzabi ko kuma masu cutar numfashi daga Wuhan da kewayenta, ko kuma wasu wuraren da aka gano cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Haɗuwa da masu cutar da ke da cutar a wani yanki (fiye da mutane 2 da suka sami cutar zazzabi ko kuma marasa lafiya da suka sami cutar numfashi a cikin makonni 2, kamar gida, gida, makaranta, ofis, da sauransu).
Alamun cutar sune: (1) zazzabi ko alamun rashin numfashi; (2) tare da alamun cutar COVID-19; (3) yawan adadin ƙwayoyin jini na farin jini wanda ke nuna yawan ƙwayoyin jini na al'ada, wanda ba ya ƙaruwa ko raguwa a matakin farko.
Binciken wanda aka tabbatar da cutar ya kamata ya dogara ne akan wanda ake zargi da cutar wanda ke nuna ɗayan waɗannan alamun cutar ko kuma wanda ya dogara da jini: (1) gwajin PCR na ainihi wanda ya nuna cutar SARS-CoV-2; (2) jerin kwayoyin cuta masu mahimmanci waɗanda ke nuna alaƙa da sabon coronavirus da aka sani; (3) gano cutar akan takamaiman IgM da IgG a cikin SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko kuma canzawar takamaiman kwayar cutar SARS-CoV-2 daga marasa lafiya, ko ƙaruwa a cikin wani wuri fiye da sau 4 a cikin lokacin warkewa fiye da lokacin cutar.
Mun lura cewa an kara gwajin kwayar nucleic acid ta numfashi ko kuma samfurin jini na lokaci a littafin na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
Gano cutar ta hanyar samfurin jini an kara shi a fitowar ta huɗu (27 Janairu 2020) da ta biyar (8 Fabrairu 2020); sannan kuma an kara bayanan jini a fitowar ta bakwai.
Wannan canji ya dogara ne akan ci gaba da bincike na bincike don ingantaccen ganowa na nucleic acid don saurin bincike, da kuma samfurori na numfashi ciki har da samfurin jini, wanda ke ba da damar samfurori daban-daban, da kuma tallafawa shigar da takamaiman kwayoyin cutar cikin tsarin da aka tabbatar.
Bugu da ƙari, akwai alamun da yawa da ke tunatar da mu game da marasa lafiya da ke da alamun rashin lafiya da kuma marasa lafiya.
Saboda haka, ya kamata a sabunta jadawalin Zhou da sauransu, kamar yadda suka rarraba mutumin da ba shi da alamun cutar a matsayin "mai ƙarancin haɗari".
Ya kamata a yi la'akari da tsarin da aka tsara a wasu ayyukan kiwon lafiya da bincike.
A ƙarshe, muna fatan ƙarin tabbaci kai tsaye zai bayyana kuma muna kira ga masu karatu su yi tsokaci.
Game da gwajin "mai yiwuwa" da "an tabbatar da cutar", muna roƙonku da ku bi kuma ku bi sababbin ƙa'idodin ƙasashenku.
Ƙungiyarmu za ta kuma riƙa sabunta ƙa'idodinmu a kai a kai don su taimaka.
Bangladesh ta sanar da sabbin mutane biyar da suka mutu daga COVID-19, wanda shine mafi girma a cikin rana ɗaya
Jiya, Bangladesh ta tabbatar da sabbin mutane biyar da suka mutu daga COVID-19 a wannan ranar.
Wannan shi ne adadin mutane da suka mutu a rana daya sakamakon cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton adadin waɗanda suka kamu da cutar, ciki har da 114 da suka kamu da cutar da 33 da suka warke.
Adadin wadanda suka mutu ya kai 17.
A wani rahoto da ya yada a yanar gizo, Daraktan IEDCR, Dr Meerjady Sabrina Flora, ta ce, wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr Meerjady, mutum biyu da suka mutu sun haura shekaru 60, biyu sun haura shekaru 51 zuwa 60 kuma daya ya haura shekaru 41 zuwa 50.
Ya kuma bayyana cewa biyu daga cikin wadanda cutar ta kashe sun fito ne daga birnin Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani ma'aikacin asibiti ya shaida wa Anadolu, wata jarida mai tasowa a kasar, cewa daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, Shugaban Hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda ke jinya a asibitin Kuwait Maitree.
A cikin sanarwar bidiyo da aka watsa ta yanar gizo a ranar Lahadi, Ministan Sufuri na Bangladesh Obaidul Quader ya ce an dakatar da zirga-zirgar jama'a fiye da yadda aka tsara har zuwa Asabar.
An shirya wannan dokar ta fara ranar 26 ga Maris kuma ta ƙare ranar Asabar, 4 ga Afrilu.
Ana iya ɗaukar kayan masarufi kamar magani, wuta da abinci.
An gano cutar COVID-19 ta farko a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da mace ɗaya.
A ranar 9 ga Maris, an warkar da mutanen uku.
SARS-CoV-2 ya riga ya kamu da mutane sama da miliyan a duniya
Rahoton Jami'ar Johns Hopkins ya nuna cewa jimillar adadin mutanen da suka kamu da cutar SARS-CoV-2 a duniya sun haura miliyan daya a ranar Alhamis.
Kimanin mutane dubu 52 ne suka mutu sakamakon cutar COVID-19, cutar da ke haifar da kwayar cutar coronavirus.
An sanar da wannan adadi ne a ranar da Malawi ta sanar da kamuwa da cutar korona ta farko da kuma mutuwar farko ta cutar a Zambia.
A ranar Alhamis, Koriya ta Arewa ta bayyana cewa tana daya daga cikin kasashen da suka rage da ba su da cutar coronavirus.
Jiya, Hukumar Lafiya ta Duniya ta sanar da cewa an tabbatar da kamuwa da cutar 1,051,635, tare da kamuwa da cutar 79,332 a cikin awanni ashirin da huɗu da suka gabata zuwa 10 na yammacin Turai (08:00 GMT) a ranar 4 ga Afrilu.
A Amurka, an ba da rahoton fiye da mutane 244,000 da suka kamu da cutar coronavirus, tare da mutuwar mutane 5,900.
Bisa ga bayanan Jami'ar Johns Hopkins, CBS News ta ruwaito cewa mutane 1,000 ne suka mutu sakamakon cutar coronavirus a Amurka a ranar Laraba.
A duniya, kasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya tsawaita dokar hana fita zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa za a ci gaba da biyan ma'aikatan Rasha albashi har zuwa ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kara wa'adin dokar ta baci na kwanaki 15 a zaben da aka yi, inda aka samu kuri'u 215, 10 suka amince, daya kuma ya ki.
Saudiyya ta kara wa'adin rufewa na birnin Makka da Madina tsawon yini guda, tun daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand na shirin kafa dokar hana fita tsakanin karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa gwamnatinsa ta tsawaita dokar hana fita zuwa ranar 1 ga Mayu.
Shagunan sayar da kayayyaki a Ostiraliya sun kafa iyakar adadin takardar wanki da mutum zai iya saya
A daren Asabar zuwa Lahadi, shagunan Woolworths da Coles na Australia sun rage adadin takarda mai tsabta zuwa biyu kuma ba a wuce fakitin takarda mai tsabta a duk shagunan a ƙasar ba.
A ranar Litinin, ALDI ta kuma ce kada a wuce fakiti ɗaya.
An sanar da iyakar adadin a matsayin sako a dandalin biyan kudi, da kuma a shafukan Facebook na shagunan.
An ce masu sayen sun sayi takardar tsabtace gidaje da yawa saboda tsoron COVID-19 lokacin da ake buƙatar keɓewa.
A ranar Laraba, Woolworths ya rage adadin takardun tsabtace gida da ke cikin kayan kwalliya zuwa fakiti ɗaya a kowane oda.
Canje-canje na gaba sun ba da izinin yin amfani da fakiti ɗaya na takardun tsabta guda huɗu waɗanda aka sanya a cikin shagon Woolworths da Coles a ranar 4 da 5 ga Maris.
A cikin sanarwar manema labarai ta watan Maris, Coles ta ce bisa ka'idojin da aka kafa na ba da kunshin takarda mai tsabta guda hudu ba, yawancin shagunan suna kashe kayayyaki bayan awa daya da sakewa, kuma ta ce sayayya "ba ta taɓa faruwa ba", yayin da ALDI ta sanar a shafin Facebook a ranar Talata cewa hakan "ba zato ba tsammani" ne.
Sayarwa ta "hujja" a makon da ya gabata, a cewar mai magana da yawun kantin sayar da kayayyaki na Woolworths.
Costco a Canberra ya rage adadin takardun tsabta zuwa biyu a makon da ya gabata.
Don rage yawan karancin takardun tsabta, Coles ya ba da umarnin manyan fakitoci ga masu siyarwa da kuma kara yawan siyarwa, kuma Woolworths ya ba da umarnin ƙarin takardun tsabta, yayin da ALDI ya kawo kayayyakin da aka shirya don tallata ranar Laraba a gaba.
Russell Zimmerman, babban jami'in kungiyar 'yan kasuwa na Australia, ya ce 'yan kasuwa na iya kara kayayyaki, amma dokokin da aka kafa a kan manyan motocin da ke sarrafa kayayyaki a yankin sun sa hakan ya zama da wahala.
Yana ganin farashin kayayyaki zai tashi, yayin da masu sayar da kayayyaki ke kokarin biyan bukatun masu sayen kayayyaki, tare da rage musu talla.
A ranar Talata, ALDI ta sanar da cewa saboda kayayyakin da aka sayi sun kare a kantin sayar da kayayyaki, wasu shagunan ba za su iya gabatar da tallace-tallace na ranar Laraba ba.
A wani rahoto da News.com.au ta wallafa, Dr Gary Mortimer, masanin harkokin kasuwanci a jami'ar Queensland University of Technology, ya ce, shagunan suna ajiye kayayyaki da daddare.
Ya kuma ce takarda mai tsabta abu ne da ake sakawa a cikin kwantena, kuma idan aka sayar da ita, tana sa a rasa wuri a kan ɗakunan ajiya, kuma hakan yana ƙara sa mutane su ji cewa an riga an sayar da su.
Russell Zimmerman na ABC News ya ce: "Colls da Woolworths suna ganin cewa samun kayayyaki da yawa a kan benaye kamar takarda mai tsabta da magungunan kashe kwari da ke kan gaba zai rage fargabar mutane".
Kamfanin Who Gives a Crap wanda ke sarrafa takarda mai tsabtace kayan masarufi ya ce kayayyaki sun yi yawa a kantin sayar da kayayyaki a ranar Laraba.
News.com.au ta ruwaito cewa kamfanin Kimberly-Clark na kera takarda mai tsabtace jiki na Kleenex da Solaris Paper na samar da takarda mai tsabtace jiki na Sorbent, sun dage cewa za su yi aiki 24/7 don samun kasuwa.
Domain.com, wani dandalin sayar da gidaje, ya sanar da cewa masu sayar da gidaje za su bayar da takardun tsabtace gidaje kyauta ga masu fara yin amfani da gidan a cikin hasumiyar Melbourne, inda aka yi amfani da hasumiyar kadan saboda masu sayen suna da hutun ranar aiki da suka dace da karshen mako.
Mujallar ranar Alhamis ta NT News, wata jaridar jarida da ke fitowa a kullum a Darwin, ta kara shafuka takwas da za a iya yankewa don amfani da su a matsayin takarda mai tsabta.
Shaguna ba su da niyyar yin takunkumi, a cewar rahoton ABC Australia na ranar 3 ga Maris, inda ya ce ba su da niyyar yin takunkumi kan sayayya.
Russell Zimmerman ya ce wasu kayayyaki da suka zama sanadin sayarwa sun haɗa da abin rufe fuska, maganin kashe ƙwari, abinci mai bushewa, sabulu da kuma kayan wanki.
Haka kuma ya faru a waje da Ostiraliya, inda a daren Lahadi, kantin sayar da kan layi na Ocado na Burtaniya ya rage takardun tsabtace Andres zuwa fiye da fakiti biyu na 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 ta yanzu da coronavirus SARS-CoV-2 ke haifarwa a matsayin annoba.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yaɗu a ƙasashe da dama, ba ta maida hankali kan yadda ta ke da tsanani ba, WHO ta nuna cewa yana da muhimmanci gwamnatoci su shiga cikin magance ta:
"Dukkanin kasashe na iya sauya yanayin annobar.
"Kasashe sun gano, sun gwada, sun yi maganin, sun keɓe waɗanda suka kamu, sun keɓe waɗanda suka yi hulɗa da su kuma sun ba da shawarar kariya", in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
"Muna matukar damuwa da yadda cutar ke yaduwa da kuma yadda ba a iya yin komai ba wajen magance ta.
A cewar Dr. Tom Frieden, tsohon Darakta Janar na Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, annobar "ba ta taɓa faruwa ba".
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce: "Babu wata kwayar cuta ta numfashi da ta wuce ta inda ta fito kuma ta zama annoba a duniya" sai dai mura.
Ghebreyesus ya shiga cikin tattaunawar inda ya ce: "Ba mu taba ganin annobar coronavirus ba".
Ya ci gaba da cewa: "Ba mu taba ganin wata cuta da za a iya magance ta ba".
Wannan yaduwar cutar ta biyo bayan sanarwar WHO a watan Janairu cewa cutar ta zama bala'in kiwon lafiya na duniya.
Babban daraktan Cibiyar Kula da Cututtuka da Cututtuka (NIAID) na Amurka, Dr. Anthony Fauci, ya ce: "A bayyane yake cewa cutar ta kara tsanantawa".
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ruwaito cewa a kalla mutane 126,000 ne suka kamu da cutar COVID-19 a duniya, inda sama da mutane 4,600 suka mutu.
Cutar cutar korona 2019/20 ita ce cutar korona ta 2019 (COVID-19), wadda cutar korona mai saurin kamuwa da cuta (SARS-CoV-2) ke haifarwa.
A watan Disamba na shekarar 2019, an gano cutar a Wuhan, China; an ayyana ta a matsayin bala'in kiwon lafiya na duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutane miliyan 1.61 sun kamu da cutar COVID-19 a kasashe da yankuna 210, wanda kusan mutane 97,000 suka mutu.
An warkar da mutane kusan 364,000.
Yawan mutuwar mutane ya kai kashi 4 cikin 100 a kasar Sin, yayin da a duniya ya kai 13.04% a Aljeriya da 0.8% a New Zealand.
Alamun sun hada da zazzabi, tari, da kuma rashin numfashi.
Alamun da suka fi tsanani sun hada da ciwon hauka da kuma matsalar numfashi.
Alamar farko na bayyanar cututtuka na iya zama kusan kwanaki biyar, amma na iya zama daga kwana biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko magani da aka sani don maganin cutar.
Maganin farko shine magance alamun cutar da kuma taimakawa mai cutar ya guji cutar. Ka'idojin rigakafi sun hada da wanke hannu, rufe baki lokacin da kake tari, kiyaye nesa da mutane, lura da kuma keɓewa daga mutanen da ake zargi da kamuwa da cutar.
Shugabannin duniya da ke fama da annobar sun dakatar da tafiye-tafiye, sanya dokar hana fita, kafa hanyoyin shiga, hana annobar a wuraren aiki da rufe masana'antu.
Cutar ta haifar da rikice-rikice na tattalin arziki da zamantakewa, jinkirta ko dakatar da wasanni, addini, siyasa da al'adu da kuma haifar da karancin kayayyaki a duniya wanda ya haifar da yawan cin kasuwa saboda tsoron cutar.
Makarantu da jami'o'i sun rufe a matakin kasa da na yanki a kasashe 193, wanda ya shafi kusan kashi 99.4 cikin dari na daliban duniya.
Labaran da ke yadawa game da cutar sun bazu a yanar gizo, inda aka samu wasu hare-haren nuna wariya da nuna wariya ga 'yan kasashen waje musamman na kasar Sin, da na gabashin da kudu maso gabashin Asiya, da kuma wasu daga yankunan da cutar ta mamaye.
Saboda rage yawan tafiye -tafiye da kuma rufe manyan masana'antu, gurɓataccen iska da kuma iska sun ragu.
A ranar 31 ga Disamba, 2019, hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun sanar da kamuwa da cutar sankarar bargo da ba a san dalilin ba, kuma a farkon watan Janairun 2020 ne aka fara gwajin.
An samu wadanda suka kamu da cutar a kasuwar Huanan Seafood Wholesale, inda ake zargin cewa cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da annobar da ake kira SARS-CoV-2, sabon kwayar cutar da aka gano tana kama da kwayar cutar coronavirus a cikin kwari, farfadowa da SARS-CoV. An gano farkon mutum da ke nuna alamun cutar a ranar 1 ga Disamba, 2019, kuma mutumin bai yi hulɗa da mutanen da ke cikin shagon ba.
An sake samun wasu cututtuka a watan Disamba na shekarar 2019, inda kashi biyu bisa uku na su suka shafi wannan cibiyar.
A ranar 3 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba da South China Morning Post ya ruwaito cewa cutar da aka gano a ranar 17 ga Nuwamba, 2019, wanda ya shafi wani mutum mai shekaru 55 a lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ba da sanarwar cewa sabbin kamuwa da cuta sun ragu a China amma suna ƙaruwa sosai a Italiya, Iran da Koriya ta Kudu, tare da sabbin kamuwa da cuta a wajen China sun zarce sabbin kamuwa da cuta a China a karon farko.
Wataƙila akwai ƙarin waɗanda ba a sanar da su ba; musamman waɗanda ke da ƙananan alamun cutar.
Har zuwa 26 ga watan Fabrairu, an samu karamin adadin masu kamuwa da cutar a tsakanin matasa, wanda ya kai kashi 2.4% na masu kamuwa da cutar a duniya. Mai ba da shawara kan kimiyyar gwamnati Patrick Vallance ya ce kashi 60% na mutanen Burtaniya na iya kamuwa da cutar kafin a yi musu allurar rigakafi.
Cutar ta shafi yawan mutanen da aka gwada su da cutar COVID-19, kuma an tabbatar da sakamakon ne bisa ka'idojin gwamnati.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada kashi 3% na yawan jama'arta, kuma ƙasashe da dama kamar Italiya, Netherlands, Spain da Switzerland sun kafa ƙa'idodin rashin gwada waɗanda ke da ƙananan alamun.
Binciken da aka fitar a ranar 16 ga Maris ya nuna cewa a ranar 23 ga Janairu, kashi 86% na mutanen da ke da cutar COVID-19 a China ba a gano su ba, kuma kashi 79% na wadanda ba a gano su ba ne suka kamu da cutar.
Binciken da aka yi a ranar 30 ga Maris ya nuna cewa adadin wadanda suka kamu da cutar a Italiya ya fi na wadanda aka sanar.
Adadin sabbin kamuwa da cutar (R0) na COVID-19 zai kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta fitar ya ce wannan adadi zai iya kaiwa 5.7.
Yawancin waɗanda suka kamu da COVID-19 suna warkewa.
A cikin marasa lafiya, lokacin bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, amma mafi yawan kwanaki 14.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutane 97,000 sun mutu sakamakon COVID-19.
A China, har zuwa 5 ga Fabrairu, kashi 80% na waɗanda suka mutu sun haura shekaru 60, kuma kashi 75% sun riga sun kamu da wasu cututtuka ciki har da cututtukan zuciya da ciwon sukari. Adadin da gwamnati ta bayar na mutuwar COVID-19 ya kasance mafi yawa ga mutanen da aka gwada su da COVID bisa ga ka'idojin gwamnati.
Adadin mutuwar COVID-19 na iya zama mafi girma fiye da yadda aka bayyana, saboda ba ya haɗa da mutuwar da ba a gwada su ba, misali, waɗanda suka mutu a gida, a wuraren kulawa da gaggawa, da sauransu.
Wasu bayanai daga Italiya sun nuna cewa adadin mutanen da suka mutu a wannan lokacin na annobar ya fi na COVID da aka ba da rahoton gwamnati sau 4-5.
"Mun san cewa adadin mutanen da suka mutu ba su dace da ainihin adadin wadanda suka mutu ba", in ji mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC), "kuma wannan ya yi daidai da rahoton da aka bayar cewa ba a sami ceto ba a Amurka. Yawancin lokaci ana samun ceto a lokacin annobar kamar yadda aka yi a lokacin annobar cutar sankara ta 2009 H1N1. An tabbatar da mutuwar farko a ranar 9 ga Janairu, 2020.
A ranar 1 ga watan Fabrairu ne mutum na farko da ya mutu a waje da China ya bayyana a Philippines, yayin da mutum na farko da ya mutu a waje da Asiya ya bayyana a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, fiye da mutane goma sha biyu a kasashen waje da suka hada da China sun mutu a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, sama da kasashe da yankuna arba'in ne suka sanar da mutuwar mutane, a duk nahiyoyi sai Antarctica. Ana amfani da matakan da dama a wurare daban-daban don lissafin adadin mutuwar.
Wannan adadi ya bambanta daga yanki zuwa lokaci, kuma ya dogara da matakan da aka ɗauka, aikin kiwon lafiya, magani, lokacin da cutar ta faru da yanayin al'umma kamar shekaru, jinsi da kuma lafiyar jama'a. Matsakaicin adadin mutuwar masu kamuwa da cutar ya nuna adadin mutuwar da adadin masu kamuwa da cutar a wani lokaci.
Bisa ga bayanan Jami'ar Johns Hopkins, matsakaicin adadin mutuwar mutane 6.0% (97 039/1 617 204) ya kasance a ranar 10 ga Afrilu 2020.
Adadin yana bambanta dangane da yankin.
A kasar Sin, matsakaicin adadin mutuwar masu kamuwa da cutar ya ragu daga kashi 17.3% (ga wadanda suka nuna alamun cutar a ranar 1-10 ga Janairu 2020) zuwa kashi 0.7% (ga wadanda suka nuna alamun cutar bayan 1 ga Fabrairu 2020). Sauran matakan sun hada da yawan mutuwar (CFR), wanda ke nuna yawan wadanda suka kamu da cutar da suka mutu, da kuma yawan kamuwa da cuta (IFR), wanda ke nuna yawan wadanda suka kamu da cutar (wadanda aka gwada ko ba a gwada su ba) da suka mutu.
Wannan lissafin ba na asali ba ne kuma yana bin wasu takamaiman mutane daga kamuwa da cutar zuwa warkewa ko mutuwa.
Jami'o'i da yawa sun yi ƙoƙari su ƙidaya yawan mutanen da suke cikin wannan rukunin.
Cibiyar Kula da Bayanai ta Jami'ar Oxford ta ce yawan kamuwa da cutar a duniya ya kai tsakanin kashi 0.1% da 0.39%.
Wannan adadin ya yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus da kuma adadin mutuwar da aka yi bisa gwajin.
Hukumar lafiya ta duniya WHO ta ce za a iya shawo kan annobar.
Ba a san lokacin da za a iya yaduwar cutar ba kuma tsawon lokacin da za a iya kamuwa da cutar ba kuma yana iya canzawa daga yanki zuwa yanki.
Maciej Boni na Jami'ar Jihar Penn ya ce: "Ba tare da kulawa ba, cututtukan cututtukan cututtuka sukan kasance a cikin wani lokaci kuma suna fara raguwa lokacin da cututtuka suka rasa masu cutar.
Amma yana da wuya a yi hasashen abin da zai faru a ƙarshen zamani.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, Zhong Nanshan, ya ce: "Wannan annoba na iya karewa a watan Yuni" lokacin da dukkan kasashe suka bi shawarar da WHO ta bayar na dakile yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magunguna ta London (London School of Hygiene & Tropical Medicine) ya ce SARS-CoV-2  zai yi tafiya daga wuri zuwa wuri, mai yiwuwa na shekara daya ko biyu.
A cewar wani bincike da kwalejin Imperial College ta gudanar karkashin jagorancin Neil Ferguson, ya kamata a kiyaye keɓewar mutane da sauran matakan "har sai an samu rigakafin (a cikin watanni 18 ko fiye).
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar, saboda yawan yaduwarta, za ta kare gaba daya" kuma "za ta iya zama wata cuta ta lokaci-lokaci, kuma ta sake dawowa kowace shekara".
Komawar wannan kwayar cutar mai saurin yaduwa zai kasance ne saboda rashin lafiyar jikin mutum da kuma sauyin kwayar cutar.
Alamun COVID-19 na iya zama na musamman kuma mutanen da ke kamuwa da cutar na iya zama marasa alamun.
Mafi yawan alamun cutar sune zazzabi (88%) da kuma tari (68%).
Alamun da ba safai ba su haɗa da gajiya, rashin jin daɗi, rashin wari, rashin numfashi, ciwon hanci da ciwon hanci, ciwon wuya, ciwon kai, sanyi, amai, tari mai jini, tari ko kuma launin shudi. WHO ta ce kusan mutum ɗaya cikin shida zai kamu da cutar kuma ya sami matsalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar cewa alamun cutar sun haɗa da matsalolin numfashi, ciwon kirji ko ciwo, rikicewar lokaci, wahalar farkawa, ciwon ido ko lebe, kuma ana ba da shawarar cewa waɗanda ke da waɗannan halayen su nemi taimakon likita nan da nan idan alamun ba su warke ba. Idan cutar ta ci gaba, za ta iya haifar da rashin nutsuwa, matsalolin numfashi mai tsanani, zub da jini, cututtukan ciki, da mutuwa.
Idan wasu masu kamuwa da cutar ba su nuna alamun cutar ba, kuma ba su nuna alamun cutar ba amma sakamakon gwajin ya nuna cewa suna da cutar, masu bincike sun ba da shawarar cewa a kula da waɗanda suka yi hulɗa da waɗanda aka tabbatar da cutar.
Kasar Sin ta ce yawan mutanen da ba su da alamun cutar ya ragu zuwa kashi 44 cikin dari.
Lokaci na al'ada na bayyanar cututtuka (lokaci tsakanin kamuwa da cuta da bayyanar cututtuka) daga rana ɗaya zuwa kwanaki 14; yawanci kwanaki kaɗan. Wani misali mai ban mamaki shine ƙididdigar waɗanda ke da COVID-19 waɗanda ba su da ƙanshin ƙanshi tun daga 30% zuwa 15%.
Ba a san wasu bayanai game da yadda cutar ke yaduwa ba.
An yi imanin cewa cutar tana yaduwa ne ta hanyar kusanci da ruwa mai guba wanda ke faruwa yayin da mutum ya yi ta yin tari, tsotsa, ko kuma kusanci da wani mutum a cikin ƙasa da mita 1 ko 2.
Bincike ya nuna cewa yin tsotsa ba tare da rufe fuska ba zai iya sa ruwa ya kai tsawon kafa 15 zuwa ashirin.
Wasu kuma sun ce kwayar cutar na iya yaduwa ta hanyar iska mai tsawo, wanda zai iya fitowa yayin magana. Hakanan za a iya fitar da ruwan numfashi ta hanyar numfashi yayin magana, wanda shine mafi yawan kwayar cutar da ke yaduwa ta iska.
Wannan ruwan zai iya shiga cikin hanci ko baki ko kuma cikin hanci na mutane masu kusanci ko kuma cikin numfashi zuwa cikin huhu.
Wasu hanyoyin magani kamar su numfashi da kuma CPR na iya sa wannan ruwan numfashi ya shiga iska kuma cutar ta yadu ta hanyar iska.
Ana iya yada shi ta hanyar taɓawa da keɓaɓɓen wuri mai cutar, kamar fata da kuma fuska, hanci, ko baki.
Yayin da ake fargabar cewa za a iya samun cutar ta hanyar hasken rana, ana ganin cewa wannan hadarin ba shi da yawa.
Gwamnatin China ta musanta cewa SARS-CoV-2 ya yadu ne daga hanjin mutum da ke dauke da cutar da kuma kwayar cutar da ke shiga cikin bakin mutum. Kwayar cutar tana yaduwa sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya yaduwa kafin bayyanar cututtuka da kuma lokacin tsananin cutar.
Mutanen da aka gwada su kuma suka gano cutar a cikin kwanaki uku kafin bayyanar cututtuka, suna iya kamuwa da cutar kafin bayyanar cututtuka.
An samu rahotanni kadan na kamuwa da cutar ba tare da bayyanar cututtuka ba wanda aka tabbatar da shi ta hanyar gwaji, amma an gano kamuwa da cutar ba tare da bayyanar cututtuka ba a wasu ƙasashe yayin gwajin da aka yi a kan mutanen da suka yi hulɗa da cutar.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta ce ba a bayyana yadda sauƙin kamuwa da cutar yake ba, wanda ke iya kamuwa da mutane biyu ko uku. Kwayar cutar tana rayuwa tsawon awanni ko kwanaki a wasu wurare.
Musamman, kwayar cutar na iya wucewa har zuwa kwanaki uku a kan kayan roba (porporopyrene) da kwanaki 304 a kan bakin karfe, rana ɗaya a kan kwali da har zuwa kwanaki huɗu a kan tagulla.
Koyaya, ya bambanta dangane da yanayin zafi da zafin jiki. Dabbobi da sauran dabbobi da aka gwada sun nuna COVID-19.
Babu wata hujja da ke nuna cewa dabbobi na iya yada kwayar cutar zuwa ga mutane, duk da cewa hukumomin Birtaniya sun ba da shawarar wanke hannu bayan sun taba dabbobi da kuma bayan sun taba wuraren da mutane masu cutar suka taɓa.
Kwayar cutar korona mai saurin kamuwa da mura (SARS-CoV-2) sabuwar kwayar cuta ce, wacce aka samo daga mutane uku da suka kamu da cutar mura mai kama da cutar mura ta Wuhan.
Dukkanin nau'ikan kwayar cutar SARS-CoV-2 suna da kamanceceniya da kwayar cutar coronavirus. Ba a jikin mutum ba, kwayar cutar tana kashe ta hanyar sabulu na gida wanda ke lalata da kuma rufe shi. Kwayar cutar SARS-CoV-2 tana da kamanceceniya da kwayar cutar SARS-CoV.
An gaskata cewa ya fito ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar korona ta kasance a cikin rukuni daya da kwayar cutar Betakorona, wacce ke cikin kwayar cutar Sarbecovirus (kwayar B) kuma dukansu sun samo asali ne daga kwari.
Ya bayyana a kashi 96% tare da sauran kwayoyin halittar coronavirus na BatCov RaTG13.
A watan Fabrairun 2020, masu bincike a China sun gano cewa akwai bambanci na amino acid guda daya a tsarin kwayoyin halittar tsakanin kwayar cutar da aka samo daga dabbobi masu shayarwa da kuma na mutane.
Ya zuwa yanzu, kwatancen dukkanin kwayoyin halitta ya nuna cewa kashi 92% na kwayoyin halitta na coronavirus na dabbobi masu shayarwa sun hada da SARS-CoV-2, wanda bai isa ya tabbatar da cewa dabbobi masu shayarwa ne suka kamu da cutar ba.
Ana iya gwada kwayar cutar a ɗan lokaci bisa ga alamun cutar, yayin da ake jiran tabbataccen tabbaci ta hanyar gwajin rRT-PCR na kwayoyin cutar ko CT.
Nazarin PCR da CT da aka yi a Wuhan ya nuna cewa CT ya fi PCR nuna yanayin kwayar cutar, kodayake ba a bayyana shi sosai ba, wasu daga cikin abubuwan da ke cikin wannan tsarin na dakin gwaje-gwaje suna da alaƙa da wasu hanyoyin gwajin cutar sankarar bargo da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazarin Nazar Nazar Nazarin Nazarin Nazar Nazar Nazar Nazar Nazar
WHO ta sanar da wasu ka'idoji na bincike na RNA na SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Ana yin gwajin ne ta hanyar gwajin rRT-PCR na zamani.
Ana iya yin gwajin ne a kan samfurori da aka samu daga hanyar numfashi ko jini.
Sau da yawa, ana samun amsoshi cikin sa'o'i ko kwanaki.
Ana yin wannan gwajin ne ta hanyar yin amfani da na'urar daukar hanci ko da yake ana iya yin amfani da na'urar daukar hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna yin amfani da na'urar daukar jini don gano kwayoyin cuta.
Ya zuwa ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan hanyoyin da suka tabbatar da cewa suna ba da cikakkun bayanai don amfani da su a wurare da yawa.
A Amurka, an amince da gwajin jini na Cellex a matsayin magani amma ana amfani da shi ne kawai a dakunan gwaje-gwaje masu lasisi.
Ana amfani da allurar daukar hoto da CT don tantance mutanen da ke nuna alamun cutar, kamar su rashin kamuwa da cutar GMO ko kuma samun ruwa a cikin huhu.
Kungiyar likitanci ta Italiya ta samar da wani babban rumbun adana bayanai na duniya game da sakamakon gwajin da aka yi wa wadanda suka kamu da cutar.
Saboda alaƙa da wasu cututtuka kamar adenovirus, gwajin PCR na ƙarfe ba zai iya nuna cutar COVID-19 ba.
Wani babban bincike da aka gudanar a kasar Sin ya kwatanta sakamakon CT da PCR na kirji kuma ya nuna cewa ko da yake gwajin na'urar daukar hoto ba ya nuna cutar, amma yana nuna yanayin kwayar cutar cikin sauri kuma a fili, wanda ake ganin shine hanyar da za a iya yin gwajin cutar.
An tsara tsarin CNN na hankali na zamani don gano yanayin kwayar cutar ta hanyar daukar hoto da CT.
Matakan da ake ɗauka don hana yaduwar cutar sun haɗa da tsaftace jiki, wanke hannu, guje wa taɓa fuska, hanci ko baki ba tare da wanke hannu ba, da yin tari ko fitsari da tawul da nan da nan a jefa shi a cikin shara.
An shawarci waɗanda suka kamu da cutar da su sanya abin rufe fuska a wuraren taruwa.
Ka'idojin hana saduwa suna da mahimmanci wajen hana yaduwar cutar. Yawancin jihohi sun hana ko kuma sun nemi mutane kada su yi tafiye-tafiye marasa mahimmanci zuwa ko daga ƙasashe da wuraren da cutar ta ɓarke.
Amma a yawancin sassan duniya, cutar ta kai ga yaduwa daga mutum zuwa mutum.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma wasu daga cikin al'umma ba su san inda suka kamu da cutar ba da kuma yadda suka kamu da ita. Ana ba da shawarar masu ba da kiwon lafiya da ke kula da wanda ke da cutar su bi ƙa'idodin kiyayewa, ƙa'idodin hana saduwa, da kuma kariya ta fuska. Binciken abokan hulɗa na mai cutar yana da mahimmanci ga hukumomin kiwon lafiya don gano asalin kamuwa da cutar da kuma hana ƙarin yaduwa.
Amfani da bayanan wurin da gwamnati ke amfani da wayar salula ya haifar da damuwar sirri inda Amnesty International da kungiyoyi sama da 100 suka fitar da sanarwa da ke neman a dakatar da wannan tsarin na sa ido.
An kirkiro wasu aikace-aikace ko kuma an nemi a yi amfani da su a kai a kai, sannan a ranar 7 ga Afrilu, 2020, ƙungiyoyin masana sama da dozin biyu sun nemi mafita mai zaman kanta kamar amfani da fasahar Bluetooth don adana bayanan wayoyin hannu da suka haɗu.
Masu amfani da wayar salula suna karɓar saƙo idan sun taɓa yin hulɗa da mutumin da aka gwada yana da cutar COVID-19. Akwai wasu bayanan da ba daidai ba game da hanyoyin kariya; misali, hanci da kuma maganin shafawa na baki ba sa kashe kwayar cutar.
Babu allurar rigakafin COVID-19, amma akwai kamfanoni da yawa da ke samar da ita.
Wanke hannu yana da mahimmanci don hana yaduwar cututtuka.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na akalla sakan ashirin; musamman, bayan sun fita daga banɗaki ko kuma idan hannayensu sun kasance da ƙazanta, kafin cin abinci, bayan yin taushi, tari ko fitsari.
Wannan ya faru ne saboda cewa idan aka kashe kwayar cutar a waje da jikin mutum, sabulu na gida yana da ikon karya shingen da ke rufe kwayar cutar.
CDC ta kuma bada shawarar amfani da maganin wanke hannu wanda ya ƙunshi aƙalla kashi 60% na barasa lokacin da sabulu da ruwa ba su samuwa.
WHO ta ba da shawarar kada mutane su taɓa fuska, hanci, ko baki da hannaye marasa tsabta.
Kwayoyin cuta da ke cikin wurare daban-daban na iya kashewa ta hanyar maganin rigakafi (a cikin minti ɗaya bayan haɗuwa da maganin rigakafi akan bakin karfe), gami da 6271% na ethanol, 50100% na isoporopanor, 0.1% na sodium hypochlorite, 0.5% na hydrogen peroxide da 0.27.5% na povidone iodine.
Sauran magunguna kamar su benzariconium corride da korohexysidine gurukonate, ba su kashe kwari yadda ya kamata ba.
CDC ta ba da shawarar cewa idan ana zargin ko an tabbatar da cutar ta COVID a cikin ofisoshin ko wuraren kula da yara, duk wuraren da ake ciki kamar ofisoshi, wuraren wanka, wuraren taruwa, kayan aikin zamani kamar su allunan hannu, fuskokin hannu, bangarorin rubutu, kwamfutar tafi-da-gidanka da na'urar ATM da aka yi amfani da su ta hanyar marasa lafiya, dole ne a yi musu maganin kashe ƙwayoyin cuta.
Ma'aikatun kiwon lafiya sun bukaci mutane su rufe bakinsu da hancinsu da wani abin rufe baki ko kuma tawul lokacin da suke tari ko yin tari kuma su watsar da tawul ɗin nan da nan.
Masks na likita sune mafi kyau ga waɗanda ke da cutar, saboda sanya abin rufe fuska yana hana yawan magunguna da ruwa da ke fitowa yayin magana, hancin da tari.
Hukumar lafiya ta duniya WHO ta fitar da ka'idoji kan lokacin da kuma yadda ake sanya abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin kwayar cuta a Jami'ar Leeds, Sanya abin rufe fuska yana rage yawan taɓa fuska, wanda shine mafi yawan kamuwa da cuta idan ba a wanke hannaye yadda ya kamata ba. Ana amfani da abin rufe fuska a cikin masu kula da wanda ke da cutar.
WHO ta ba da shawarar cewa mutanen da ba su da cutar su sanya abin rufe fuska ne kawai idan suna da babban haɗarin kamuwa da cutar, kamar su kula da wanda ke da COVID-19, kuma ta yarda cewa sanya abin rufe fuska yana hana mutane taɓawa fuska.
Kasashe da dama sun fara karfafawa 'yan kasarsu gwiwa kan sanya abin rufe fuska.
A Amurka, CDC ta bukaci mutane su sanya abin rufe fuska da aka yi da kayan da ba na likita ba. Musamman, China ta bukaci mutanen da ba su da cutar su yi amfani da abin rufe fuska na likita da aka zubar bayan an yi amfani da su musamman idan sun kusanci wasu a nesa da ƙasa da mita 1.
Hong Kong ta bukaci mutane su sanya abin rufe fuska na likita lokacin da suke tafiya ko kuma a wuraren da jama'a suke.
Jami'an kiwon lafiya a Thailand za su karfafa mutane su yi amfani da abin rufe fuska da aka yi da tufafi a gida da kuma wanke su a kullum.
A Jamhuriyar Czech da Slovakia an hana mutane fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska a wuraren taruwa don kare kansa da kuma wasu.
Gwamnatin Ostiraliya ta bukaci duk wanda ya shiga kantin sayar da abinci ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasa da su sanya abin rufe fuska a wuraren taruwa.
1 ga Afrilu; Taiwan, wadda ke samar da abin rufe fuska sama da miliyan goma a kowace rana, ta bukaci fasinjojin jiragen kasa da na bas da ke zirga-zirga su sanya abin rufe fuska.
Panama ta sanya sanya abin rufe fuska a duk lokacin da ta fita waje, kuma ta bukaci yin abin rufe fuska na gida ga waɗanda ba za su iya sayan kayan da aka yi a masana'antu ba.
Ana amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Kauracewa kusanci (wanda kuma ake kira nisantar juna) ya ƙunshi ayyukan da ke nufin hana kamuwa da cutar don rage yaduwar kwayar cutar da kuma nisantar mutane.
Matakan sun hada da keɓewar mutane, hana tafiye-tafiye da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko shagunan.
Mutane za su iya yin amfani da tsarin ƙin kusanci ta hanyar zama a gida, rage tafiye-tafiye, guje wa taron jama'a, yin amfani da gaisuwa ba tare da haɗuwa ba, da kuma nisantar juna.
A halin yanzu, ƙasashe da yawa suna ba da umarni ko kuma ba da shawarar cewa mutane su guji hulɗa da juna a yankunan da cutar ta yadu.
An rage iyakar taron jama'a da hukumomin jihohi da cibiyoyin kiwon lafiya na Amurka ke buƙata daga mutane 250 (lokacin da aka san babu cutar COVID-19 a yankin) zuwa 50, daga baya zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron mutane sama da biyu. CDC ta shawarci tsofaffi da waɗanda ke da wasu cututtuka kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma rashin aikin rigakafi da ke cikin haɗarin kamuwa da cututtuka da cututtuka su zauna a gida idan sun sami damar kamuwa da cutar daga wasu. A ƙarshen Maris, 2020, WHO da sauran kungiyoyin kiwon lafiya sun fara amfani da kalmar "tsayawa kusa" a matsayin "tsayawa nesa da juna", suna mai da hankali kan kiyaye nesa tsakanin mutane.
Amfani da kalmar "kauracewa saduwa" ya sa mutane suyi tunanin cewa ya kamata su ware kansu, maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da umarni game da jima'i mai kyau a lokacin cutar.
Wannan umarnin ya ce kawai ya kamata ka yi jima'i da wanda kake da shi, wanda ba shi da kwayar cutar ko kuma alamun cutar.
Keɓe kai a gida ya zama dole ga mutanen da aka gwada sun kamu da COVID-19 ko kuma waɗanda ake zargin suna da cutar.
Cibiyoyin kiwon lafiya sun ba da cikakkun bayanai game da yadda za a keɓe kai. Kasashe da yawa sun ba da umarni ko sun buƙaci keɓewa ga duk waɗanda ke zaune a yankunan da ke da cutar.
An ba da umarnin keɓewa ga waɗanda ke cikin rukunin masu haɗarin kamuwa da cutar.
Wadanda suka iya kasancewa tare da mai cutar COVID-19 da kuma waɗanda suka yi tafiya kwanan nan zuwa ƙasashe ko yankuna masu kamuwa da cutar an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga ranar da suka iya kasancewa tare da cutar.
Matakan rigakafin cutar shine a hana ko dakatar da ita da kuma rage yaduwarta.
Ana gudanar da rigakafin ne a farkon barkewar cutar kuma yana nufin bi da kuma keɓe waɗanda suka kamu da cutar da kuma samar da ƙarin matakan rigakafi da allurar rigakafi don hana cutar daga yaduwa cikin sauran al'umma.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, sai a mayar da hankali kan rage yaduwar cutar: ana daukar matakai don rage yaduwar cutar da rage tasirin cutar a kan ma'aikatun kiwon lafiya da al'umma.
Za a iya ɗaukar matakan hanawa da rage yaduwar cutar a lokaci guda.
Dakatar da cutar na bukatar tsauraran matakai na dakile cutar ta hanyar rage yawan sabbin kamuwa da cutar zuwa kasa da 1.
Yana rage matsalolin kiwon lafiya na yawan marasa lafiya da kuma samun isasshen lokaci don neman allurar rigakafi da magani.
Hanyoyin da ba na maganin rigakafi ba sun hada da magance cutar ta hanyar matakan kariya na mutum kamar tsabtace gida, sanya abin rufe fuska da keɓewa; matakan keɓewa na al'umma kamar rufe makarantu da dakatar da ayyukan jama'a; yana buƙatar wayar da kan jama'a da amsawa; da kuma matakan muhalli kamar tsabtace wuraren da aka fi yawa. Sauran manyan matakan da aka ɗauka don magance cutar a China lokacin da cutar ta fara sun haɗa da keɓewar birane da sake kafa dokar hana zirga-zirga.
Sauran ƙasashe ma sun ɗauki matakai daban-daban don hana yaduwar cutar.
Koriya ta Kudu ta fara yin gwajin mutane da yawa da keɓe wasu yankuna da kuma sanar da tafiye-tafiye da ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar da suka keɓe kansu kuma ta sanya manyan tarar ga waɗanda ba su yi hakan ba.
Taiwan ta kara samar da abin rufe fuska da kuma hukunta masu satar kayayyakin kiwon lafiya. Har ila yau, Burtaniya da Amurka sun nuna cewa rage kamuwa da cuta (rage yawan kamuwa da cuta ba tare da dakatar da yaduwar cutar ba) da kuma hana shi (rage yawan sabbin kamuwa da cuta) sun kasance manyan matsaloli.
Matakan rage yawan kamuwa da cuta na iya rage yawan bukatar kula da lafiya da kashi biyu bisa uku da kuma mutuwar da kashi biyu, amma ba zai hana dubban mutane mutuwa ba kuma cibiyoyin kiwon lafiya na ci gaba da karbar adadin marasa lafiya.
Dakatar da barkewar cutar shine mafi kyawun zaɓi amma ya kamata a ci gaba da yin hakan muddin cutar ta bazu tsakanin mutane (ko kuma har sai an sami rigakafi, dangane da abin da ya faru a baya), ya zama mai yaduwa kuma cutar ta sake dawowa da zarar an sassauta matakan.
Aikin da aka yi na dogon lokaci na dakile cutar yana da matukar tasiri ga zamantakewar al'umma da tattalin arziki.
Babu wani magani na musamman da aka amince da shi don rage cutar COVID-19, amma ana ci gaba da aikin samar da shi, gami da nazarin magungunan da ke rage cutar.
Shan magungunan mura ba tare da takardar magani ba, shan ruwa mai yawa da hutawa na iya taimakawa wajen rage alamun cutar.
Saboda rashin lafiya, ana bukatar maganin oxygen, maganin ruwa, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya sa ka rashin lafiya.
Ana gudanar da bincike kan magungunan da aka amince da su don magance wasu cututtukan da ke haifar da kwayar cutar COVID-19.
Hukumar lafiya ta duniya WHO ta ce: "Kayan gargajiya da magunguna na gida na iya rage cutar SARS-CoV-19".
Ƙara iyawa da sauya fasalin da aka yi la'akari da bukatun cibiyoyin kiwon lafiya wajen kula da marasa lafiya da COVID-19 an bayyana shi ta WHO a matsayin babban mataki na magance cutar.
ECDC da Hukumar Kula da Lafiya ta Duniya ta WHO sun fitar da umarni ga asibitoci da masu samar da sabis na kiwon lafiya na asali don sauya ayyukan da aka yi amfani da su a wasu bangarori, kamar mayar da hankali kan ayyukan dakin gwaje-gwaje kan gwajin COVID-19, dakatar da ayyukan likita marasa mahimmanci, keɓewa da keɓewar waɗanda ke da cutar COVID-19, da haɓaka sabis na gaggawa ta hanyar horar da likitoci da haɓaka yawan na'urorin oxygen da gadaje.
Akwai bayanai daban-daban game da asalin kamuwa da cutar (wanda aka fara gano cutar) da kuma inda cutar ta fara.
An gano sabon kwayar cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya tashi.
Mafi yawan wadanda suka kamu da cutar sun kasance ne daga kasuwar Huanan Seafood Wholesale, inda ake sayar da dabbobi masu rai, kuma wasu bayanai sun nuna cewa cutar ta samo asali ne daga wasu daga cikin wadannan dabbobi; a wasu kalmomin, ta samo asali ne daga dabbobi. An gano wadanda suka kamu da cutar da ba a san dalilin da ya sa ba a ranar 26 ga watan Disamba kuma likita Zhang Jixian na asibitin lardin Hubei ya kula da su, in ji Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
A ranar 30 ga watan Disamba, wani kwamitin likitoci na asibitin Wuhan ya sanar da abokan aikinsa cewa akwai "SARS mai kama da kwayar cutar korona".
Likitoci takwas, ciki har da Li Wenliang, sun yi wa 'yan sanda tambayoyi game da yada jita-jita, yayin da wani, mai suna Ai Fen, ya shawo kan shugabanninsa game da bayyana batun.
Hukumar kiwon lafiya ta Wuhan ta fitar da sanarwar gama gari a ranar 31 ga watan Disamba tare da bayar da bayanai ga WHO.
An sanar da hukumomin kiwon lafiya game da yawan kamuwa da cutar sankarar bargo a Wuhan, wanda ya haifar da fara gwajin a farkon watan Janairu. Tun farkon barkewar cutar, masu kamuwa da cutar sun ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, wanda ya samo asali ne daga yaduwar zirga-zirgar ababen hawa a kasar Sin da kuma Wuhan, wanda shine babban cibiyar zirga-zirgar jiragen kasa tsakanin larduna.
A ranar 20 ga watan Janairu, kasar Sin ta sanar da kusan sabbin mutane 140 da suka kamu da cutar a cikin kwana daya, ciki har da biyu a Beijing da daya a Shenzhen.
Daga baya, bayanan gwamnati sun nuna cewa mutane 6,174 sun nuna alamun cutar a ranar 20 ga Janairu, 2020.Zuwa 26 ga Maris, Amurka ta zarce China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya.Zuwa 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 da suka kamu da cutar a duniya; tare da mutuwar sama da 97,000 da sama da 364,000 da suka warke.
Kusan kasashe 200 da yankuna sun sami mutum daya ko sama da haka da suka kamu da cutar.
Sakamakon barkewar cutar a Turai, ƙasashen yankin Schengen sun rage tafiye-tafiye kuma sun kafa matakan kariya a kan iyakoki.
Kasashe sun kafa matakan hana yaduwar cutar kamar su keɓewar kai (wanda kuma aka sani da dokar hana fita) da kuma takunkumi. Ya zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300 ko kusan kashi 90% na al'umma sun kasance a cikin irin wannan dokar hana fita a Amurka, kuma sama da miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu da mutane biliyan 1.3 a Indiya suna cikin dokar hana fita.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin tsarin dokar hana fita, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu, kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An fara gano cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; rahotanni marasa tushe sun ce an fara gano cutar ne a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ya bi sawun mutanen da suka kamu da cutar sankarar bargo a ranar 26 ga watan Disamba, kuma asibitin da yake aiki da shi ya sanar da Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin farko na kwayar halitta da aka yi wa marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai SARS mai kama da kwayar cutar.
Sanarwar ta fito ne daga Hukumar Lafiya ta Wuhan a ranar 31 ga watan Disamba.
An sanar da WHO a ranar.
A cikin sanarwar, 'yan sanda sun yi gargadin likitocin Wuhan kan "yaduwar jita-jita" game da cutar.
Hukumar lafiya ta kasar Sin ta fara sanar da cewa babu "bayanan da suka nuna" cewa mutum zai iya daukar kwayar cutar.
A karshen watan Janairu, gwamnatin China ta sanar da kaddamar da wani babban kamfen, wanda babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya bayyana cewa "mutane ne za su yi yakin" don hana yaduwar cutar.
A cikin abin da aka bayyana a matsayin "mafi yawan keɓewar keɓaɓɓu a tarihin ɗan adam", an sanar da dokar hana fita a ranar 23 ga Janairu tare da dakatar da zirga-zirga zuwa ko daga Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya kai kusan mutane miliyan 57.
An dakatar da motocin mutane a cikin gari.
An dakatar da bikin sabuwar shekara ta kasar Sin (25 ga Janairu) a wurare da dama.
Jami'ai sun kuma sanar da cewa za a gina asibitin wucin gadi na Huoshenshan, wanda aka gina cikin kwanaki 10.
An gina wasu asibitoci a baya kamar asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitoci da aka gina, kasar Sin ta maida wasu gine-gine 14 a Wuhan, gine-gine na taro da filayen wasa zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta ba da ƙarin umarni kan yadda za a magance cutar COVID-19, gami da samar da ka'idojin kiwon lafiya ga matafiya da kuma tsawaita hutun bazara.
Jami'o'i da makarantu a kasar ma sun rufe.
Yankunan Hong Kong da Macau sun dauki matakai daban-daban; musamman, game da makarantu da jami'o'i.
An dauki matakan yin aiki ta nesa a yankuna daban-daban na kasar Sin.
An fara aiwatar da dokar hana zirga-zirga a ciki da wajen Hubei.
An sauya hanyoyin sufuri na jama'a kuma an rufe gidajen tarihi na kasar Sin na ɗan lokaci.
An gudanar da sa ido kan tafiye-tafiyen jama'a a birane da dama, inda aka ce kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun shiga dokar hana fita. Bayan barkewar cutar a watan Maris, hukumomin kasar Sin sun dauki matakan tsaurara don hana cutar " shiga kasar " daga wasu kasashe.
Misali, Beijing ta kafa dokar hana fita na kwanaki 14 ga duk wani dan kasashen waje da ya shigo birnin. A ranar 23 ga watan Maris, mutum daya ne a kasar Sin ya kamu da cutar a cikin kwanaki biyar da suka gabata, wanda ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an samu nasarar shawo kan yaduwar cutar a cikin gida, kuma an shawo kan annobar a kasar Sin.
A ranar 26 ga Maris, 2020, Ma'aikatar Harkokin Wajen kasar Sin ta sanar da cewa an dakatar da masu shigowa da ke da takardar izinin shiga ko izinin zama daga ranar 28 ga Maris, ba tare da ba da takamaiman bayani kan lokacin da dokar ta ƙare ba.
Wadanda suke son shiga kasar Sin dole ne su nemi biza a ofishin jakadancin China.
30 ga Maris; gwamnatin kasar Sin ta bukaci masu sana'ar kasuwanci da masana'antu da su sake budewa, tare da bayar da tallafin kudi don farfado da harkokin kasuwanci. Majalisar gwamnati ta sanar da fara ranar makoki ta minti uku a duk fadin kasar da za a fara a karfe 10:00 na ranar 4 ga Afrilu, wanda ya yi daidai da bikin al'adun Qingming, inda gwamnati ta bukaci iyalai su yi addu'o'i ta hanyar yanar gizo don hana haɗuwa da kuma hana sake barkewar cutar COVID-19.
A ranar 20 ga Janairu, an tabbatar da cewa COVID-19 ya isa Koriya ta Kudu daga China.
A ranar 20 ga watan Fabrairu, Ma'aikatar Lafiya ta kasa ta sanar da karuwar wadanda suka kamu da cutar, musamman sakamakon taron da aka yi a Daegu na sabon addini da ake kira Shincheonji Church of Jesus.
An zargi mabiya Shincheonji da suka ziyarci Daegu daga Wuhan da haddasa cutar.
A ranar 22 ga watan Fabrairu, adadin masu bin addinin na 9,336, wanda 1,261 ko kusan 13% suka ba da rahoton cewa suna da alamun cutar. A ranar 23 ga watan Fabrairu, 2020, Koriya ta Kudu ta ba da rahoton mafi yawan adadin masu kamuwa da cutar.
A ranar 28 ga watan Fabrairu, an tabbatar da mutane sama da 2,000 da suka kamu da cutar a Koriya, kuma a ranar 29 ga watan Fabrairu, adadin ya kai 3,150.
An killace dukkan cibiyoyin sojin Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin zirga-zirgar jiragen sama, saboda haka an canza su. Koriya ta Kudu ta ƙaddamar da tsarin gwajin cutar, wanda aka ɗauka a matsayin mafi girma kuma mafi dacewa a duniya don gwada yawan jama'a game da cutar, da kuma bin diddigin da keɓe waɗanda suka haɗu da waɗanda suka kamu da cutar.
Tsarin gwajin ya hada da gano lokacin da akwai alamun cutar a kan masu shigowa daga kasashen waje ta hanyar manhajar wayar salula, gwajin cutar a kan mutanen da ba su sauka daga motar ba inda sakamakon ya bayyana a washegari, da kuma kara karfin gwajin zuwa mutum 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin wanda ya yi nasara wajen hana barkewar cutar ba tare da sanya dukkan biranen cikin keɓewa ba. Da farko dai, mutanen Koriya ta Kudu sun nuna rashin jituwa kan yadda Shugaba Moon Jae-in ya magance cutar.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a gurfanar da Moon a gaban kotu saboda rashin kulawar gwamnati kan cutar, wasu kuma sun yaba da yadda ta magance cutar.
A ranar 23 ga watan Maris, an sanar da cewa Koriya ta Kudu tana da mafi karancin adadin masu kamuwa da cutar a kowace rana a cikin makonni huɗu.
A ranar 29 ga watan Maris, an sanar da cewa daga ranar 1 ga watan Afrilu, duk wanda ya shigo daga kasashen waje dole ne ya keɓe kansa na tsawon makonni biyu.
A ranar 1 ga Afrilu, kamar yadda kafofin watsa labarai suka ruwaito, Koriya ta Kudu ta sami buƙatun ƙasashe 121 don taimaka mata wajen gwada kwayar cutar.
A ranar 18 ga watan Fabrairu, Iran ta sanar da cewa an samu mutum na farko da ya kamu da cutar SARS-CoV-2 a Qom, tare da mutuwar mutum biyu a ranar, a cewar Ma'aikatar Lafiya da Ilimin Kiwon Lafiya.
Matakan farko da gwamnati ta sanar sun hada da dakatar da bukukuwa da sauran ayyukan al'adu, wasanni, sallar Juma'a, rufe jami'o'i, gidajen shakatawa da makarantun.
Iran ta bayar da dala tiriliyan biyar don yaki da cutar.
A ranar 26 ga Fabrairu, 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na keɓe wuraren da cutar ta bulla, amma kawai waɗanda ke da cutar ne za a keɓe.
An sanar da shirin rage zirga-zirgar birane a watan Maris, kodayake an ci gaba da yawan zirga-zirgar birane kafin bikin murnar shekara ta Farisa ta Nowruz.
Masallacin Shia na Qom ya ci gaba da budewa masu yawon bude ido har zuwa 16 ga Maris, 2020.A watan Fabrairu, Iran ta samu adadi mafi girma na masu kamuwa da cutar bayan China.
An ci gaba da zargin Iran da ɓoye adadin waɗanda suka kamu da cutar, inda a ranar 28 ga Fabrairu sama da ƙasashe goma suka bi diddigin waɗanda suka kamu da cutar daga Iran; yana nuna cewa cutar na iya zama mafi muni fiye da mutane 388 da gwamnatin Iran ta ba da rahoton cutar a wannan kwanan wata.
Majalisar dokokin Iran ta dakatar da aiki, inda 23 daga cikin mambobinta 290 suka kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch (HRW) ta bukaci hukumomin tsare-tsare na Iran da su saki masu fafutukar kare hakkin dan Adam da aka tsare saboda nuna rashin amincewarsu da gwamnati ba tare da wani takunkumi ba, da kuma sakin duk fursunonin da aka yarda da su.
Ya kara da cewa zai iya zama da haɗari sosai idan cutar ta yaɗu a cikin ƙananan wurare kamar gidajen kurkuku, inda ba a samun isasshen magani.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shine mafi girma a kasar tun bayan barkewar cutar.
17 ga Maris, aƙalla 'yan siyasa ko ma'aikatan gwamnati 12 da ke aiki ko kuma waɗanda suka yi aiki a Iran sun mutu sakamakon cutar.
Har zuwa ranar 23 ga watan Maris, ana samun sabbin kamuwa da cutar a kowace awa 50 a Iran kuma mutum daya na mutuwa a kowane minti goma daga cutar coronavirus.
Wani jami'in WHO ya ce akwai yiwuwar cewa adadin wadanda suka kamu da cutar a Iran ya ninka na wadanda aka samu.
An kuma ce takunkumin Amurka kan Iran na iya shafar ikon tattalin arzikin kasar wajen yaki da cutar.
Kwamitin kare hakkin dan adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki kan kasashen da cutar ta shafa ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da isowar cutar a Italiya lokacin da aka gwada wa wasu 'yan yawon bude ido biyu na kasar Sin cutar SARS-CoV-2 a Rome.
Cutar ta fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk zirga-zirgar jiragen sama daga China kuma ta ba da sanarwar dokar ta baci.
An gano mutane da dama da suka kamu da cutar COVID-19 inda a ranar 21 ga watan Fabrairu, an samu mutane 16 da suka kamu da cutar a Lombardy. A ranar 22 ga watan Fabrairu, Majalisar Ministocin ta ba da sanarwar sabon dokar hana yaduwar cutar, wanda ya hada da keɓe mutane sama da 50,000 a birane daban-daban na arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce: "An hana shiga da fita daga yankunan da ake fama da cutar.
An riga an umarci dakatar da ayyuka da ayyukan wasanni a yankunan.A ranar 4 ga Maris, gwamnatin Italiya ta umarci rufe makarantu da jami'o'i a duk faɗin ƙasar, yayin da Italiya ta yi asarar rayuka 100.
Duk manyan wasannin wasanni, ciki har da wasannin gasar cin kofin Italiya, an buga su ba tare da magoya baya ba har zuwa watan Afrilu; amma a ranar 9 ga Maris, an sanar da dakatar da duk wani wasan motsa jiki na akalla wata daya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya bukaci dakatar da kusan dukkan ayyukan kasuwanci ban da kantin sayar da kayayyaki da kantin magani. A ranar 6 ga watan Maris, Kwalejin SIAARTI a Italiya ta ba da umarnin likita game da hanyoyin gwajin da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasa da ta fi kowacce mutuwa a duniya sakamakon cutar coronavirus bayan ta bayar da rahoton mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta tura jiragen sama tara na soja dauke da kayan aikin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da kamuwa da cutar 128,948, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, yawancinsu a yankin Lombardy.
Rahoton CNN ya nuna cewa yawan tsofaffi a Italiya da kuma rashin iyawar yin gwajin cutar a wannan lokacin na iya haifar da yawan mutuwar.
A baya dai, an ga cewa matakin da Birtaniya ta dauka na yaki da cutar ya yi kasa da kasa; kuma har zuwa ranar 18 ga watan Maris na shekarar 2020, gwamnatin Burtaniya ba ta kafa dokar keɓewa ko kuma ta keɓe kai ba.
Saboda haka, gwamnati ta zarge shi da rashin hanzarta aiki da kuma tsaurara matakan magance cutar. A ranar 16 ga Maris, Firayim Ministan Burtaniya Boris Johnson ya sanar da cewa duk tafiye-tafiye marasa mahimmanci da tarurrukan jama'a an hana su, yana ba da shawarar mutane su yi aiki daga gida a duk lokacin da zai yiwu kuma su guji wuraren taruwa kamar mashaya, gidajen cin abinci da gidajen sinima.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya, wuraren motsa jiki da wuraren shakatawa za a rufe su da wuri-wuri, kuma ta yi alƙawarin biyan har zuwa kashi 80% na albashin ma'aikata da kuma ba fiye da fam 2,500 a wata don hana rashin aikin yi a lokacin annobar. A ranar 23 ga Maris, Firayim Minista ya sanar da cewa an kafa matakan hana kusanci, hana haɗuwa da mutane fiye da biyu, dakatar da tafiye-tafiye da ayyukan waje da abubuwan da suka zama dole.
An riga an dauki wasu matakai daban-daban, wadanda suka hada da sanya wa 'yan sanda tara da kuma korar masu halarta.
An umarci a rufe yawancin kasuwancin, ban da ayyukan da ake ɗauka da "bukatarwa", ciki har da kantin sayar da abinci, kantin magani, bankunan, shagunan kayan gini, tashoshin mai da iskar gas da gidajen abinci.
A ranar 20 ga watan Janairu, an tabbatar da mutum na farko da aka gano yana dauke da cutar COVID-19 a yankin Pacific Northwest na jihar Washington, wanda mutum ne da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu, an kafa Kwamitin Shugaban Amurka kan cutar coronavirus.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana gagarumar matsalar lafiya ta kasa, kuma ta sanya dokar hana shigowa daga kasar Sin.
A ranar 28 ga Janairu, 2020, CDC, babbar hukumar kula da lafiyar jama'a ta Amurka, ta sanar da cewa ta samar da kayan aikin da za a yi amfani da su wajen gano cutar.
Duk da wannan, Amurka ta fara gwajin cutar a hankali, wanda bai bayyana ainihin yanayin cutar ba a lokacin.
Binciken kwayar cutar da aka cire daga wuyan hannu da kayan aikin da ba su da inganci da gwamnatin Amurka ta yi a watan Fabrairu, rashin amincewar gwamnatin Amurka da kayan aikin da ba ta yi ba (kamar na jami'o'i, kamfanoni da asibitoci) har zuwa karshen watan Fabrairu, da kuma umarnin da aka ba wa waɗanda suka sami izinin yin gwajin har zuwa farkon Maris (bayan da ake buƙatar takardar izinin likita).
Har zuwa ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa an gwada mutane 4,000 ne kawai a Amurka.
Har zuwa ranar 13 ga Maris, The Atlantic ta ruwaito cewa an gwada mutane 14,000 kawai.
A ranar 22 ga watan Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Mutane da dama da ke da alamun cutar da kuma takardar shaidar likita suna jiran sa'o'i ko ma kwanaki don a gwada su.Bayan mutuwar farko a Amurka a Washington a ranar 29 ga watan Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci a jihar, wasu jihohi kuma sun yi hakan nan take.
Makarantu a yankin Seattle sun dakatar da karatu a ranar 3 ga Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, wani kwamitin bincike na cututtukan cuta na Kwalejin Imperial ta London ya shawarci Amurka game da tasirin sabon coronavirus a kan ƙasar.
A ranar ne Shugaba Trump ya sanya hannu kan dokar yaki da cutar coronavirus, wacce ta samar da dala biliyan 8.3 don taimakawa ayyukan gaggawa na hukumomin Amurka wajen yaki da cutar.
Kamfanoni sun dakatar da tafiye tafiyen ma'aikata, sun dakatar da tarurruka, kuma sun karfafa ma'aikatansu su yi aiki daga gida.
An dakatar da ayyukan wasanni da wasanni. A ranar 11 ga watan Maris, Trump ya sanar da dakatar da tafiye-tafiye daga Turai, ban da Burtaniya na tsawon kwanaki 30 daga ranar 13 ga watan Maris.
Washegari, sai ya ƙara Ingila da Ireland a jerin ƙasashen da aka hana wa'azi.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci, wanda ya haifar da samun taimakon Amurka don magance cutar.
Tun daga ranar 15 ga watan Maris, yawancin kamfanoni sun rufe ko rage lokutan aiki a duk faɗin Amurka don rage yaduwar cutar.
Ya zuwa ranar 17 ga watan Maris, an tabbatar da cewa cutar ta kai ga jihohi 50 da Gundumar Columbia. A ranar 23 ga watan Maris, an sanar da cewa birnin New York yana da mutane 10,700 da suka kamu da cutar, wanda ya fi kowacce a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce an yi nasarar kawar da hulɗa da juna, maimakon sau biyu na cutar da ke ɗaukar kwanaki 2.0 zuwa 4.7.
A ranar 28 ga watan Maris, an tabbatar da mutane 32,308 a birnin New York, inda 672 suka mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka ta sanar da cewa tana da adadin mutane da suka kamu da cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya. Har zuwa ranar 8 ga watan Afrilu, an tabbatar da mutane 400,335 a Amurka, tare da mutuwar mutane 12,841.
A cewar rahotanni a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita dokar hana fita har zuwa ranar 30 ga watan Afrilu.
A wannan ranar, jirgin USNS Comfort mai dauke da asibiti da gadaje 1000, ya isa gabar tekun New York.
A ranar 3 ga Afrilu, mutane 884 ne suka mutu a Amurka sakamakon cutar coronavirus a cikin awanni 24.
A ranar 3 ga Afrilu, adadin masu kamuwa da cutar a jihar New York ya zarge shi da yin watsi da cutar da kuma sarrafa saƙonni, kuma ya umarci jami'an kiwon lafiya da masana kiwon lafiya da su bincika maganganun jama'a da kuma bayanan da ofishin mataimakin shugaban kasa, Mike Pence ya fitar.
Gabaɗaya, amincewa da yadda Trump ya magance cutar ya kasance mai rikitarwa tsakanin masu goyon bayansa.
Wasu jami'an Amurka da manema labarai sun soki Amurka kan yadda take jinkirin shigo da kayayyakin masarufi daga China, ciki har da kayan aikin kiwon lafiya na asali.
An yi nazarin tafiye-tafiye na jirgin sama don ganowa da kuma tsara yadda cutar za ta iya yaduwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 na Kungiyar Jiragen Sama ta Duniya (IATA), Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan masu zirga-zirga daga Wuhan.
An kuma ce Dubai, Sydney, da Melbourne sun fi yawan masu zuwa daga Wuhan.
An bayyana Bali a matsayin daya daga cikin birane 20 da aka fi ziyarta da ba su da shiri sosai don magance cutar, yayin da biranen Australiya suka kasance a shirye. A ranar 7 ga Fabrairu, Ostiraliya ta sanar da wani shiri na yaki da sabon nau'in kwayar cutar coronavirus (COVID-19).
Ya ce akwai abubuwa da yawa da za a bincika game da COVID-19, kuma Australia za ta mai da hankali kan kula da kan iyakoki da kuma musayar bayanai kan yadda za a magance cutar.
A ranar 21 ga watan Maris, Ostiraliya ta ba da sanarwar hana kamuwa da cutar da kuma kare jama'a.
Sakamakon dakatar da zirga-zirgar jama'a a Wuhan, Hubei, kasashe da dama sun shirya kwashe 'yan kasarsu da' yan takararsu, galibi ta hanyar jigilar jiragen sama, tare da samar da takardun shaida daga hukumomin kasar Sin.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand na daga cikin kasashen da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta sake daukar 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta dauki 'yan Brazil 34 ko kuma danginsu ban da 'yan Poland hudu, da Sinawa da kuma Indiya.
An tura 'yan kasar Poland, China da Indiya zuwa Poland, inda jirgin Brazil ya tsaya jim kadan kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka je Wuhan a wani sansanin soja da ke kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 a jirgin farko da 39 a jirgin na biyu da gwamnatin Amurka ta bayar) daga Wuhan zuwa CFB Trenton don keɓewa na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya yi hatsari a CFB Trenton.
A ranar 3 da 4 ga Fabrairu, hukumomin Australiya sun kai mutane 277 zuwa kurkukun da ke tsibirin Kirsimati, inda aka mai da su wuri mai zaman kansu na tsawon kwanaki 14.
Jirgin da ke dauke da mutanen da ke dawowa New Zealand ya isa filin jirgin saman Auckland a ranar 5 ga Fabrairu; fasinjojin (ciki har da na Australiya da na tsibirin Pacific) an killace su a sansanin soji na Whangaparoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta dawo da Amurkawa da ke cikin jirgin Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin da ke dauke da fasinjoji 129 na Kanada ya yi hatsari a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin South African Airways da gwamnatin Afirka ta Kudu ta bayar ya kwashe 'yan Afirka ta Kudu 112.
An fara gudanar da gwajin asibiti, inda 'yan Afirka ta Kudu hudu suka nuna alamun cutar coronavirus da aka yi musu allurar rigakafi don rage hadarin.
Sai dai 'yan Afirka ta Kudu da ba su nuna alamun cutar ba ne kawai aka yi wa allurar.
Sakamakon gwajin ya nuna cewa duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal da sojoji da ke aikin agaji, an ci gaba da sanya su a cikin keɓewa na kwanaki 14 a cikin gidan shakatawa na Ranch.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu dakarunta daga kasar Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da agaji ga China.
Wasu daliban jami'o'in kasar Sin a Amurka sun hada kai don taimakawa wajen tura kayan agaji zuwa yankunan da cutar ta addabi kasar Sin, inda wata babbar kungiya a Chicago ta tattara kayan rufe fuska N95 50,000 da aka bayar a asibitocin lardin Hubei a ranar 30 ga watan Janairu. Kungiyar agaji ta Direct Relief, tare da FedEx, ta aika da kayan rufe fuska 200,000 da sauran kayan kariya na musamman, ciki har da safofin hannu da riguna, a cikin jirgin sama na musamman zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da tallafin dala miliyan 100 ga WHO don tallafawa aikin bincike kan allurar rigakafi da magunguna da kuma kare "mutane masu fama da cutar a Afirka da Asiya".
Tashar talabijin ta Interaksyon ta ruwaito cewa gwamnatin China ta ba da kayan rufe fuska 200,000 ga Philippines a ranar 6 ga watan Fabrairu, bayan da Sanata Richard Gordon ya aika da kayan rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin da ya kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya zuwa Wuhan, Turkiyya ta tura kayan aikin likita, Rasha ta tura karin tan na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar abin rufe fuska miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban-daban ciki har da kayan kariya na musamman 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin bayar da ƙarin dala miliyan 100 don tallafawa tattalin arzikin sauran ƙasashen da cutar ta shafa. Bayan raguwar adadin masu kamuwa da cutar a China, kasar tana tura tallafi ga ƙasashen da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da kwararru don taimakawa Italiya wajen magance cutar coronavirus.
Wani mai kudi mai suna Jack Ma ya tura kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kuma kayan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba su ga kungiyar tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000 zuwa Panama, da abin rufe fuska 100,000, da kuma na'urorin numfashi 5.
Kasashen Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da na'urorin gwaji da aka yi a China.
Misali, Spain ta dakatar da amfani da kayan gwajin cutar coronavirus 58,000 da aka yi a China wadanda suke da ingancin kashi 30%, yayin da Netherlands ta janye kayan rufe fuska 600,000 da aka yi a China saboda suna da lahani.
Belgium ta janye masks 100,000 da ake zargin sun fito ne daga kasar Sin, amma a gaskiya daga kasar Colombia.
A gefe guda, tallafin da China ta bayar ya samu karbuwa a sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da ayyukan agaji na gaggawa a kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa ayyukan da hukumomin China ke yi wajen sarrafawa da hana barkewar cutar.
Hukumar Lafiya ta Duniya ta ce akwai bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin China da yin asiri da kuma hana matakan rigakafi da sarrafawa, da kuma barkewar cutar ta yanzu inda gwamnati "ta ba da cikakken bayani don hana mutane jin tsoro kafin hutun Sabuwar Shekara.
A ranar 23 ga watan Janairu, bayan da babban jami'in ya yanke shawarar aiwatar da dokar hana zirga-zirga a Wuhan, wakilin Hukumar Lafiya ta Duniya Gauden Galea, ya ce duk da cewa "ba shawarar WHO ba ce", amma "ta zama babbar alama ce ta son hana barkewar cutar a inda ta fi girma" kuma ya kira ta "wanda ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga watan Janairu, bayan da aka tabbatar da cewa mutane sun kamu da cutar a wajen kasar Sin kuma adadin wadanda suka kamu da cutar ya ci gaba da karuwa a wasu ƙasashe, Hukumar Lafiya ta Duniya ta sanar da annobar a matsayin gaggawa ta Duniya ta Duniya (WHO) ta shida a matsayin babbar matsalar lafiya a lokacin da aka gano cutar ta coronavirus a matsayin annoba ta duniya ta shida a shekarar 2009.
Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom ya ce PHEIC na da matukar hadarin yaduwa a duniya, musamman a cikin kasashe masu tasowa da masu karamin karfi da ba su da ingantaccen tsarin kiwon lafiya.
Dangane da aiwatar da takunkumin hana zirga-zirga, Tedros ya ce "babu buƙatar aiwatar da matakan da ba dole ba don hana zirga-zirgar mutane da kasuwanci" kuma "WHO ba ta ba da shawarar hana kasuwanci da tafiye-tafiye ba".
A ranar 5 ga watan Fabrairu, WHO ta nemi kasashen da su ba da dala miliyan 675 don tallafawa shirye-shiryen cutar a ƙasashe masu tasowa, tana mai cewa akwai gaggawa a tallafa wa ƙasashe "waɗanda ba su da tsarin gano cutar, ko da kuwa za a gano su".
Tedros ya kuma bayyana cewa "dukkanmu muna da ƙarfi kamar yadda muke da rauni" kuma ya yi kira ga ƙasashe "su saka hannun jari a yanzu ko kuma su biya da yawa daga baya".A ranar 11 ga Fabrairu, a taron manema labarai, WHO ta tabbatar da cewa COVID-19 shine sunan cutar.
A wannan ranar, Tedros ya sanar da cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya ba da "duk karfin Majalisar Dinkin Duniya wajen neman mafita".
Saboda haka aka kafa Ƙungiyar Kula da Rikicin Majalisar Ɗinkin Duniya, wadda ta daidaita ayyukan Majalisar Ɗinkin Duniya, kuma Hukumar Lafiya ta Duniya ta ce hakan zai sa "ya fi mayar da hankali ga kula da lafiyar jama'a yayin da sauran ɓangarori za su iya kawo ƙwarewarsu wajen magance tasirin cutar a kan zamantakewa, tattalin arziki, da kuma ci gaba gaba ɗaya".
A ranar 14 ga watan Fabrairu, an kafa wata kungiya mai hadin gwiwa karkashin jagorancin WHO tare da kasar Sin don zabar kwararrun kasashen duniya da na WHO da za a tura zuwa kasar Sin don taimakawa wajen sarrafawa da kuma kula da yadda cutar ke yaduwa da kuma yaduwa" ta hanyar gudanar da tarurruka tare da manyan hukumomi da hukumomi a kasar da kuma ziyarar wurare daban-daban don kimanta "tasirin da ayyukan rigakafin cutar ke iya haifarwa a larduna da yankuna ciki har da yankunan karkara da birane". A ranar 25 ga Fabrairu, WHO ta sanar da cewa "ya kamata duniya ta kara shiri don magance cutar coronavirus", duk da cewa har yanzu akwai lokacin da za a fara kiran cutar, "farkon farawa".
A wani bangare na magance cutar da ke yaduwa a Iran, WHO ta aika da wata tawagar hadin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a inganta matakin tantance cutar coronavirus a duniya daga matakin "babba" zuwa "mafi girma", matakin gargadi da kimantawa.
Mike Ryan, mataimakin daraktan ayyukan agaji na WHO, ya yi gargadin cewa "Wannan shi ne ainihin abin da ya kamata a yi wa kowace kasa a duniya: Ku farka.
Wannan kwayar tana gabatowa kuma ya kamata ku kasance cikin shiri", ya jaddada cewa tsauraran matakai na magance ta na iya taimakawa wajen kaucewa "taron da take haifarwa".
Ryan ya kara da cewa bayanan da ake da su ba su sa hukumomin kiwon lafiya su ayyana cutar a matsayin annoba ta duniya ba, yana mai cewa yin hakan na nufin "a zahiri mun yi imani cewa kowa a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, WHO ta ayyana cutar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO "ta damu matuka game da yadda cutar ke yaduwa cikin hanzari da kuma rashin daukar mataki". WHO ta yi suka kan rashin daukar matakan da suka dace wajen hana barkewar cutar, kamar sanarwar da ta yi game da matsalar lafiyar jama'a da kuma sanya cutar a cikin jerin cututtuka.
A cikin zanga-zangar akwai bukatar da ake yi wa Darakta Janar na WHO Tedros Adhanom ya yi murabus, wanda ya samu sa hannun mutane 733,000 a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, masana kan hakkin dan adam na Majalisar Dinkin Duniya sun jaddada girmama hakkin dan adam a lokacin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun aikin da zai kare lafiyar sa kuma hakkin gwamnati ne.
Ƙungiyar ta nanata cewa rashin kuɗi ko inshorar lafiya bai kamata ya zama dalilin nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya, gami da nakasassu, mutanen da ke cikin kungiyoyin da ba su da lafiya, tsofaffi, wadanda suka rasa gidajensu, marasa gidaje, wadanda ke cikin matsanancin talauci, mutane da ke cikin kurkuku, da kuma 'yan gudun hijira da sauran kungiyoyi masu matukar bukatar taimakon gwamnati.
Ƙungiyoyin haɗin gwiwar ƙasashen duniya suna magance matsalolin tattalin arziki da zamantakewar da cutar ta COVID-19 ta haifar.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kafa wani dandalin sada zumunta da ke ba da cikakkun bayanai kan hanyoyin magance matsalar a kasashen duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofin karfafa ikon ma'aikatar lafiya da tattalin arziki na duniya don rage tasirin dokar hana fita da rage yawan zirga-zirgar mutane, matakan da aka ɗauka sun haɗa da hanyoyin ganowa, kuma an tsara su don taimakawa ƙasashe su koya daga juna da kuma taimaka musu su haɗa kan matakan duniya don magance cutar coronavirus.
Gwamnatin China ta fuskanci zargi daga Amurka, Ministan Ministocin Burtaniya Michael Gove, da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro, kan yadda suka dauki matakin da ya shafi cutar da ta bulla a lardin Hubei.
An kori wasu manyan jami'an jam'iyyar kwaminis ta kasar Sin (CPC) daga mukamin saboda yadda suka dauki matakin killace mutane a tsakiyar kasar Sin, wanda ke nuna rashin jin dadin matakin da hukumomin siyasa suka dauka na shawo kan annobar a yankunan.
Wasu masu sharhi sun ce an dauki wannan matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu jami'an kasar Sin, ciki har da Zhao Lijian sun ki amincewa da bayyanar cutar coronavirus a Wuhan, suna goyon bayan ka'idojin karkatar da hankali game da COVID-19 daga Amurka ko Italiya.
Gwamnatin Donald Trump a Amurka ta kira coronavirus "kwayar cutar Sin" ko kuma "kwayar Wuhan" inda ta ce China ta boye bayanai da ke haifar da cutar ta zama annoba ta duniya. Amma wasu mutane sun yi tir da wannan a matsayin nuna bambanci da kuma karkatar da hankalin jama'a daga gazawar gwamnatinsa wajen shawo kan annobar.
Shafin yanar gizo na "The Daily Beast" ya sami bayanan gwamnatin Amurka game da hanyoyin sadarwa da ake zargin sun fito ne daga kwamitin tsaron kasa, inda aka bayyana cewa "duk sun shafi China.
An gaya mana cewa dole ne mu yi duk abin da za mu iya, mu yada wannan sakon a ko'ina kamar a cikin hirarraki da manema labarai da kuma talabijin. "Tsoffin kafofin watsa labarai kamar Politico, Foreign Policy, da Bloomberg sun nuna cewa kokarin da China ke yi na tura tallafi zuwa wasu ƙasashe wata hanya ce ta samun rinjaye a duniya.
Shugaban siyasar kasashen waje na Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai matsalar dangantakar siyasa tsakanin kasashe da suka hada da neman mamaye wasu kasashe ta hanyar nuna kai da kuma 'siyasa ta alheri'.
Borrell ya kara da cewa, "China ta ba da sako a fili cewa, ba kamar Amurka ba, tana da kyakkyawar abokiyar hulda mai aminci".
China ta kuma bukaci Amurka ta dage takunkumin da ta kafa kan Syria da Venezuela da Iran, yayin da ake zargin cewa China ta tura tallafi zuwa Venezuela da Iran.
A ranar 3 ga watan Afrilu, an kama kyautar Jack Ma ta kayan rufe fuska 100,000 da za a kai Cuba saboda takunkumin Amurka.
An kuma zargi gwamnatin Amirka da tura taimakon da ake samu daga ƙasashen waje zuwa ƙasarsu.
Akwai wasu takaddama game da abin rufe fuska da suka taso tsakanin wasu ƙasashe; kamar Jamus, Austria da Switzerland; har ma tsakanin Jamhuriyar Czech da Italiya.
Ƙari ga haka, ƙasar Turkiya ta kwace ɗarurruwan na'urorin numfashi da suka zo daga ƙasar Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai kan rashin nuna goyon baya ga Italiya a lokacin da cutar coronavirus ta addabe ta.
Maurizio Massari, jakadan Italiya a Tarayyar Turai ya ce: "China ce kawai ta taimaka wa Italiya.
Wannan ba alama ce mai kyau ba ta haɗin kan Turai".
A ranar 22 ga watan Maris, bayan tattaunawar wayar tarho da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya rundunar sojin Rasha don tura sojojin likitoci, motocin kashe kwayoyin cuta, da sauran kayan aikin kiwon lafiya zuwa Italiya.
Jaridar La Stampa ta Italiya ta nakalto "wani babban jami'in gwamnati" wanda bai ambaci sunansa ba, wanda ya ce kashi 80 cikin 100 na tallafin Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Mai bayar da rahoton ya zargi Rasha da neman haifar da "matsalolin siyasa da diflomasiyya" tsakanin kasashen.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Maio, sun musanta rahoton da aka wallafa a kafafen yada labarai kuma sun bayyana cewa suna jinjina wa Rasha.
Rasha ta kuma aika da jirgin sama mai dauke da kayan agaji na likita zuwa Amurka.
Dmitry Peskov, mai magana da yawun shugaban Rasha ya ce: "Tare da taimakon da Putin ya ba wa abokan aikinsa na Amirka, yana ganin cewa idan Amirkawa suka ƙware wajen yin kayayyakin kiwon lafiya, za su iya taimaka mana idan ya zama dole".
Za a gudanar da atisayen sojin NATO "Defender 2020" da aka shirya a Jamus, Poland, da kuma kasashen Baltic, wanda shine atisayen sojin NATO mafi girma tun bayan karshen yakin sanyi.
Babban sakataren yaki da yaduwar makaman nukiliya, Kate Hudson ta soki aikin Defender 2020: "A cikin wannan yanayin na kiwon lafiyar jama'a, ba wai kawai yana barazana ga rayukan sojoji daga Amurka da sauran ƙasashen Turai ba har ma da na al'ummomin da ke cikin ƙasashen da suke aiki". Cutar ta yi tasiri sosai a kan gwamnatin Iran, inda wasu manyan jami'an gwamnati 24 da tsoffin jami'an siyasa suka kamu da cutar.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani, ya rubuta wasika ga shugabannin duniya, yana mai cewa kasarsa tana fuskantar matsalar magance cutar saboda rashin iyawa da kasuwannin duniya saboda takunkumin Amurka akan Iran. Cutar ta sa Amurka ta bukaci aiwatar da manufofin inganta rayuwa da suka dace da sauran kasashe masu arziki, gami da kiwon lafiya na al'ada, kula da yara a duk duniya, hutun iyali da aka biya, da kuma inganta ingantacciyar kiwon lafiya.
Masu sharhi kan siyasa sun yi hasashen cewa hakan na iya yin illa ga damar Donald Trump na sake zabarsa a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki Japan kan "ta amfani da karfi wajen killace mutane" bayan da Japan ta sanar da cewa duk wanda ya bar Koriya ta Kudu zai killace kansa na tsawon makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai, mutanen Koriya ta Kudu sun nuna rashin fahimtarsu game da yadda Shugaba Moon Jae-in ke bi da wannan batu.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a tsige Moon daga mukaminsa saboda zargin rashin kulawa da gwamnatin a kan yadda ta magance annobar, ko kuma suna yaba wa yadda ta magance ta.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya sa gwamnati ta dage a kan mulki.
A Hungary, majalisar dokoki ta kada kuri'ar amincewa da Firayim Minista Viktor Orbán ya hau mulki har abada, dakatar da majalisar dokoki da zaben da kuma hukunta wadanda aka zarga da yada labaran karya game da cutar da kuma yadda gwamnati ke magance matsalar.
Cutar ta coronavirus ta haifar da karancin kayayyaki da yawa, daga karuwar amfani da kayayyakin rigakafin cutar a duniya, yawan sayayya da ake yi saboda fargaba, da kuma rikicewar masana'antu.
Hukumar Kula da Abinci da Magunguna ta Amurka ta yi gargadin rashin isassun magunguna da kayan aikin kiwon lafiya saboda karuwar bukatar masu sayen da kuma tashin hankalin masu samar da kayayyaki.
A wurare da dama, an lura da yawan sayayya a cikin tsoro wanda ya haifar da wasu kayan masarufi kamar abinci, takarda mai tsabta, ruwan kwalba, wanda ke haifar da ƙarancin kayayyaki a kasuwa.
Kamfanonin fasaha musamman sun yi gargadin mutane game da jinkirin aika kayan lantarki.
A cewar Daraktan Hukumar Lafiya ta Duniya Tedros Adhanom, bukatar rigakafin cutar ta ninka sau 100.
Wannan ya haifar da hauhawar farashin da ya ninka na al'ada sau ashirin kuma ya haifar da jinkirin samar da kayan aikin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakan kuma ya haifar da karancin kayan rigakafi a duniya, wanda WHO ta ce hakan zai haifar da barazana ga lafiyar ma'aikatan kiwon lafiya.
A Ostiraliya, annobar ta samar da sabbin dama ga masu cinikin haramtacciyar hanyar sayar da kayayyakin Australiya zuwa China.
Wannan ya haifar da raguwar samar da madara ga jarirai a wasu yankuna kuma daga baya Gwamnatin Australiya ta dakatar da shi. Duk da karuwar adadin masu kamuwa da cutar COVID-19 a arewacin Italiya da lardin Wuhan, tare da karuwar yawan masu bukatar abinci, waɗannan yankuna biyu ba su taɓa fuskantar matsalar karancin abinci ba.
Matakan da China da Italiya suka ɗauka don su magance cin hanci da rashawa da kuma cinikin haram sun yi nasara, kuma hakan ya sa ba a yi rashin abinci a Turai da kuma Arewacin Amirka ba.
Arewacin Italiya, wanda ke da yawan amfanin gona, bai yi kasa ba sosai, amma wakilan masana'antu sun ce farashin zai iya tashi.
Shagunan abinci da ba su da komai sun kasance na ɗan lokaci, har ma a Wuhan, jami'an gwamnatin China sun buɗe wuraren adana kayan naman alade don tabbatar da wadatar abinci ga jama'a.
Irin wannan doka a ƙasar Italiya ta bukaci masana'antun abinci su adana kayan da za su iya ceto a lokacin bala'i.
Sakamakon tattalin arzikin duniya ya kai har zuwa China: a cewar rahotanni na yau da kullum a ranar 16 ga watan Maris, tattalin arzikin kasar Sin ya yi matukar wahala a cikin watanni biyu na farko na shekarar 2020 sakamakon matakan da gwamnati ta dauka na dakile yaduwar cutar, kuma yawan kasuwancin da ake yi ya ragu da kashi 20.5%.
Saboda tattalin arzikin China da masana'antarta, cutar ta zama babbar matsala ga tattalin arzikin duniya.
Agathe Demarais na sashen bincike na The Economist' ya ce kasuwannin za su ci gaba da zama masu saurin tashi har sai an sami cikakken hoto game da yiwuwar samun riba.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa matsalar tattalin arziki da cutar ta haifar a kan tattalin arzikin duniya na iya wuce cutar SARS a 2002-2004.
Wani kimantawa da masana suka yi a jami'ar Washington da ke St. Louis ya nuna cewa tasirin da ya shafi yawan farashin kayayyaki a duniya ya kai dala biliyan 300 kuma zai iya wucewa na tsawon shekaru biyu.
An ce kungiyar OPEC ta "yi matukar damuwa" bayan faduwar farashin mai saboda China ba ta da bukatar.
A ranar 24 ga watan Fabrairu, kasuwannin hada-hadar kuɗi da na hannun jari na duniya sun yi kasa saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, sakamakon karuwar matsalar yaduwar cutar coronavirus, wasu alamomin farashin kasuwar Amurka da na kasafin kudi, ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun nuna mummunan hasara tun shekarar 2008, inda Dow ya fadi da maki 1,191, mafi muni a cikin kwana daya tun bayan barkewar rikicin tattalin arziki na 2007-08.
Dukkanin matakan uku sun ƙare mako a ƙasa da 10%.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya amince da matakin bashi na kasar Sin, amma ya ci gaba da zama mara kyau.
Kasuwannin hada-hadar kuɗi da na hannun jari sun yi kasa saboda tsoron cutar coronavirus, wanda ya kai ga raguwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi sanyi.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna na kasa da na jihohi saboda matakan ceto na kan lokaci.
Babban bankunan duniya sun tashi da wuri daga wannan annoba fiye da yadda suka yi a lokacin da aka yi babban koma bayan tattalin arziki a shekarar 2008.
Yawon shakatawa na ɗaya daga cikin fannonin da cutar ta fi shafawa saboda takunkumin tafiye -tafiye, rufe wuraren taruwa da wuraren shakatawa, da kuma shawarwarin gwamnati game da hana duk wani tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da dama sun dakatar da zirga-zirgar jiragen sama saboda karancin fasinjoji, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na Burtaniya Flybe ya rufe.
Sakamakon da jirgin ya yi wa manyan jiragen ruwa ya kai matakin da ba a taɓa gani ba.
An rufe jiragen ƙasa da tashoshin jiragen ruwa da yawa.
Cutar ta faru ne a lokacin Chunyun, babban lokacin tafiye-tafiye na bikin sabuwar shekara ta kasar Sin.
Yawancin ayyukan da aka fi so da yawa sun dakatar da su ta hanyar gwamnatocin jihohi da na gida, gami da bukukuwan Sabuwar Shekara, inda kamfanoni masu zaman kansu suka rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe bukukuwan Sabuwar Shekara da wuraren shakatawa da dama don kaucewa taron jama'a, ciki har da Forbidden City a Beijing da kuma wuraren shakatawa na gargajiya da aka shirya a cikin gidajen ibada.
A larduna 24 daga cikin 31 na kasar Sin, manyan birane da yankuna, hukumomi sun tsawaita hutun sabuwar shekara har zuwa 10 ga watan Fabrairu, suna ba da umarnin cewa wuraren aiki da dama ba za su sake buɗewa ba har zuwa wannan ranar.
Yankunan suna da kashi 80% na GDP da 90% na fitarwa.
Hong Kong ta kara matakan rigakafin cutar, ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta dakatar da bukukuwan bikin Sabuwar Shekara. Kasuwanci ya yi matukar tasiri, tare da rage lokutan buɗe shaguna ko rufewa na ɗan lokaci.
Baƙi zuwa wuraren cinikayya na Turai da Kudancin Amurka sun ragu da kashi 40%.
Kasuwanci a Arewacin Amurka da Gabas ta Tsakiya sun ragu da kashi 50-60%.
Wannan kuma ya haifar da raguwar mutane 33-43% a cikin kasuwancin kasuwanci a watan Maris idan aka kwatanta da na Fabrairu.
Manyan manyan kantunan duniya sun kara matakan, kamar su tsaftace tsabta, shigar da na'urorin auna zafin jiki don auna yawan zafin jiki na masu siye, da kuma dakatar da ayyukan hutu.A cewar Hukumar Kula da Tattalin Arzikin Latin Amurka ta Majalisar Dinkin Duniya, annobar za ta bar tsakanin mutane miliyan 14 zuwa 22 a Latin Amurka cikin matsanancin talauci fiye da yadda zai kasance ba tare da shi ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi tsanani a Wuhan, mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin ma'aikatan karkara na kasar Sin miliyan 300 suna tsare a gida a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 ne suka rasa ayyukansu kuma suka nemi taimakon gwamnati.
A Indiya, Shirin Zaunar da gida ya bar miliyoyin 'yan asalin Indiya ba tare da aiki ba. Wani bincike da kamfanin Angus Reid ya gudanar ya nuna cewa kashi 44% na iyalai a Kanada sun fuskanci matsalar rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da Shirin Zaunar da gida ya fara a tsakiyar watan Maris na 2020.
A rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi a basu tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan daya na Burtaniya sun nemi a basu tallafin tsarin bashi na wucin gadi. Kimanin rabin miliyan na kamfanoni a Jamus sun tura ma'aikatansu cikin shirye-shiryen wucin gadi da gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransa da Ingila sun soma amfani da tsarin biyan kuɗi na ɗan lokaci a Jamus.
Cibiyoyin fasaha da al'adun gargajiya sun sami mummunan rauni sakamakon cutar, saboda ta shafi yadda kamfanoni da mutane (masu mallakar da masu zaman kansu) ke aiki a duniya.
Ƙungiyoyin al'adu da fasaha sun yi ƙoƙari su kula da alhakin su (yawanci ana tallafa musu da kuɗi) na kiyaye abubuwan al'adu, kula da lafiyar ma'aikata da jama'a, da kuma tallafa wa masu fasaha a duk inda zai yiwu.
A watan Maris na shekarar 2020, a duk fadin duniya da kuma a fannoni daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu sun rufe gaba daya kuma an dakatar da ko kuma jinkirta baje kolin su, bukukuwa da kuma ayyukan su.
A wani bangare, an dauki matakan kara samar da ayyukan lantarki. Wani babban matakin da aka dauka kwanan nan wanda ke hanzarta raguwar cutar, shine dakatar da duk wani taron jama'a, manyan wasanni da sauran abubuwan da suka hada da kide kide da wake-wake, tarurrukan fasaha da nunin kayan kwalliya.
Vatican ta sanar da cewa za a dakatar da bikin Lahadi Mai Tsarki a Roma, wanda ke faruwa a makon ƙarshe na azumi.
Da yawa cikin diocese sun bukaci tsofaffi su zauna a gida maimakon zuwa coci a ranar Lahadi; wasu ikilisiyoyi sun watsa taronsu ta hanyar rediyo, Intane, ko kuma talabijin, wasu kuma sun shirya su saurari taronsu daga motocinsu.
Sa'ad da cocin Katolika ya rufe majami'u da kuma manyan gidajen ibada da kuma babban wurin ibada na St. Peter's, wasu addinai sun dakatar da tarurruka kuma sun rage yawan tarurruka a majami'u, masallatai, majami'u, da sauransu.
Ma'aikatar lafiya ta Iran ta sanar da dakatar da sallar Juma'a a yankunan da cutar ta addabi da kuma rufe wuraren ibada, yayin da Saudiyya ta hana masu yawon shakatawa na kasashen waje shiga da kuma hana mazauna yankin shiga wuraren ibada a Makka da Madina.
Cutar ta haifar da babbar matsala ga jadawalin wasanni a duniya tun bayan yakin duniya na biyu.
An dakatar da ko kuma dage wasannin wasanni da dama, ciki har da gasar cin kofin duniya ta 2019 UEFA 20, gasar zakarun Ingila ta 2019 20, gasar cin kofin Turai ta 2020, gasar cin kofin hannu ta Amurka ta 2019 20, da kuma gasar NHL ta 2019 20.
Cutar ta kuma kawo cikas ga shirin gasar wasannin Olympics na bazara na 2020 da aka shirya fara a karshen watan Yuli; a ranar 24 ga Maris kwamitin wasannin Olympics na kasa da kasa ya sanar da cewa za a "dakatar da wasannin zuwa 2020 amma ba daga lokacin bazara na 2021 ba". An rufe gidajen caca da sauran wuraren wasanni a duk duniya, kuma an dakatar da wasu wasannin karta kamar Poker.
Wannan ya sa yawancin caca suka koma kan layi, inda yawancin rukunin caca ke ba da rahoton karuwar yawan rajista. An kuma shafi nishaɗi, inda yawancin ƙungiyoyin kiɗa suka dakatar ko jinkirta tafiye-tafiyen wasan kwaikwayo.
Manyan gidajen wasan kwaikwayon kamar su Broadway sun daina yin wasan kwaikwayon.
Wasu masu zane-zane sun nemi hanyoyin ci gaba da samarwa da kuma raba abubuwan da suke yi ta hanyar yanar gizo a matsayin madadin al'ada na yin wasan kwaikwayo na kai tsaye, yin wasan kwaikwayo ta hanyar Intanet, ko yin "bikin" na yanar gizo wanda masu zane-zane ke halarta, don haka suna yadawa, har ma da tallata ayyukansu.
Hotunan ban dariya da ke nuna cutar coronavirus sun bazu a Intanet saboda mutane da yawa suna neman abin dariya da kuma shagala yayin da ba su san inda lamarin zai kai ba.
Tun farkon annobar COVID-19, akwai nuna bambanci, ƙiyayya ga baƙi, da wariyar launin fata ga mutanen asalin China da Gabashin Asiya, har ma da mutanen da suka fito daga wuraren da cutar ta fi yawa a Turai, Amurka da sauran ƙasashe.
Tsoro, wariya, da kuma faɗa sun zama ruwan dare a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya da Fasifik.
Rahotanni na watan Fabrairu (lokacin da mafi yawan masu kamuwa da cutar ke kasar Sin) sun nuna halin wariyar launin fata da aka samu a tsakanin kungiyoyi daban-daban a duniya, suna cewa ko Sinawa sun cancanci cutar ko kuma za a hukunta su.
Wasu ƙasashe a Afirka ma sun ga ƙiyayya da ake yi wa Sinawa.
Yawancin mazauna Wuhan da Hubei sun ce an nuna musu wariya bisa ga asalinsu.
Akwai tallafi ga Sinawa, a zahiri da kan layi, har ma da waɗanda ke cikin yankunan da cutar ta shafa.
Yayin da cutar ke yaduwa zuwa wasu kasashe, mutanen Italiya, wanda shine mafi yawan masu kamuwa da cutar COVID-19 a Turai, na iya fuskantar matsalar rashin jin daɗi da kuma ƙin baƙi. Jama'a a kasashe da suka hada da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardar neman a hana Sinawa shiga ƙasashensu don hana yaduwar cutar.
A Japan, hashtag #ChineseDontComeToJapan ya yi ta yaduwa a shafin Twitter.
A ƙasar Ingila da kuma Amirka, mutanen da suka fito daga ƙasar Sin da Asiya sun ce ana yawan zaluntarsu kuma ana kai musu hari.
An kuma soki shugaban Amurka Donald Trump da yin amfani da kalmar "Chinese Virus" a matsayin kalmar nuna wariyar launin fata da kuma nuna adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan motocin bas da ke dauke da mutanen da aka kora daga Ukraine da kuma kasashen waje daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, wanda ke iyaka da China, suna karatu a manyan biranen Indiya saboda cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na yankin West Bengal Dilip Ghosh ya ce Sinawa sun lalata muhalli "saboda haka Allah ya hukunta su".
Ofishin jakadancin China a Kolkata ya yi tir da wannan matakin, inda ya ce "ba daidai ba ne". A kasar Sin, an yi ta kara nuna nuna wariya ga 'yan kasashen waje da kuma wariyar launin fata, inda aka yi wa 'yan kasashen waje lakabi da "tarkace na kasashen waje" kuma ya kamata a jefar da su.
Yawancin jaridu da ke da shafukan yanar gizo masu biyan kuɗi sun cire wasu ko duk kuɗin da aka caje don labarai game da coronavirus.
Masu wallafa littattafan kimiyya sun wallafa littattafan kimiyya game da annobar kuma kowa zai iya karanta su.
Wasu masana kimiyya sun zaɓi su raba sakamakon binciken da suka yi a baya-bayan nan a kan sabobin aikace-aikace kamar bioRxiv.
Cutar cututtuka - cututtukan da ke haifar da ƙwayoyin cuta, sau da yawa suna da sabon abu a cikin bayyanar ko kuma a cikin hanyar kamuwa da cuta
Cutar cuta da cuta - Sakamakon cuta da kuma yadda ake yaduwa
Jerin cututtuka da annoba  Jerin mutuwar annoba
Kashe Dabbobi da Cutar Cutar - Tasirin Lafiya na Cinikin Dabbobi
Gwajin gwaji na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 mai alaƙa sun haɗa da gano kwayar cutar da kuma gano ƙwayoyin cuta da jiki ke samarwa don yaƙi da cutar.
Za a iya tabbatar da kwayar cutar a cikin gwajin ta hanyar RT-PCR, wanda ke gano RNA na kwayar cutar.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano kwayar cutar SARS-CoV-2 RNA.
Ana amfani da shi wajen tabbatar da kamuwa da cutar a kwanan nan ko kuma a cikin marasa lafiya.
Za a iya amfani da gano kwayoyin cuta (gwajin jini) don tantancewa da kuma lura da jama'a.
Gwajin rigakafin jiki na nuna yawan mutanen da ke da cutar, gami da waɗanda ke da alamun cutar da ba su da yawa don sanar da masu kula da cutar ko kuma waɗanda ba su da alamun cutar.
Za a iya tantance ainihin adadin mutuwar cutar da matakin rigakafin cutar a cikin al'umma daga sakamakon wannan gwajin.
Saboda karancin adadin mutanen da aka gwada, a watan Maris na shekarar 2020 babu wata kasa da ke da ingantaccen bayani game da yaduwar kwayar cutar a cikin al'ummarta.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada sama da kashi 3 cikin 100 na yawan jama'arta, kuma akwai bambancin da ke tsakanin yadda aka gudanar da gwajin a duk ƙasashe.
Wannan canji kuma zai iya shafan mutuwar mutane sosai, wataƙila a wasu ƙasashe.
Ta hanyar yin amfani da saurin daukar hoto da kuma nazarin kwayar cutar (rRT-PCR), ana iya yin gwajin cutar ta hanyar yin amfani da gwaje-gwajen numfashi da aka samo ta hanyar hanyoyin daban-daban, ciki har da gwaje-gwaje na hanci ko na hanci.
Sakamakon yana samuwa a cikin 'yan sa'o'i zuwa kwana 2.
Gwajin RT-PCR da aka yi ta hanyar samfurin fitsari ne kawai hanyar da za a iya dogara da ita a cikin makon farko na kamuwa da cutar.
Bayan haka, kwayar cutar na iya ɓacewa a cikin hanci yayin da take ci gaba da ƙaruwa a cikin huhu.
Ga mutanen da suka kamu da cutar a mako na biyu, zai zama da kyau a sake yin wasu gwaje-gwaje kamar su gwaji na kwayar cutar.
An gwada daya daga cikin sabbin gwajin PCR a Charité a Berlin a watan Janairun 2020 ta hanyar amfani da tsarin saurin daukar hoto da kuma nazarin kwayar cutar (rRT-PCR) tare da kayan aikin 250,000 da Hukumar Lafiya ta Duniya ta bayar.
A ranar 28 ga Janairu, 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya shirya gwajin gwajin na'urar bincike ta SARS-CoV-2 bisa PCR (PowerChek Coronavirus).
Binciken kwayar "E" da ke yaduwa ta hanyar kwayar cutar coronavirus ta mutum, da kuma kwayar RdRp da aka gano a cikin SARS-CoV-2. A cikin China, BGI Group na ɗaya daga cikin kamfanoni na farko da Cibiyar Kula da Kiwon Lafiya ta China ta ba da izini don amfani da kayan aikin SARS CoV-2 na PCR. A Amurka, Cibiyar Kula da Cututtuka (CDC) tana rarraba kayan aikin RT-PCR Diagnostic don gano sabon Coronavirus 2019 (2019-nCoV) a cikin manyan dakunan gwaje-gwaje ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje guda uku na kwayar halitta a cikin sigar farko ta kayan aikin bincike ya haifar da rashin daidaito saboda rashin ingantattun magunguna da aka yi amfani da su, da kuma matsalolin gwaji a Cibiyar Kula da Cututtuka (CDC) a Atlanta; wannan ya haifar da matsakaicin gwaje-gwaje 100 a kowace rana don ingantaccen gwaji a cikin watan Fabrairu 2020.
Ba a shirya yin gwajin kashi biyu ba har zuwa 28 ga Fabrairu, 2020, kuma har sai lokacin ne aka ba da izinin cibiyoyin gwaje-gwaje na jihohi da na yankuna su fara gwajin.
An amince da gwajin ta hanyar Hukumar Abinci da Magunguna don ba da izinin gaggawa. Laboratoriyoyin kasuwanci a Amurka sun fara gwaji a farkon Maris 2020.
Har zuwa 5 ga Maris, 2020, LabCorp ta sanar da cewa an sami damar yin gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Quest Diagnostics kuma ta samar da gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu adadin da aka ƙayyade; tattara da sarrafa samfuran da aka ɗauka dole ne a yi su bisa ga buƙatun Cibiyar Kula da Cututtuka (CDC).
A Rasha, an tsara kuma an gudanar da gwajin COVID-19 ta Cibiyar Nazarin Kwayar cuta da Fasahar Kayan Kwayar cuta ta VECTOR.
A ranar 11 ga Fabrairu, 2020, Cibiyar Kula da Kiwon Lafiya ta Amurka ta fara gwajin kwayar cutar. A ranar 12 ga Maris, 2020, an ba da sanarwar cewa asibitin Mayo ya kirkiro na'urar da za ta iya gwada cutar ta COVID-19. A ranar 13 ga Maris, 2020, FDA ta amince da Roche Diagnostics don ƙirƙirar na'urar da za ta iya ba da sakamako a cikin awanni 3,5 a matsakaicin lokaci, wanda hakan zai ba da damar na'urar guda ɗaya ta iya gwada mutane 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don yin gwaji akan tsarin Abbott m2000; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta sami izinin gaggawa daga FDA don gwajin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar ƙara yawan zafin jiki a kan sinadarin nucleic acid maimakon PCR.
Saboda wannan baya buƙatar jerin hanyoyin musayar zafi, wannan hanyar na iya samar da sakamakon cutar a cikin kimanin minti biyar da kuma sakamakon cutar a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 na irin wannan nau'in a Amurka kuma Abbot na shirin kara karfin su zuwa gwaje-gwaje 50,000 a kowace rana. A Taiwan, ana gudanar da gwajin da ke amfani da kwayar cutar N-type coronavirus kuma ana fatan zai iya samar da sakamako tsakanin mintuna 15 zuwa 20 kamar na'urar gwajin mura mai sauri.
A watan Maris na shekarar 2020, takardun bincike sun kammala da cewa "a farko, yin amfani da na'urar daukar hoto a cikin kirji ba shi da matukar amfani wajen yin bincike, kuma ana iya samun bayanai ta hanyar CT kafin bayyanar cututtuka.
Abubuwan da ke cikin fasahar CT na gani sun hada da iya duba dukkan bangarorin huhu, tare da nuna bangarorin gefe, tsakiya da baya.
Rashin ƙarancin ƙananan huhu, da kuma tsananin ƙarancin wasu sassan da ke cikin hanjin yana ƙaruwa yayin da cutar ke ƙaruwa.
Binciken da aka yi na gwada PCR da CT a Wuhan don gano asalin cutar ya nuna cewa cutar ta fi tsanani a Wuhan saboda ta haɗu da cututtukan numfashi da yawa.
Ya zuwa Maris 2020, Cibiyar Kula da Cututtuka (CDC) ta ba da shawarar cewa "Ba za a sake amfani da hanyoyin da ake amfani da su a Wuhan don gano cutar CoronavirusCOVID-19 ba". Ya zuwa Maris 2020, Cibiyar Kula da Cututtuka (CDC) ta ba da shawarar cewa PCR shine farkon gwajin.
Ɗaya daga cikin hanyoyin da jiki ke amfani da shi wajen yaki da kamuwa da cuta shi ne samar da kwayoyin cuta masu kare jiki da suka hada da IgM da IgG.
Wannan zai iya taimakawa wajen gano kamuwa da cutar a cikin mutane daga rana ta 7 ko bayan bayyanar cututtuka na farko, a cikin ƙimar rigakafi da kuma yin bincike a cikin al'umma. Ana iya yin nazarin samfurori a cikin dakin gwaje-gwaje na yau da kullun (CLT) ko kuma a wasu wuraren da aka tsara don yin gwaji (PoCT).
Za a yi amfani da samfurori da aka yi amfani da su a cikin gwaji a yawancin dakunan gwaje-gwaje na asibiti don yin bincike, amma samun sakamakon zai dogara ne da saurin aikin.
A cikin dakunan gwaje-gwaje, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da wasu misalai don a lura da rigakafi.
A wani wuri kuma, ana samun jini guda ɗaya ne kawai bayan an yi masa kutse.
Ba kamar PCR ba, ba a buƙatar samfurin farko kafin a gwada. A ranar 26 ga Maris, 2020, FDA ta sanar da cewa kamfanoni 29 sun sanar da shi a matsayin abin da ake buƙata kuma yanzu suna iya samar da gwajin rigakafin da suka yi.
Ya zuwa ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya kawai don a yi shi tare da izinin gaggawa.A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostic sun sami takardar izini ta Turai don kayan aikin gwajin su, wanda zai iya gano rigakafin IgG da IgA a cikin gwajin jini.
Ana iya samun damar yin gwajin kamuwa da cuta ta hanyar yin daruruwan gwaje-gwaje a cikin sa'o'i kaɗan, wanda ya fi saurin gwajin PCR da aka saba amfani da shi don gano RNA mai kwayar cuta.
Yawancin lokaci ana iya ganin rigakafin jiki a cikin kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu kayan aikin gwajin rigakafin da ta saya kuma babu wanda zai iya amfani da shi yadda ya kamata.
Hong Kong ta kafa tsarin da zai sa duk wanda ake zargi da kamuwa da cutar ya zauna a gida, inda ma'aikatar agaji za ta ba shi "kayan aikin da aka tsara", wanda za a cire daga ciki sannan a mayar masa da shi kuma a ba shi sakamakon daga baya. Hukumar Lafiya ta Burtaniya (NHS) ta sanar da cewa tana shirin gabatar da gwajin gida ga waɗanda ake zargi da kamuwa da cutar, wanda zai kawar da haɗarin mai haƙuri ya iya cutar da wasu yayin asibiti, ko kuma ya zama dole a sanya maganin kashe ƙwayoyin cuta a cikin motar da mai haƙuri ya kawo.
Cibiyoyin gwajin kekuna sun ba Koriya ta Kudu damar yin wasu gwaje-gwaje mafi sauri, kuma mafi yawa a cikin ƙasashe. A Jamus, a ranar 2 ga Maris, Kungiyar Kula da Lafiya ta Likitoci ta sanar da cewa tana da damar yin gwaje-gwaje kusan 12,000 a rana ta amfani da kayan aikin gaggawa kuma an gwada kusan 10,700 a makon da ya gabata.
Asusun inshorar lafiya ne ke biyan kuɗin idan likita ya umurce shi.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwajin mutum 160,000 a kowane mako.
Tun daga ranar 19 ga watan Maris, an gudanar da gwaje-gwaje a manyan birane da dama.
Har zuwa 26 ga Maris, 2020 ba a san adadin gwajin da aka yi a Jamus ba, saboda an ba da rahoton kawai.
Binciken farko na dakin gwaje-gwaje ya bayyana cewa a makon 12/2020 an gwada mutane 483,295 ciki har da kwayar cutar 12/2020, wanda aka gano cewa mutane 33,491 (6.9%) sun kamu da cutar SARS-CoV-2. A Isra'ila, masu bincike a asibitocin Technion da Rambam sun kirkiro kuma sun gwada hanyar da za ta iya gwada marasa lafiya 64 a lokaci guda, inda za su iya daukar gwaje-gwaje kuma su sake gwada su idan an gano cutar. A Wuhan, wani dakin gwaje-gwaje na gaggawa mai girman murabba'in 2000 m2 da ake kira "Huo-Yan 火眼" a Sinanci, ko "Idan wuta" a Yaren mutanen China, an gabatar da shi a ranar 5 ga watan Fabrairu 2020 ta hanyar BGI, wanda ke da damar gwada mutane sama da 10,000 a rana.
Ginin da ya kasance a karkashin jagorancin Wang Jian wanda ya kafa BGI kuma ya dauki kwanaki 5, samfurori sun nuna cewa cutar za ta karu da kashi 47% a Hubei kuma farashin magance keɓewa zai ninka idan ba a sami wannan damar ba.
Wuhan Laboratory ya biyo bayan Huo-Yanmu Laboratories a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk fadin kasar Sin.
Ya zuwa 4 ga Maris, 2020, ana yin gwaje-gwaje 50,000 a kowace rana. Hanyar da ta fi sauri kuma mai amfani da kowa da kowa da Origami Assays ta gabatar na iya gwada gwaje-gwaje 1,122 na marasa lafiya na COVID19 tare da gwaje-gwaje 93 kawai. Ana iya yin wannan hanyar ta daidaitawa a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar yin amfani da robobi masu sarrafa abubuwa ba.
Har zuwa watan Maris, raguwa da rashin isassun magungunan gwaji sun kasance babbar matsala ga gwajin mutane da yawa a cikin EU, United Kingdom da Amurka.
Wannan ya sa wasu marubuta suka yi rubutu game da tsarin gwajin da ake buƙatar dumama su zuwa 98 °C (208 °F) na tsawon minti 5 don nuna ƙwayoyin da ke haifar da sake gwadawa. A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa ta kasance a kan gaba wajen samun damar gwada yawan jama'arta fiye da sauran ƙasashe, tare da shirin yin gwajin kusan dukkanin mazaunan ƙasar.
Wannan ya samo asali ne daga hada ikon tantance mutane a cikin motocin su, da kuma sayen dakunan gwaje-gwaje masu iya tantance mutane da yawa a lokaci guda a Group 42 da BGI (bisa ga dakunan gwaje-gwaje masu saurin Huo-Yan).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje na iya yin gwaje-gwaje sama da dubu goma na RT-PCR a kowace rana kuma shine na farko a duniya da ke aiki a waje da China.
An gabatar da tsarin gwaji daban-daban da ke rufe bangarori daban-daban na tsarin coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da shirin da Jamus ta bayar na samar da kayayyakin da za a tura wa ƙasashe masu tasowa da ba su da kuɗin da za su iya samar da nasu.
A ranar 17 ga Janairu, 2020, Jamus ta sanar da cewa, tsarin da Cibiyar Kula da Cututtuka ta Amurka ta samar ba zai kasance ba har zuwa ranar 28 ga Janairu, wanda ya haifar da jinkirin gwaji a Amurka. China da Amurka suna da matsala game da rashin amincewa da ingancin kayan aikin gwaji da ake da su, kuma waɗannan ƙasashe da Ostiraliya ba su da ikon cika kasuwar kayan aikin da suke da su da kuma bin shawarar masana kiwon lafiya.
Amma masana sun ce, inganta tsarin gwajin cutar a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar.
Gwamnatin Koriya ta Kudu ta gina ikon yin gwaji, musamman a dakunan gwaje-gwaje masu zaman kansu, tsawon shekaru.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta bukaci kasashen duniya da su kara yawan gwaje-gwaje da shirye-shiryen da suka dace domin su zama mafi inganci wajen rage yaduwar cutar ta COVID-19.Yawan bukatar kayan aikin gwaji saboda yaduwar kwayar cutar, wanda ya sanya yawancin su ke fuskantar kalubale ga dakunan gwaje-gwaje na Amurka, ya haifar da babbar matsala wajen samar da kayan aiki da magunguna da ake bukata don magance cutar.
A watan Maris na shekarar 2020 kasar Sin ta sanar da cewa akwai wasu matsaloli game da ingancin kayan aikin gwajin ta.
A Amurka, kayan aikin da Cibiyar Kula da Cututtuka ta Amurka ta samar sun kasance masu lahani, kuma Gwamnati ta cire shingen da ke hana gwajin mai zaman kansa. Spain ta sayi kayan aiki daga Shenzhen Bioeasy Biotechnology Co Ltd, wani kamfani na kasar Sin amma ta gano cewa ba su da inganci.
Cibiyar ta bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin tattara samfurin da kyau ko rashin amfani da kayan aiki.
Ma'aikatar harkokin wajen Spain ta ce za ta cire kayan aikin da ke ba da sakamako mara kyau daga kasuwa kuma za a maye gurbinsa da na kamfanin Shenzhen Bioeasy. Kashi 80% na kayan aikin da Czech ta sayo daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayayyakin da suka kai miliyan 1.2 daga China kuma ta gano cewa ba su da inganci.
Firayim Minista Matovič ya yi fatan a jefa su cikin kogin Danube. Ministan kiwon lafiya na Turkiyya Ateş Kara ya ce kayan gwajin da aka sayo daga China ba su da inganci kuma kada a yi amfani da su. Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma kwanan nan a watan Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba.
Gwajin, sannan kuma keɓewar mutane da kuma gano waɗanda suka haɗu da cutar SARS-CoV-2, ya ba da sakamako mai kyau.
Masu bincike a garin Vò na Italiya, inda aka samu mutuwar COVID-19 ta farko a Italiya, sun yi gwajin sau biyu ga kusan mazauna 3,400, a cikin kwanaki goma.
Kusan rabin waɗanda suka kamu da cutar ba su da alamun cutar, kuma an keɓe duk waɗanda suka kamu da cutar.
Dakatar da tafiye-tafiye zuwa wasu yankuna ya kawo ƙarshen sabon kamuwa da cutar.
Sakamakon tsauraran matakan lura da kamuwa da cuta, hana zirga-zirgar mutane, gwaji da keɓewa, kamuwa da cutar coronavirus ta 2020 a Singapore ya kasance mai ƙarancin gaske idan aka kwatanta da sauran ƙasashe masu tasowa kuma an yi hakan ba tare da rufe gidajen abinci da wuraren kasuwanci ba.
An dakatar da ayyuka da yawa, kuma Singapore ta fara ba da shawarar zama a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23 ga Maris.
Kasashe da yawa da suka kuma shawo kan cutar sun kafa hanyoyin ganowa, hana tafiye-tafiye na cikin gida, gwaji, keɓewa, da kuma zama a gida amma ba mai tsanani ba, kamar Iceland da Koriya ta Kudu.
Binciken ya nuna cewa ƙasashe da suka yi gwaje-gwaje da yawa, dangane da yawan mutuwar, suna da ƙananan ƙimar mutuwa, wataƙila saboda waɗannan ƙasashe suna da ikon gano waɗanda ke da ƙananan alamun cutar ko waɗanda ba su da alamun cutar.
Hukumar Lafiya ta Duniya ta bukaci kasashen da ba su da isassun wuraren gwaji da kuma dakunan gwaje-gwaje da ke da damar yin gwajin COVID-19 da su aika da gwaje-gwajen mutanen farko biyar da suka kamu da cutar da kuma na mutane goma da suka kamu da cutar COVID-19 daga dakunan gwaje-gwaje na WHO guda 16 don tabbatar da gwajin.
A cikin dakunan gwaje-gwaje guda 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin teburin da ke ƙasa, "Cigaba a matsayin kashi na gwajin" na iya canzawa dangane da manufofin gwajin ƙasa.
Kasar da ke gwada kawai waɗanda suka yi asibiti za ta sami matsakaicin adadin waɗanda suka kamu da cutar a cikin gwajin, idan aka kwatanta da ƙasar da ke gwada yawan jama'a, ko da kuwa suna da alamun cutar ko a'a, idan ba a canza komai ba.
Wanke hannu, da kuma tsabtace hannu, yana nufin wanke hannu don kawar da ƙura, mai, ƙwayoyin cuta, ko kuma wasu abubuwa da ba a so.
Wanke hannu a kai a kai a "mafi mahimman lokuta" na rana yana hana yaduwar cututtuka da yawa kamar su ciwon farji, kwalara, waɗanda ke yaduwa ta hanyar hanci da bayan baki.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko mura, misali, idan ba su wanke hannayensu ba kafin su taɓa fuska, hanci, ko baki (watau, gabobin da ke da ciwon hanci).
A cikin muhimman lokutan biyar na rana inda wanke hannu da sabulu ya zama dole sun hada da: kafin da bayan wankewa, bayan shayar da jariri ko canza masa sutura, kafin ciyar da jariri, kafin cin abinci da kuma bayan shirya abinci ko kama naman alade, kifi, ko kaza.
Idan ba a samu sabulu da ruwa ba, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin, lokacin da ake dafa abinci, da kuma bayan hakan.
Kafin ka kula da marar lafiya da kuma bayan ka yi hakan.
Bayan an canja wa jariri sutura ko bayan an wanke jariri bayan an yi amfani da wanka.
Bayan ka yi taushi ko tari ko kuma tsotsa.
Bayan ka taɓa dabba, ka ciyar da ita, ko kuma ka wanke ta.
Tsabtace hannu a fannin kiwon lafiya na nufin ayyukan tsabtace jiki.
Wanke hannu kafin a ba da magani ko kuma kula da mai haƙuri na iya hana ko rage yaduwar cuta.
Babban manufar wanke hannu a cikin likita shine tsabtace hannaye daga cututtukan cututtuka (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta masu cutarwa) da kuma magunguna waɗanda zasu iya haifar da cutar ko cuta.
Wannan yana da muhimmanci musamman ga masu shirya abinci ko kuma masu kula da lafiyar jiki, amma yana da kyau a yi hakan.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, kwayar cutar coronavirus, da sauran cututtukan annoba; hana wasu abubuwan da ke haifar da cutar zazzabin cizon sauro; rage cututtukan numfashi;
kuma suna rage yawan mutuwar jarirai da ake haifa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu yana taimaka wa yara da ba su kai shekara biyar su yi girma da kyau.
A ƙasashe masu tasowa, ana iya rage mutuwar yara daga cututtukan numfashi da kuma ciwon tari ta wajen yin canje-canje a salon rayuwarsu, kamar wanke hannu da sabulu.
Wannan hanya mai sauki na iya rage yawan mutuwar cututtuka da kusan kashi 50%.
Ayyukan da ke inganta wanke hannu na iya rage kusan kashi ɗaya bisa uku na kamuwa da cutar farji kuma wannan ya yi daidai da samar da ruwa mai tsafta a yankunan da ke da ƙarancin rayuwa.
Za a iya danganta raguwar cututtukan da suka shafi tari da kashi 48% tare da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da mafi arha don hana tari da cututtukan numfashi masu tsanani (ARI), wanda ya kamata ya zama al'ada a gida, makaranta da kuma a cikin iyali.
Cutar kumburi, cuta mai tsanani ta numfashi, ita ce sanadin mutuwar yara da ba su kai shekara biyar ba, tana kashe yara miliyan 1.8 a kowace shekara.
Cutar zazzabin cizon sauro da kuma ciwon daji suna kashe yara miliyan 3.5 kowace shekara.
Bisa ga rahoton da Hukumar Kula da Lafiyar Yara ta Majalisar Dinkin Duniya (UNICEF), yin amfani da sabulu a kai a kai kafin cin abinci da kuma bayan wanka na iya ceton rayuka fiye da duk wani allurar rigakafi ko magani, kuma zai rage kusan rabin mutuwar asusu da kashi ɗaya cikin huɗu na mutuwar cututtukan numfashi.
Wanke hannu sau da yawa yana cikin ayyukan tsabtace ruwa, tsabtace jiki da kuma tsabtace (WASH).
Wanke hannu yana kuma kāre mutum daga cututtukan fata da ake samu ta wurin shafar wasu.
Wani karamin illa na wanke hannu shine cewa wanke hannu sau da yawa na iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike da aka yi a Denmark a shekarar 2012 ya nuna cewa yawan wanke hannu na iya haifar da rashin ci, wanda ake kira da cututtukan fata na hannu, wanda ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sosai kuma alama ce ta rashin tausayi na halin rashin tausayi (OCD).
Akwai muhimman lokuta guda biyar na rana inda wanke hannu da sabulu ke da mahimmanci don rage kamuwa da cututtukan cututtukan hanci da na baki: bayan yin sallama (dakatar da, shafawa), bayan yin numfashi (canja sutura), kafin ciyar da yaro, kafin cin abinci da kuma kafin / bayan shirya abinci ko kama naman alade, kifi, ko kaza.
Sauran wuraren da ya kamata a yi amfani da wanke hannu don hana kamuwa da cuta sun hada da kafin da bayan kula da rauni ko rauni; bayan yin tari, tari, ko taushi; bayan taɓawa da ƙazamar dabba ko kula da dabba; da kuma bayan taɓawa da ƙazamar.
A ƙasashe da yawa, akwai ƙananan ƙa'idodi don wanke hannu da sabulu.
Binciken wanke hannu da aka gudanar a kasashe 54 a shekarar 2015 ya nuna cewa kimanin kashi 38.7% na gidaje sun yi amfani da sabulu wajen wanke hannu. Binciken na shekarar 2014 ya nuna cewa Saudi Arabiya tana da mafi girma na kashi 97%; Amurka tana da kusan kashi 77%; kuma China tana da mafi ƙarancin kashi 23%. A halin yanzu akwai sauye-sauye na tunani don karfafawa mutane hannu da sabulu a cikin mawuyacin yanayi. Wanke hannu sau ɗaya a cikin yara masu zuwa makaranta a cikin ƙayyadaddun lokutan yau da kullun shine ɗayan hanyoyin da za a iya amfani da su a cikin ƙasashe masu tasowa don koyar da yara da tsabtace hannu.
Shirin Kula da Lafiya na Ma'aikatar Ilimi ta Philippines misali ne mai kyau na ayyukan da aka tsara don inganta lafiyar yara da ilimi.
Shan maganin kashe ciwon daji sau biyu a shekara, tare da wanke hannu yau da kullun da sabulu, da kuma goge haƙora yau da kullun da fluoride, shine tushen shirin na ƙasa.
An yi amfani da shi sosai a ƙasar Indonesia.
Ana iya ƙara ƙarin sabulu ko kayan tsabtace jiki a cikin ruwa don kawar da ƙwayoyin cuta.
Babban fa'idar sabulu da kayan tsabtace jiki shine rage abubuwan hana tsotsa da haɓaka ƙarfin tsotsa.
Ruwa kaɗai ba ya tsabtace fata sosai domin mai da mai, kamar yadda yake a ƙasa, ba ya narkewa cikin ruwa.
Tsaftace-tsaftace yana nufin yin amfani da isasshen ruwa.
Saurin sake amfani da sabulu da ba ruwa ba zai iya riƙe ƙwayoyin cuta da suka kamu da cutar da suka kamu da ita daga masu amfani da su.
An yi bincike kadan kan yadda ake kamuwa da kwayar cutar ta hanyar gurbata sabulu, kuma an gano cewa ba za a iya kamuwa da cutar ba saboda an shafe kwayar cutar da kumfa.
Hukumar Kula da Cututtuka (CDC) ta ci gaba da cewa "yawan sabulu da kuma wurin da za a yi amfani da shi ba tare da yin amfani da mai tsabta ba ne hanya mafi kyau".
Mutanen da suke kula da lafiyarsu sun yaba wa sabulu mai kashe ƙwayoyin cuta.
A halin yanzu, babu wata hujja da ta nuna cewa maganin rigakafi ko maganin kashe ƙwayoyin cuta na zaɓaɓɓu suna da juriya ga ƙwayoyin cuta da aka sani da juriya ga maganin kashe ƙwayoyin cuta.
Amma, sabulu na kashe ƙwayoyin cuta suna ɗauke da maganin kashe ƙwayoyin cuta kamar triclosan, wanda ke da ƙwayoyin cuta da yawa da ba za a iya sarrafa su ba.
Saboda haka, ko da yake ba a zaɓi maganin rigakafi daga maganin sauro ba, amma ba zai yi tasiri sosai ba kamar yadda ake talla.
Baya ga kare yanayin da fata, ana iya samun sinadarin sinadarin acid (acetic acid, ascorbic acid, lactic acid) kamar su Iodogen, benzoic acid da sauran abubuwan kare jiki (creams, sunadarai, menthol, da sauran magungunan shuka). Binciken da aka yi a cikin cikakken bincike da Jami'ar Oregon School of General Medicine ta yi ya nuna cewa sabulu na yau da kullun yana da ikon karewa da kuma kawar da cututtukan cututtukan cututtukan hannu kamar yadda sabulu na yau da kullun ke da.
Ruwan zafi da ake amfani da shi wajen wanke hannu ba ya isa ya kashe kwayoyin cuta.
Kwayar cuta tana girma da sauri a zafin jiki (37 °C).
Amma ruwan zafi mai sabulu yana da amfani fiye da ruwan sanyi mai sabulu wajen kawar da mai da ke cikin ƙasa da kuma ƙwayoyin cuta.
Sabanin yadda mutane suke tunani, binciken kimiyya ya nuna cewa ruwan zafi ba ya rage yawan kwayoyin cuta a hannu.
Maganin hannu ko maganin hana kamuwa da cuta na hannu shine maganin tsabtace hannu ba tare da ruwa ba.
A ƙarshen shekarun 1990 da kuma farkon ƙarni na 21, wanke hannu da maganin kashe ƙwayoyin cuta (wanda ake kira da maganin shafawa na hannu) ya zama sananne kuma ya zama sananne.
Mafi yawan isopropyl ko ethanol an yi su ne ta hanyar hada Carbomer da man fetur ko kuma kara wani abu mai sauki kamar su kerosene zuwa sinadarin turare ko kumfa domin saukaka amfani da shi da kuma rage tasirin shan giya.
Ƙara iskar hydrogen peroxide a buɗe yana ƙara ƙwayoyin cuta. Maganin wanke hannu wanda ya ƙunshi aƙalla 60 zuwa 95% na giya, yana iya zama mai tasiri wajen kashe ƙwayoyin cuta.
Maganin wanke hannu na barasa yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu tsayayya da magunguna (MRSA da VRE), tarin fuka, da sauran ƙwayoyin cuta (ciki har da cutar kanjamau, herpes, RSV, rhinovirus, tsutsa, mura, da hepatitis) da kuma ƙwayoyin cuta masu saurin kamuwa da cuta.
Sanitary na hannu yana da kashi 70% na kashe 99,97% (3.5 raguwa, daidai da raguwar decibel 35) na ƙwayoyin cuta a cikin sakan 30 bayan amfani da kuma 99,99% zuwa 99,999% (ragewa tsakanin 4 da 5) na ƙwayoyin cuta a cikin minti 1 bayan amfani. Sanitary na hannu yana da tasiri sosai a kan ƙwayoyin cuta amma yana da ƙarancin ƙwayoyin cuta.
Ana amfani da maganin wanke hannu wanda ba shi da tasiri a kan cutar Norwalk, wanda ke haifar da cututtukan hanta. Ya kamata a yi amfani da maganin wanke hannu ta hanyar da zai iya zama mai narkewa ko ya yadu a hannaye biyu.
A shafa gaba da bayan hannu da tsakanin da kuma ƙarshen yatsun hannu kusan na tsawon dakika 30 har sai ruwa, kumfa ko kayan wanki sun bushe.
Yana da mahimmanci a wanke hannu sosai tare da rufe hannayenka. Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar wanke hannu da maganin kashe ƙwayoyin cuta musamman idan hannayen sun kasance masu ƙazanta.
Amfani da wannan hanyar ya dogara ne da sauƙin amfani da kuma saurin kashe ƙwayoyin cuta; duk da haka, wannan hanyar ba za ta maye gurbin hanyar wanke hannu ta yau da kullun ba sai dai idan sabulu da ruwa ba su da.
Yin amfani da kayan shafawa na hannu na giya sau da yawa na iya sa fata ta bushe sai dai idan an ƙara kayan shafawa ko kayan shafawa.
Za a iya rage ko kuma kawar da wannan ƙyama ta giya ta hanyar amfani da glycogen ko kuma wani magani mai sauƙaƙa fata.
A binciken da aka yi a asibiti, kayan wanke hannu da ke ɗauke da barasa da kuma kayan shafawa sun fi sabulu da magungunan kashe ƙwayoyin cuta ƙarfi.
Rashin jin daɗin fata, ƙwayoyin cuta, ko kuma rashin jin daɗi na jiki da ke tattare da barasa a cikin man shafawa ba safai ba ne.
Rashin haɗarin lalacewar fata ya sa wannan hanyar ta fi amfani da wanke hannu da sabulu da ruwa.
Ko da yake suna da amfani, masu wanke hannu ba sa wanke hannayensu don su kawar da dukan datti, amma suna cire ƙwayoyin cuta ne kawai.
Wannan shine dalilin da ya sa maganin wanke hannu ba ya aiki kamar sabulu da ruwa wajen hana yaduwar kwayar cutar, saboda kwayar cutar tana zaune a hannu.
Ingancin kayan aikin wanke hannu marasa giya ya dogara ne da abubuwan da ke ciki, kuma a baya ba su da inganci kamar giya da sauran abubuwan maye.
Kwanan nan, an nuna cewa maganin benzalkonium chloride yana da tasiri mai ƙarfi na rigakafin ƙwayoyin cuta bayan amfani, sabanin giya, wanda aka nuna cewa yawan amfanin sa yana raguwa bayan amfani da shi sau da yawa, mai yiwuwa saboda tasirin fata.
Mutane da yawa da suke da kuɗi kaɗan ba sa samun sabulu, saboda haka, suna amfani da toka ko kuma ƙasa.
Yin amfani da toka ko ƙasa yana da kyau fiye da yin amfani da ruwa kawai, amma ba shi da kyau kamar yin amfani da sabulu.
Wani abin damuwa shi ne cewa ƙura ko ƙasa suna da ƙananan ƙwayoyin cuta waɗanda za su iya cutar da cutar kuma hakan zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, ƙura tana kashe ƙwayoyin cuta domin tana yin acidic ruwa.
Idan ba a samun sabulu, Hukumar Lafiya ta Duniya ta ba da shawarar a yi amfani da toka ko yashi.
Ka'idodin wanke hannu da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cutar sune kamar haka:
Wanke hannuwanka da ruwan sanyi ko ruwan zafi mai gudana.
Ya kamata a yi amfani da ruwa mai gudana saboda ruwan da ke cikin kwalba na iya zama mai guba, kuma yawan zafin ruwan ba ya canzawa sosai.
Ka wanke hannayenka da turare, ka yi wanka sosai da sabulu mai yawa, ka wanke bayan hannu, tsakanin hannu da kuma ƙarƙashin hannu.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannuwansu da sabulu fiye da ruwa.
Wanke hannuwanka na akalla dakika 20.
Yin amfani da yatsun hannu sosai yana sa a yi taɓawa, yana taimaka wajen kawar da ƙwayoyin cuta daga fata, kuma yin amfani da yatsun hannu sosai yana kawar da yawancin ƙwayoyin cuta.
Wanke hannuwanka sosai da ruwa mai gudu.
Yin amfani da ruwan wanka a cikin wanka zai iya sake gurɓatar da hannayenka.
Ka wanke hannunka da tawul mai tsabta ko kuma ka bushe shi da iska.
Hannun da aka wanke ko bushe suna iya sake kamuwa da cuta. Yankunan da aka saba manta da su sune yatsun hannu, yatsun hannu, tsakanin yatsun hannu, da kuma ƙarƙashin yatsun hannu.
Ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
Ana ba da shawarar yin amfani da man shafawa don hana saurin hannu; fata mai bushewa na iya lalacewa kuma yana ƙara haɗarin yaduwar cutar.
Za a iya amfani da wasu hanyoyin da ba su da tsada don sauƙaƙe wanke hannu idan babu kayan wanki ko sabulu, kamar su zubar da ruwa ta hanyar tsinkaye (da tsinkaye) ko ƙarfe mai ƙura ko amfani da toka idan ya zama dole a ƙasashe masu tasowa. Idan akwai ƙarancin ruwa (kamar a makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin sarrafa ruwa kamar tsinkaye da sauran hanyoyin da ba su da tsada.
Kandagirukarebe fasaha ce mai sauki wacce ke amfani da jaket da ke rataye a kan igiya, zubar da ruwa da ƙafa, da wanke hannayenka da ruwa da sabulu.
Yin wanka da kyau yana da muhimmanci a tsaftace hannu, amma ana ta muhawara a kan yadda za a wanke hannu a cikin gidan wanka.
Bincike da yawa sun nuna cewa takarda da ake amfani da ita wajen wanke hannu tana da tsabta sosai fiye da na'urar wanke hannu da ake amfani da ita a gidajen wanka da yawa.
A shekara ta 2008, jami'ar Westminster da ke Landan, da wani kamfani mai yin kayan shafawa mai suna "The European Tissue Symposium" ya tallafa wa, sun gudanar da wani bincike da ya gwada yadda kayan shafawa da na'urar wanke hannu da kuma na'urar wanke hannu suke da tsabta.
Bayan wanka da shafa hannu da na'urar bushewa ta iska mai zafi, an gano cewa yawan kwayoyin cuta sun karu da kashi 194% a hannu da kuma kashi 254% a tsakiyar hannu.
Goge hannu da iska mai guba ya haifar da karuwar adadin kwayoyin cuta a matsakaici na kashi 42% a hannun hannu da kuma matsakaici na kashi 15%.
Bayan wanke hannu da kuma bushewa da takarda, an rage yawan ƙwayoyin cuta a matsakaita na 76% a kan kayan wanki da 77% a kan hannu. Masana sun kuma gudanar da bincike don gano yiwuwar yaduwar kamuwa tsakanin masu amfani da gidan wanka da kewaye saboda kowane irin bushewa.
Na'urar wanka, wacce ke fitar da iska a saurin 180m/s (650km/h; 400mph), na iya cire kwayoyin cuta daga hannu da sauran wurare da kuma iyawar cutar da sauran masu amfani da gidan wanka da kuma fitar da kwayoyin a nesa da mita 2.
Yin amfani da na'urar wanke hannu mai zafi yana kawar da kwayoyin cuta har zuwa mita 0.25 daga wurin.
Tsabtace takarda ya nuna cewa ba ya yada ƙwayoyin cuta sosai.A cikin binciken TÜV Produkt und Umwelt na 2005, an bincika hanyoyin tsabtace hannu daban-daban.
An lura da canje-canje masu zuwa a cikin adadin ƙwayoyin cuta bayan wanke hannu:
Akwai masana'antun wanke hannu da yawa, kuma an kwatanta wanke hannu da takardar wanke hannu.
Wanke hannu da maganin wanke hannu na gargajiya wani zaɓi ne idan mutum yana tafiya ba tare da sabulu da ruwa ba.
Dole ne a yi amfani da giya a cikin kayan wanke hannu da ke da kashi 60 cikin dari.
An tilasta wa likitoci su wanke hannuwansu bayan da likitan ƙasar Hungary, Ignaz Semmelweis ya gano cewa wanke hannu yana da amfani sosai a asibiti (a shekara ta 1846).
Wasu na'urori suna tunasar da ma'aikatan asibiti cewa su wanke hannayensu idan sun manta.
Wasu bincike sun nuna cewa amfani da su ya rage yawan kamuwa da cutar.
Wanke hannu na likita yana ɗaukar aƙalla sakan 15 tare da sabulu mai yawa da ruwa ko maganin shafawa kuma ya haɗa hannayenka biyu.
Ya kamata a haɗa hannayen hannu sosai.
Idan akwai datti a ƙarƙashin ƙwanƙwasa, ƙwanƙwasawa na iya cire shi.
Tun da yake ƙwayoyin cuta suna rayuwa a cikin ruwa a hannayen, yana da muhimmanci a wanke hannayenka sosai da kuma wanke su da tawul mai tsabta.
Bayan wanke hannu, ya kamata a yi amfani da takarda don rufe ruwa (kuma buɗe ƙofar idan ya cancanta).
Wannan yana hana hannayen da kuma wuraren da aka taɓa su sake gurɓata.
Dalilin wanke hannu a wuraren kula da lafiya shine don kawar da ƙwayoyin cuta da ke haifar da cuta da kuma hana yaduwar su.
Jaridar New England Journal of Medicine ta ba da rahoto cewa wanke hannu har ila yana da wuya a asibitoci, inda yawancin likitoci da ma'aikatan jinya sukan manta da wanke hannu kafin su taɓa marasa lafiya, kuma hakan yana sa ƙwayoyin cuta su yaɗu.
Wani bincike ya nuna cewa wanke hannu da sauran hanyoyin da suka dace na iya rage kamuwa da cututtukan jini da kashi 66%. Hukumar Lafiya ta Duniya ta fitar da takarda mai nuna yadda za a wanke hannu da kuma amfani da kayan tsabtace hannu a fannin kiwon lafiya.
Ana iya samun tsarin kula da tsabtace hannu na kamfanin a dandalinsa don ra'ayoyi.
Whitby da wasu sun yi gyara mai muhimmanci.
Kayan aiki na kasuwanci na iya auna da tabbatar da tsabtace hannu, idan an nemi a bayyana bukatun da umarni.
Hukumar Lafiya ta Duniya ta kafa "Lokaci biyar" na wanke hannu:
bayan ka sadu da jini/ruwa
kafin a yi maganin, da kuma
bayan kula da mai cutar. Ƙara maganin kashe ƙwayoyin cuta a sabulu (sabunan "magani" ko "mai kashe ƙwayoyin cuta") yana sa wanke hannu ya taimaka wajen kashe ƙwayoyin cuta.
Ana iya buƙatar wannan maganin rigakafi kafin tiyata ko kuma a cikin yanayin da ke da ƙwayoyin cuta masu tsayayya da maganin rigakafi. Don wanke hannu sosai kafin tiyata, yana da mahimmanci a sami robin da za'a iya rufewa da buɗewa ba tare da amfani da hannaye ba, maganin chlorhexidine ko iodine, wankin hannu mai tsabta bayan wanka, da kuma buroshi mai tsabta da kuma kayan aikin tsabtace hannu.
Dole ne ku cire duk kayan ado.
Wannan hanyar tana buƙatar wanke hannaye da hannaye har zuwa gwiwoyi, yawanci tsakanin minti 2 zuwa 6.
Ba lallai ba ne a wanke hannaye na tsawon minti goma.
Ka yi amfani da ruwa mai tsabta don kada ya sake sauka a hannunka.
Bayan ka gama wanke hannunka, ka goge shi da takalmi mai tsabta kuma ka saka tufafin da za ka yi amfani da shi a cikin dakin tiyata.
Don rage yawan kamuwa da cuta, yana da kyau a wanke hannu ko amfani da maganin wanke hannu kafin da kuma bayan kula da mai haƙuri.
A cikin binciken asibitoci na maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Wanke hannu da sabulu na yau da kullun yana haifar da fiye da sau uku na cututtukan cututtukan abinci fiye da wanke hannu da sabulu. Idan aka kwatanta amfani da maganin shafawa da sabulu na 30 seconds, duk sun nuna cewa amfani da kayan aikin wanke hannu yana rage yawan kamuwa da cuta da kashi 26% fiye da sabulu.
Amma wanke hannu da sabulu da ruwa ya fi amfani da maganin tsabtace hannu don rage kwayar cutar A/H1N1 da sauran ƙwayoyin cuta masu cutarwa da ke riƙe da hannu. Ayyukan tsabtace hannu na asibiti na iya haɗawa da koyar da ma'aikata don wanke hannu, ƙara tsabtace hannu da kuma tunatar da ma'aikata ta hanyar rubutu da magana.
Ana bukatar ƙarin bincike don nuna yadda wannan taimakon yake da amfani a kulawar lafiya a wurare da yawa.
A ƙasashe masu tasowa, wanke hannu da sabulu ana ɗaukansu hanya mafi mahimmanci da mafi arha don samun ƙoshin lafiya, da kuma abinci mai gina jiki.
Duk da haka, rashin samun ruwa, sabulu, ko kayan wanke hannu a gida, makaranta, da kuma wurin aiki, babban cikas ne da ke hana samun tsabtace hannu ga kowa.
Alal misali, a yankunan karkara da yawa a Afirka, ana samun ƙarancin wuraren wanke hannu kusa da wuraren wanka na jama'a ko na masu zaman kansu, duk da cewa akwai wasu hanyoyin da za a iya gina wuraren wanke hannu da ba su da tsada.
Koyaya, ƙarancin wanke hannu na iya zama saboda al'adar rashin wanke hannu maimakon rashin sabulu ko ruwa.
Ingantawa da kuma karfafawa wajen wanke hannu da sabulu na iya kawo sauyi a cikin ayyuka, wayar da kan jama'a game da amfanin wanke hannu da kuma sauya halayyar jama'a na dogon lokaci.
Don a yi wannan a hanya mai kyau, ana bukatar a riƙa lura da su kuma a riƙa bincika su.
Binciken binciken 70 ya gano cewa tsarin zamantakewar al'umma yana da tasiri wajen kara yawan wanke hannu a cikin LMICs, yayin da tallata ayyukan a shafukan sada zumunta ba shi da tasiri. Misali daya shine inganta wanke hannu a makarantu a matsayin "Tsarin taurari uku" na UNICEF ta hanyar karfafa makarantun suyi amfani da sauki, hanyoyin da basu da tsada don karfafawa dalibai su wanke hannu da sabulu, da sauran kayan aikin tsabta.
Idan aka cimma daidaito na asali, makarantu na iya tashi daga tauraro ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama daya daga cikin hanyoyin da za a inganta al'adar wanke hannu don rage cututtuka da mutuwar mutane.
Ranar wanke hannu ta duniya wani misali ne na kamfen na karfafawa mutane gwiwa kan wanke hannu domin cimma burin sauya dabi'u.Dangane da annobar cutar coronavirus ta 2019-20, UNICEF ta inganta emoji na wanke hannu.
Ƙananan bincike sun nuna yawan amfanin wanke hannu a ƙasashe masu tasowa idan aka kwatanta da DALYs.
Duk da haka, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran ayyukan ruwa da tsabtace jiki tasiri.
Amfanin wanke hannu a cikin lafiyar ɗan adam; musamman, marasa ƙarfi kamar uwaye masu haihuwa ko sojojin da suka ji rauni a yaƙi waɗanda ke asibiti, an nuna a tsakiyar karni na 19 ta hanyar masu gabatar da tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Florence Nightingale, Ingilishi "mai gabatar da sabon tsarin aikin jinya".
A lokacin, mutane da yawa suna tunanin cewa cututtuka masu saurin kamuwa da cuta suna faruwa ne ta wurin ƙanshin da ake kira foda.
A shekarun 1980s, cututtukan cututtukan abinci da cututtukan da ke tattare da magani sun sa CDC ta Amurka ta kara karfafa wayar da kan jama'a game da tsabtace hannu a matsayin muhimmin mataki na hana yaduwar cututtuka.
Cutar mura ta alade ta 2009 da cutar COVID-19 ta 2020 sun sa kasashen duniya su kara fahimtar muhimmancin wanke hannu da sabulu wajen hana kamuwa da cututtukan da ke dauke da cutar.
Alal misali, manyan takardu da ke nuna "yadda za a wanke hannu" an rataye su a gefen wankan hannu a gidajen wanka na jama'a da na ofisoshin gwamnati da kuma filayen jiragen sama a Jamus.
Kalmar nan "wanke hannuwansa" game da wani abu tana nufin rashin yarda da abin da mutum ya yi ko kuma ya ƙyale yaudara a cikin aikin.
Ya samo asali ne daga littafin Matta na Littafi Mai-Tsarki inda Bilatus Babunti ya wanke hannunsa bayan ya yanke shawarar giciye Yesu Kristi, amma kalmar ta ci gaba da kasancewa a cikin harshen Turanci.
A cikin wasan Shakespeare na Macbeth, Madamu Macbeth ta fara wanke hannayenta don kawar da abin da ta ɗauka cewa ta yi, wanda ke nuna cewa zuciyarta tana taƙama game da zunubinta da kuma abin da ya sa mijinta ya yi.
An gano cewa mutane, bayan sun tuna ko tunanin yin wani abu mara kyau, suna ƙoƙarin wanke hannayensu sau da yawa fiye da sauran, kuma suna ba da fifiko ga kayan wanke hannu.
Kuma waɗanda aka yarda su wanke hannayensu bayan sun yi tunani game da waɗannan munanan ayyukan ba sa son yin wasu ayyukan "tsabta" da suka tuba kamar yin ayyukan da aka yi da son rai.
Wasu addinai suna buƙatar mabiyan su su wanke hannayensu a matsayin tsabta da kuma yin al'adun addini. Wanke hannu yana nuna al'adun addini, tare da ruwa kawai ba tare da sabulu ba bayan wanke hannu, yana cikin al'adun addinai da yawa, gami da Baha'i, Hindu, Ta'ida da Diamond Nectar a cikin Yahudanci, Rava'u a cikin Yesu, da kuma wudu a cikin Islama. Addinai kuma suna buƙatar mabiyan su su wanke hannayensu, musamman bayan yin ayyuka na musamman.
Hindu, Yahudanci da Musulunci sun bukaci wanke hannu bayan bayan bayan gida.
Kuma addinan Hindu, Buddha, Sikh, Yahudawa, da Musulmai suna bukatar a wanke hannu kafin da kuma bayan kowane abinci.
Matakan rigakafin COVID-19 a wuraren aiki
Matakan rigakafin COVID-19 a wuraren aiki na da mahimmanci wajen tabbatar da lafiya da lafiya a wuraren aiki a cikin shirin rigakafin cutar coronavirus na 2019 (COVID-19).
Ingantattun matakan rigakafin cutar a wuraren aiki sun dogara ne da yanayin aiki da kuma yanayin aiki, bisa la'akari da yiwuwar kamuwa da cutar, yawan kamuwa da cutar a cikin al'umma da kuma hadarin kamuwa da cutar COVID-19 a tsakanin ma'aikata masu rauni.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), aikin da ke da ƙananan haɗarin kamuwa da kwayar cuta shi ne aikin da ma'aikata ke hulɗa da mutane da kuma sauran ma'aikata, inda aka ba da umarnin kiyayewa na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan sun yi rashin lafiya, umarnin rigakafin cututtukan numfashi da tsabtace jiki na yau da kullun da kuma maganin kashe ƙwayoyin cuta a wurin aiki.
Aiki mai haɗarin kamuwa da cutar shine aiki wanda ke buƙatar haɗuwa da mutane da yawa ko haɗuwa da waɗanda ba a san ko ake zargin suna da COVID-19 ba, amma suna iya kamuwa da cutar ta hanyar sadarwa ko tafiya zuwa ƙasashen waje.
Akwai ma'aikata da ke aiki a cikin jama'a kamar su ma'aikatan makaranta, ma'aikatan da ke aiki a wuraren da jama'a suke da yawa da kuma ma'aikatan da ke aiki a manyan kantuna.
Ƙarfafawa ga ma'aikatan ya haɗa da ka'idojin rigakafin cututtuka na asali, waɗanda suka haɗa da isasshen iska ta hanyar tsabtace iska, kayan aikin numfashi, da kuma samar da tufafin kariya na musamman idan aka haɗu da mutumin da ke dauke da COVID-19.
OSHA ta ba da shawarar cewa ma'aikatan kiwon lafiya da wuraren shakatawa waɗanda suka haɗu da wanda aka san ko ake zargin yana da COVID-19 suna da haɗarin kamuwa da cutar, wanda ke ƙara haɗarin idan waɗannan ma'aikatan suna yin aikin numfashi, ɗaukar ko gwajin mutum da aka sani ko ake zargin yana da COVID-19.
Kyakkyawan hanyoyin hana yaduwar cutar ga waɗannan ma'aikata sun haɗa da amfani da kayan aikin da aka tsara kamar ɗakunan iska da kayan kariya na musamman don aikin su.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata suna iya yin jinkiri a wurin aiki domin rashin lafiya, bukatar kula da wasu, ko kuma tsoron kamuwa da cuta.
Yanayin kasuwancin na iya canzawa, ko dai game da yadda ake shigo da kayayyaki ko kuma yadda ake sayen kayayyakin (kamar sayen kayayyaki a lokutan da ba su da tsada ko kuma sabis na sarrafawa ko isar da kayayyaki ta mota).
A ƙarshe, jigilar kayayyaki daga yankunan da cutar ta COVID-19 ta shafa na iya zama abin birgewa. Shirye-shiryen rigakafi da rigakafin cutar na iya zama abin amfani don ayyukan rigakafi.
Shirye-shiryen suna nuna haɗarin da ke cikin yawancin wuraren aiki da kuma aiki, gami da haɗarin da ke tattare da cutar, haɗarin gida da na jama'a da haɗarin da ma'aikata ke da shi ta hanyar tsufa ko kuma cututtuka na yau da kullun.
Ya kuma bayyana mahimman hanyoyin da za a bi wajen magance cutar ta hanyar kawar da wannan hadarin da kuma wasu matakan da za a iya ɗauka idan ba a yi nasara ba a lokacin annobar.
Za a iya aiwatar da shirye-shirye da kuma kula da cututtukan cututtuka a matakin ƙasa ko yanki.
Matakan rigakafin cutar a cikin wasu al'ummomi sun hada da rage yaduwar cutar tsakanin ma'aikata, kare mutane masu hadarin gaske daga wasu cututtukan da suka kamu da su, ci gaba da bude kasuwancin, da rage tasirin sauran kamfanoni a cikin sarrafawa da sarrafa kayayyaki.
Rashin lafiya a cikin al'ummomin da ke da kasuwancin da ke da alaƙa da su na iya shafar matakan da aka ɗauka.
An yi amfani da jerin matakan rigakafin cutar a cikin rigakafin cutar don tabbatar da lafiyar aiki da lafiya bisa ga yawan aiki.
Inda ba za a iya hana barkewar COVID-19 ba, hanya mafi inganci don magance cutar ita ce ta amfani da kayan aikin da aka tsara, sannan kuma tare da matakan gudanarwa da kayan kariya na musamman.
Kula da kamuwa da cuta ta hanyar kayan aiki na musamman shine kare ma'aikata daga haɗarin aiki ba tare da la'akari da halayyar ma'aikaci ba kuma yana iya zama mai sauƙi a aiwatar da shi.
Matakan gudanarwa canje-canje ne a cikin ƙa'idodin aiki ko aiki wanda ma'aikaci ko mai aiki ke buƙatar aiwatarwa.
Kayan kariya na mutum (PPE) an dauke su da rashin inganci kamar na biyun da suka gabata, amma suna iya taimakawa wajen hana kamuwa da cutar.
Duk nau'ikan PPE dole ne a zaɓi bisa ga haɗarin da ma'aikaci ke da shi, daidai da aikinsa (misali, masu numfashi), saka shi akai-akai da kyau, bincika shi akai-akai, kula da shi da kyau kuma canza shi kamar yadda ya cancanta kuma cire shi, tsabtace shi da adana shi ko zubar da shi don hana yaduwar cutar.
A cewar OSHA na Amurka, aikin da ke da ƙananan haɗarin kamuwa da cuta shi ne aikin da ke da matukar damuwa ga jama'a da abokan aiki.
Dole ne a bi matakan rigakafin kamuwa da cuta a duk wuraren aiki kuma ya hada da wanke hannu akai-akai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ka'idojin rigakafin cututtukan numfashi ciki har da rufewa lokacin tari ko tari, samar da kayan aikin tsabta da wuraren zubar da abubuwa, tsara hanyoyin sadarwa ta hanyar fasaha, hana sauya ma'aikata zuwa aiki da fita a lokaci guda idan ya cancanta, hana ma'aikata amfani da kayan aikin juna da kuma tsabtace da kuma maganin kashe ƙwayoyin cuta a wuraren aiki akai-akai.
Ganowa da kuma ware mutane da ke da cutar da wuri yana da muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
CDC na Amurka ta ba da shawarar cewa ma'aikata da ke da alamun cutar numfashi mai tsanani su zauna a gida har sai an sami zazzabi, zazzabi da sauran alamun cutar aƙalla awanni 24 ba tare da shan maganin rage zazzabi ko wasu magungunan cutar ba, da kuma sauƙaƙa hanyoyin neman izinin rashin lafiya, ba da izinin ma'aikata su zauna a gida tare da dangin da ke da rashin lafiya da kuma sanar da ma'aikata game da waɗannan matakan.
A cewar OSHA, aikin da ke da hadarin kamuwa da kwayar cuta shi ne wanda ke buƙatar haɗuwa da mutane ko kuma nesa da nesa da ƙasa da mita 1.8 tare da mutanen da ba a san ko ana zargin cewa suna da cutar COVID-19, amma suna iya kamuwa da cutar SARS-CoV-2 ta hanyar yaduwar cutar tsakanin mutane a wuraren kasuwanci ko kuma saboda mutane sun yi tafiya kwanan nan zuwa wuraren da cutar ta COVID-19 ta kamu da su.
Ya hada da ma'aikata masu yawan hulɗa da jama'a kamar masu aiki a makarantu, masu aiki a wurare masu yawa da kuma kantunan da ke karɓar baƙi. Yin amfani da kayan aikin da aka tsara don waɗannan ma'aikata da sauran ƙungiyoyin haɗarin haɗari sun haɗa da tsabtace iska, ƙara yawan masu amfani da iska, da sanya alamun rashin ƙarfi kamar su takunkumin filastik don kare ku yayin da kuke murmushi da kuma sanya tagogin da ke ba da sabis ga ma'aikata ba tare da barin motar ba. Matakan gudanarwa don buɗe ɗakunan wanka da sauran hanyoyin hana ma'aikata haɗarin kamuwa da cuta sun haɗa da ƙarfafa ma'aikata masu cutar da ke iya zama a gida, shawarwarin sauya yanayin aiki ta hanyar amfani da kayan aiki na zamani, hana masu amfani da takunkumi ko kayan aikin gida ko na gida don hana cutar, da kuma samar da wasu kayan aikin da ake buƙata don hana cutar COVID-19, da kuma samar da takunkumin rufe fuska, da kuma samar da kayan aiki na yau da kullun don hana cutar, da kuma samar da kayan aiki na gida, da kuma samar da kayan aiki na gida don hana cutar COVID-19.
Ma'aikata a cikin wannan rukunin haɗarin ba sa buƙatar yin amfani da inhaler.
Idan mutum ya kamu da cutar a cikin jirgin, dole ne a dauki matakan kariya na musamman ga ma'aikata da sauran fasinjoji, wanda ya hada da warewar mutum daga sauran mutane da kuma nisantar mutum da nisan mita biyu, sanya ma'aikacin jirgin daya da zai kula da shi, sanya masa abin rufe fuska, ko kuma ya bukaci ya rufe baki da hanci da tawul lokacin da yake tari ko yin tari.
Ma'aikatan jirgin sama dole ne su sanya safofin hannu na likita na likita da aka yi amfani da su lokacin da suke kula da marasa lafiya a cikin jirgin ko taɓa ruwan jiki ko aiki a wuraren da ke iya zama masu ƙazanta da kuma sanya tufafin kariya na musamman idan ya zama dole idan mai haƙuri a cikin jirgin yana da zazzabi, tari mai zafi ko rashin numfashi.
Ya kamata a ajiye safofin hannu da sauran kayan aikin da aka yi amfani da su a cikin kwandon da aka yi niyya kuma a goge wuraren da suka gurbata kuma a yi musu maganin kashe ƙwayoyin cuta bayan an yi amfani da su. A kan jiragen fasinja, gami da jiragen yawon shakatawa da sauran jiragen fasinja, maganin cutar ya hada da jinkirta tafiye-tafiye idan akwai rashin lafiya da kuma keɓewa da kuma sanar da asibitin jirgin nan da nan idan akwai zazzabi ko wasu alamun cutar a cikin jirgin.
A cikin makarantu da makarantun renon yara, CDC ta ba da shawarar a tsare shi na ɗan lokaci don wankewa ko maganin kashe ƙwayoyin cuta lokacin da mutum mai cutar ya bayyana a cikin makarantar, ba tare da la'akari da yiwuwar cutar ba.
Ko da akwai ƙananan ko kuma yawan yaduwar cutar tsakanin mutane, ana iya aiwatar da matakan hana haɗuwa ta hanyar dakatar da tafiye-tafiye na makaranta da taron jama'a kamar motsa jiki ko karatun waƙa ko cin abinci a cikin cafeteria, ƙara tazarar tsakanin kujeru, ƙuntata tazarar shiga da fita, hana ziyarar da ba ta da mahimmanci da kuma amfani da asibiti na waje ga yara masu alamun cutar kamar mura.
Idan akwai yaduwar cutar a cikin al'umma, ban da matakan hana haɗuwa da rufe makarantu na dogon lokaci, ana iya yin la'akari. Ga ma'aikatan tsaro waɗanda ke aiki na yau da kullun, haɗarin kamuwa da cutar nan take yana da ƙarancin gwargwadon CDC.
Jami'an tsaro da suka sadu da wanda aka tabbatar da cutar ko wanda ake zargi da cutar COVID-19 ana buƙatar su bi ka'idodin da likitoci masu aiki sosai suka tsara, gami da sanya kayan kariya na musamman.
Idan akwai haɗuwa a lokacin kama mutum, ma'aikata su goge da kuma shafa kayan aikin da suka saka da kayan aikin su kafin sake amfani da su ta hanyar amfani da kayan aikin gida ko kuma gogewa da kuma bin ka'idojin kiyayewa da zubar da kayan kariya na musamman da aka yi amfani da su wajen ajiye da kuma wanke tufafi.
OSHA ta ba da shawarar cewa wasu ma'aikatan kiwon lafiya da na hutu suna da babban ko kuma babban haɗarin kamuwa da cutar.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da ma'aikatan kiwon lafiya, masu aikin gwaje-gwaje, da masu jigilar kayayyaki da ke zuwa ko dawowa daga asibiti waɗanda wataƙila sun haɗu da wanda aka sani ko ake zargin yana da cutar COVID-19.
Waɗannan suna da haɗarin kamuwa da cutar yayin da masu aiki ke yin ayyuka kamar su numfashi, ɗaukar ko bincika samfurin mutum da aka sani ko ake zargin yana da COVID-19.
Ayyukan ƙarawa na oxygen sun haɗa da yin allurar rigakafi, yin fitsari, yin allurar rigakafi, wasu ayyukan hakori da kuma yin bincike ko kuma yin wasu gwaje-gwaje na ciki.
Mafi yawan haɗarin kamuwa da cuta a wurin shakatawa ya shafi ma'aikatan da ke shirya gawawwakin mutanen da aka sani ko ake zargin suna da cutar COVID-19 a lokacin da suka mutu; suna da haɗari mafi girma yayin da suke yin gwajin gwaji don gano abin da ya sa mutum ya mutu. Kuma sarrafa kamuwa da cuta ta hanyar kayan aiki na musamman sun haɗa da rukunin haɗari ciki har da ɗakunan keɓewa don waɗanda aka sani ko ake zargin suna da cutar COVID-19, gami da yin aikin numfashi ga marasa lafiya.
Na'urar motsa jiki ta musamman na iya zama mai kyau ga wasu likitoci da ma'aikatan hutu.
Dole ne a yi gwajin a cikin tsari na matakin 3 na lafiyar asibiti.
WHO ta ba da shawarar a ware marasa lafiya da ke zuwa asibiti a wuraren jira saboda zargin COVID-19. Kuma a cikin tufafin kariya na musamman, OSHA ta ba da shawarar yin amfani da na'urorin numfashi ga ma'aikatan da ke aiki a nesa da mita 2 daga waɗanda aka sani ko ake zargi da cutar, waɗanda ke da cutar SARS-CoV-2 da kuma waɗanda ke ba da iska.
A Amurka, dole ne a yi amfani da na'urar numfashi ta NIOSH mai lamba N95 ko mafi inganci bisa tsari mai kyau, wanda ya ƙunshi tantancewa, horo da kuma gwajin asibiti.
Wasu nau'ikan na'urorin numfashi na iya kare mai ɗaukar hoto da kyau kuma su sa ma'aikaci ya fi jin daɗi. WHO ba ta ba da shawarar ma'aikata su sa riguna ba saboda COVID-19 cuta ce ta numfashi maimakon cuta mai yaduwa ta ruwa.
WHO ta ba da shawarar cewa kawai masu karɓar baƙi ne za su sa abin rufe fuska.
WHO ta ba da shawarar cewa masu daukar gwajin numfashi, masu kula da marasa lafiya, ko masu ɗaukar marasa lafiya na COVID-19 ba tare da ƙarin iska ba, su sanya abin rufe fuska, abin rufe fuska, rigar rigakafi da safofin hannu.
Idan ana yin aikin numfashi, ana maye gurbin abin rufe fuska na asibiti da na numfashi na N95 ko FFP2.
Saboda rashin isasshen maganin rigakafin mutum (PPE) a duniya, WHO ta ba da shawarar rage buƙatun rigakafin mutum (PPE) tare da amfani da hanyoyin warkewa, samar da wuraren da za a iya samun mutane kamar windows, da kuma ba da damar shiga cikin ɗakin mai cutar COVID-19, amfani da PPE kawai lokacin da ake buƙatar takamaiman aiki, ci gaba da amfani da na'urar numfashi guda ɗaya ba tare da ɓata lokaci ba yayin kula da marasa lafiya da yawa masu haɗuwa, saka idanu da kuma aiwatar da ayyukan PPE da hana amfani da abin rufe fuska ga marasa alamun cutar.
BY: Katherine Maher, Shugabar Wikimedia Foundation
TAMBAYA: Dukan ma'aikatan Wikimedia Foundation
TAMBAYA: [COVID-19] Rage nauyi da kuma shiri don nan gaba
LOKACI/Kwanan da aka buga: 14 ga Maris 2020, 00:24 UTC
CC0: Babu takamaiman haƙƙin mallaka
Mun shiga wani yanayi na musamman a wannan watan.
Cutar COVID-19 ita ce hujja cewa duniya ta zama ƙauye kuma dole ne mu taimaki juna.
Ba mu taɓa fuskantar irin waɗannan ƙalubalen ba, amma mun san cewa hanyar da ta fi dacewa don magance cutar ita ce fahimtar matsalolin duniya, haɗa kai da kuma ci gaba da kasancewa tare a cikin wannan al'umma.
Kyakkyawan kulawa da kulawa da muka samu daga dukkan abokan aikinmu ta hanyar imel, kira da hira suna nuna irin mutuntakar da muke da ita da muka yi sa'ar yin aiki tare da ku.
Ba zan iya gode muku ba ko in nuna muku yadda nake alfahari da ku duka a matsayin abokan aiki.
A makon da ya shige, wani ya nuna mini cewa yana son aikinmu.
Ya tunatar da ni cewa a yanzu haka, duniya tana amfani da Wikipedia sosai, wanda ke nuna cewa shafin yanar gizo ne mai amfani da kuma ya kamata ya kasance a kan layi kuma ya kasance ga kowa.
Aikinku ne yake sa hakan ya yiwu, ko dai ku ci gaba da yin amfani da wannan dandalin ko kuma ku biya kuɗin da muke bukata ko kuma ku sa wurin aikinmu ya kasance mai tsaro.
Duniya na bukatar bayanan da Wikipedia ke bayarwa a yanzu fiye da kowane lokaci.
Lokaci ya yi da za mu yi tunani ba kawai game da abin da muke yi ba amma kuma yadda muke yinsa, domin mu kawo canji mai amfani a duniya.
Saboda muhimmancin wannan aiki da kuma matsayin da kake da shi, za mu yi wasu canje-canje masu muhimmanci a yadda muke aiki, daga mako mai zuwa.
Yin gyara ga ayyukanmu da kuma tsarinmu
Kamar yadda Robyn ta ce, tawagarmu ta taru a daren jiya don tattauna hanyoyinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan talifin, mun tattauna abin da muke ganin zai iya zama amsar da ta dace ga abin da muke fuskanta da kuma yadda za mu ci gaba da inganta iyali a wannan zamani.
Musamman, muna son mu kawar da matsaloli kuma mu ci gaba da hidimarmu na dogon lokaci.
Idan kana son ka kira, ba matsala.
Ga ma'aikata, ga waɗanda aka ba da alkawari, da kuma ga dukan waɗanda suke aiki a ƙarƙashin alkawari:
Za a yi aiki na awa 4 a rana ko kuma awa 20 a mako har sai an ba da ƙarin bayani.
Ba za mu kira shi hutu ba; idan za ka iya yin aiki a kai a kai, za mu yi amfani da shi a hidimarmu.
Amma a yau, yanayin duniya yana canjawa, kuma idan kana bukatar ka kula da waɗanda kake ƙauna, ka je cin abinci, ko kuma ka je kasuwa, rayuwarka ce ta fi muhimmanci.
Ba ma bin sawun lokacin da kake aiki.
Idan kana rashin lafiya, kada ka je aiki.
Ba a faɗi ba amma mun ambata.
Ba lallai ne ka nemi izinin rashin lafiya ko kuma izinin biya ba, sai ka sanar da shugabanninka kuma ya taimaka wa ƙungiyarka ta sake tsara jadawalin da kuma jadawalin don ci gaba da aikin.
(Idan ka gwada kana da cutar COVID-19, ka sanar da Bryan wanda ke aiki a T&amp;C Ops domin T&amp;C ta ba ka tallafi da kulawa ta al'ada.
Za a biya duk wanda aka biya sa'a ɗaya.
Mun sake yin tunani kuma mun sake cika alkawarinmu na biyan kuɗin da aka ba mu a kan lokaci.
Za a biya kowa bisa ga ainihin awoyin da ya yi a yanayi na yau da kullum.
Akwai lokacin da ba za ka iya yin aiki ba domin kana rashin lafiya.
Idan kana son yin aiki, za mu tallafa maka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su kawar da damuwa da ke damunsu a wannan duniyar.
Abin da muke yi na iya zama da muhimmanci musamman a wannan lokaci.
Kuma, makasudin shi ne ka kula da kanka.
Manufarmu ita ce ka yi magana da mai kula da kai, don mu san abin da za mu yi tsammani kuma mu daidaita yadda ake gudanar da ayyukan.
Wasu ayyuka suna da muhimmanci.
Akwai abubuwa da muke bukatar mu ci gaba da yi.
Ƙungiyoyin SRE, HR Ops, Trust &amp; Safety da kuma masu tara kuɗi (da sauransu) suna yin aiki mai mahimmanci wanda ke buƙatar ƙarin taimako.
Za mu fara duba a duk sassan don duba manufofin da ke akwai da kuma daidaita mayar da hankali don tallafawa mahimman abubuwan da ke cikin aikinmu.
Akwai abubuwa masu muhimmanci da ya kamata mu yi, amma akwai wasu ayyuka masu muhimmanci da ya kamata mu mai da hankali a kai.
Yin wasu ayyuka a yanzu ba zai kawo sakamako ba.
Ba mu da shirin yin kusan sau biyu don biyan lokacin da muka rasa bayan annobar ta ƙare.
Ba za a bukaci ka yi aiki na sa'o'i da yawa ba don ka ci gaba da yin aikin da aka ba ka.
Mun yarda cewa abubuwa sun canza kuma za mu yi aiki don kafa sababbin manufofi da jadawalin lokaci a inda ya dace.
Menene zai faru da shirin shekara?
Don daidaita yanayin da ya rage na lokutan aiki na yau da kullun, muna son canza jadawalin shirin na 2020-2021.
Manufarmu ita ce a ba da shawarar a tsawaita lokacin tsara jadawalin 2019-2020 don samar da lokacin tsara kasafin kuɗi don bawa ma'aikata damar mayar da hankali kan aikin su, kula da kansu da kuma ƙaunatattun su yayin da muke tallafawa waɗanda ke neman ko suke son yin aiki na ɗan lokaci a cikin 'yan makonnin da ke tafe.
Wannan ƙarin lokacin yana rage aikin da aka tsara a cikin al'umma gaba ɗaya.
Za mu gabatar da shawararmu ga kwamitin gudanarwa a mako mai zuwa kuma zan ba da sabuntawa ga sauran wakilan jam'iyyun game da umarnin na gaba da wuri-wuri da zarar an amince.
Kungiyar da ke tsara shirin ta yi amfani da kwarewar da ta nuna.
Yanayin da ake ciki, yadda mutane suke da haɗari, da kuma tsabta
A makon da ya gabata, mun gano cewa wani abokin aikinmu da ke aiki a SF ya sadu da wani wanda zai iya kamuwa da cutar COVID-19.
Amma, saboda muna da hankali, mun yi aiki da ƙungiyar tsabtace ƙwayoyin cuta don su yi amfani da maganin kashe ƙwayoyin cuta a ko'ina a ofishinmu da ke San Francisco.
Sun yi amfani da tsarin rigakafin cutar a asibiti kuma sun kashe kwari a duk wuraren da mutane ke shiga har ma da na'urorin bincike na banki da suka kai ga teburinmu.
Ginin yana aiwatar da ka'idojin rigakafin cutar ta hanyar amfani da kayan aikin kiyaye lafiyar masu amfani.
Muna fatan ofishin zai kasance a shirye idan muka yanke shawarar sake yin hakan.
Ofishinmu na DC wanda ke WeWork, ya raba yarjejeniyar COVID-19 tare da mu da kuma dukkan ma'aikatan da ke DC.
Har zuwa makon da ya gabata, ofishinmu na DC ya sauya zuwa aiki na nesa don bin umarnin San Francisco.
Kamar yadda wasu abokan aikina da ke hidima a birnin New York suka sani, mun soma tattaunawa don mu yi hayar gida a Brooklyn.
Za a ci gaba da tattaunawar, amma za a iya yin hakan na ɗan lokaci.
Wasu abokan aikina za su yi aiki da na'ura mai nisa a karon farko.
Abokanmu da suka saba yin amfani da na'urar ta nesa sun san cewa za a iya canzawa kuma muna so mu ba da shawara:
Ku rage lokacin taron zuwa awa ɗaya ko biyu idan ya makara.
Idan ba a bukatar zaman, ku yi tunanin yadda za ku rage yawan lokacin da ake nazari.
Ka bayyana shawarwarin da kyau, ka yi bayani dalla-dalla a kan abin da za ka yi nazari a kai, kuma ka aika da takardun da aka rubuta a kan lokaci.
Ka daina amfani da bidiyo a matsayin abu na farko ta amfani da aikace-aikace kamar Google Docs da Zoom don sauƙaƙe hulɗa da raba bayanai a cikin lokaci.
Bari babban darakta ya jagoranci kowane taro, tare da mai duba tambayoyin da kuma kula da jerin masu magana da wanda ya dauki bayanin taron (ko kuma ya taimaka wajen rubuta bayanin taron).
Ka aika imel zuwa wurin tallafi idan kana bukatar mai magana da ya fi dacewa.
Ka ci abinci mai sauƙi don ka kasance da koshin lafiya.
Shiga tashar #remoties a kan Slack don bayyana ƙalubalen da kuka fuskanta yayin yin aikin da aka ba ku
Ayyukan Kungiyar ma'aikata na duba ka'idojin gudanar da bita da aka gabatar ta hanyar intanet domin neman taimako da kuma kara yawan ayyukan da ake yi a cikin Kungiyar.
A makon da ya gabata, mun nemi dukkan kungiyoyin da ke samun tallafi su dakatar da ayyukan neman tallafin Wikimedia a matsayin wani shiri na horar da sabbin marubuta na intanet, har sai WHO ta sanar da cewa annobar ta kare.
Mun gaya musu cewa mun san cewa yin watsi da waɗannan ayyuka da kuma bin wasu dokoki suna sa ya yi wuya sosai a kammala aikin tara kuɗi da suka ƙudura niyya kuma ba wanda zai hukunta su don jinkiri ko kuma canja makasudinsu.
A mako mai zuwa, za mu ci gaba da ƙarin bayani game da Wikimania da kuma wasu taron yanki na musamman.
Tunanin da aka saba yi game da ƙungiyoyin duniya yana da zafi saboda dakatar da aiki amma akwai ta'aziyya, fahimta da kuma ikon mayar da hankali kan ƙungiyoyin su, Wikimedia da sauransu.
Don haka CRT tana kafa shafi a kan Meta-Wiki don samar da damar al'umma ta lura da tasirin da kuma bayanan da muke tattaunawa.
Ci gaba da tattaunawa kan matsalar COVID-19
Za mu aika muku da gayyatar zuwa kalandarku a ranar Alhamis mai zuwa, da karfe 14:00 UTC/07:00 PT don taron musamman na ma'aikata.
Za mu yi amfani da wannan lokacin don kawo muku sabuntawa, amsa tambayoyinku da kuma ƙarin lokaci don musayar bayanai.
Dukanmu muna cikin wannan annoba kuma muna nan don tallafawa juna yadda za mu iya.
A halin yanzu, za ka iya samun sabuntawar wannan imel da sauran muhimman bayanai game da COVID-19 a Wiki Office.
CRT za ta ci gaba da sabunta shafukan kuma duk bayanan za su kasance a wuri guda.
Muna neman hanyoyin da za mu ci gaba da sadarwa tare da ma'aikatan da ke zaune a kasashen da cutar ta addabi a halin yanzu.
Idan kana da wata tambaya game da tafiye-tafiye, ayyuka, aiki ko matsalar intanet ko wani abu da kake bukatar taimako, kada ka yi jinkirin sanar da mu kuma ka yi aiki tare da CRT.
Muna nan don taimaka muku ta hanyar daidaita ayyukan da ake buƙata.
Idan kana da wata matsala ta sirri ko kuma da ke bukatar kulawa, ka aika imel zuwa Bryan Judan, Babban Daraktan Ma'aikata da Ayyuka na Duniya.
Kada mu ɗauki waɗannan canje-canjen a matsayin barin aikinmu ko kuma hakkinmu.
Maimakon haka, yana nufin cewa a yau, aikinmu da hakkinmu suna iya canjawa sosai fiye da dā.
Waɗannan su ne matakan da muke ganin suna da muhimmanci wajen taimaka wa juna wajen ci gaba da aiki, da yin aikin da aka ba mu bisa ga bukatunmu da kuma samar da duniya da sabis da za ta iya tafiya.
Aikin da muka shirya zai kasance a wurin har sai lokacin ya yi.
A yanzu, muna cikin lokacin da za mu taimaka wa juna da kuma samun lokaci don yin aiki mai mahimmanci a cikin makonni masu zuwa kuma wataƙila a cikin watanni masu zuwa.
Muna bukatar ku duka domin a cimma wannan kuma muna bukatar ku kula da kanku da kuma iyalanku domin ku kasance cikin koshin lafiya idan bukata ta kama.
Yanzu, ya kamata ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran mambobin kwamitin gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
b Angiotensin-converting enzyme 2 (ACE2) is shine sinadarin da ke sanya sinadarin a cikin kwayar halitta ta waje (kwararrun kwayar halitta) na huhu, jijiyoyin jini, zuciya, koda, da kuma hanji.
ACE2 yana daidaita aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang (((1-7) yana mai da shi mai bada shawara don maganin cututtukan zuciya. ACE2 kuma yana taimakawa a matsayin hanyar shiga kwayar halitta ga wasu coronaviruses.
Siffar ɗan adam akan furotin da ke yin enzyme ana kiransa hACE2.
Kwayar halitta Angiotensin-con 2 shine zinc-containing metalloenzyme wanda ke zaune a cikin endothelial surface da kuma sauran kwayoyin halitta.
Kwayar ACE2 tana dauke da N-terminal na peptidase M2 da kuma C-terminal na collectrin wanda ke daukar acid a cikin koda.
ACE2 shine mai karɓar furotin mai nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
An rarraba wani sashi na ACE2 a cikin kwayar halitta ta hanyar wani sinadarin da ake kira sheddase, kuma an samar da shi ta hanyar hanyar shiga cikin kwayar halitta sannan kuma a fitar da shi daga cikin kwayar halitta.
ACE2 yana samuwa a cikin yawancin kwayoyin halitta: ACE2 yana kama da kwayoyin halitta, musamman kwayoyin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ana samun bayyanar ACE2 mRNA a cikin kwakwalwar kwakwalwa, a cikin striatum, a cikin hypothalamus, da kuma a cikin kwakwalwar kwakwalwa.
Aikin farko na ACE2 shine daidaita daidaiton ACE.
ACE yana wucewa ta hanyar enzymes na angiotensin I inda angiotensin II ke da tasirin rage karfin jini.
ACE2 kuma yana samar da phenylalanine na amino acid mai amfani da carboxyl-terminal a cikin angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da kuma hydrolyses a cikin angiotensin mai girma (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya kuma rarraba peptides kamar [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana taimakawa wajen daukar kwayar amino acid mai aiki SLC6A19 kuma yana da tasiri a cikin cutar Hartnup.
A matsayin furotin mai yaduwa, ACE2 yana aiki a matsayin babban hanyar shiga cikin kwayar cutar ta coronaviruses, wato HCoV-NL63; SARS-CoV (kwayar cutar SARS); da SARS-CoV-2 (kwayar cutar COVID-19).
A takaice dai, haɗuwa da kwayar SARS-CoV S1 da SARS-CoV2 zuwa wani ɓangaren kwayar ACE2 a cikin kwayar halitta yana haifar da tsarin haɓakar ƙwayar cuta da ƙaura daga wurin da kwayar cutar take da kuma kwayar halitta zuwa cikin kwayar halitta.
Wannan hanyar shiga kuma tana shirya furotin S don aiki ta hanyar rarraba TMPRSS2, kuma bincike yana neman yadda za a hana shi aiki wanda shine babban maganin. Wannan ya haifar da tunanin cewa rage matakan ACE2 a cikin kwayar halitta na iya taimakawa wajen magance cutar.
Duk da haka, yawancin kamfanoni masu sana'a da hukumomin kulawa sun nemi ci gaba da hana ACE aiki a allurai da kuma maganin ARB.
Wani cikakken bita da kuma bincike mai zurfi da aka fitar a ranar 11 ga Yuli, 2012, ya gano cewa "yin amfani da maganin ACE ya nuna raguwar kashi 34% na hadarin kamuwa da cutar zazzabin cizon sauro idan aka kwatanta da wadanda aka yi wa gwaji".
Bugu da kari, "an rage hadarin kamuwa da cutar sankarar bargo a cikin marasa lafiya masu saurin kamuwa da cutar da aka yi wa maganin ACE, musamman a cikin masu ciwon zuciya, da kuma wadanda ke fama da rashin aiki.
An kuma gano cewa amfani da maganin ACE ya rage mutuwar cutar sankara, ko da yake sakamakon ba shi da tsanani fiye da hadarin kamuwa da cutar sankara gaba daya.
Ana amfani da ACE2 (rhACE2) a matsayin sabon magani don cutar cututtukan huhu, kuma yana nuna cewa yana inganta yaduwar jini a cikin huhu da kuma ƙara yawan iskar oxygen a wuraren da kwayoyin cutar ke cutarwa.
Rabin rayuwar rhACE2 a cikin mutane sa'o'i 10 ne kuma yana farawa bayan minti 30 fiye da lokacin da tasirin ya fara bayyana (lokacin) a cikin awanni 24.
Yawancin bincike sun gano cewa rhACE2 na iya zama ingantaccen magani ga mutanen da ke da rashin haƙuri ga tsarin hana yin renin-angiotensin (RAS inhibitors) ko kuma cututtukan da ke da yawan jini na angiotensin II. An gwada maganin rhACE2 a cikin gwaji na asibiti don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
COVID-19 aikace-aikacen wayar hannu ne da aka tsara don gano lambobin sadarwa na mutum don gano cutar coronavirus 2019-20, misali, a cikin aikin gano lambobin sadarwa ("lambobi") waɗanda zasu iya kasancewa tare da mai cutar.
An yi amfani da aikace-aikace da yawa ko kuma an nemi mutane da yawa su yi amfani da su, kuma gwamnatoci a wasu larduna da yankuna suna kula da su.
An kafa tsarin da yawa don gina software da ke fahimtar yadda mutane suke saduwa.
An nuna damuwa game da ɓarnatar da bayanan sirri, musamman game da tsarin tushen wurin da ke amfani da masu amfani da aikace-aikacen.
Wani zaɓi mai saurin shiga ciki shine amfani da hanyar sadarwa ta Bluetooth don shiga da sanin wasu wayoyin hannu ta hanyar aikace-aikacen da ke kusa.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su shigar da wannan fasalin don tallafawa aikace-aikacen da ke da tushen Bluetooth kuma za a shigar da shi nan da nan a cikin tsarin aiki na Android da iOS.
A China, gwamnatin China, tare da haɗin gwiwar Alipay, ta ƙaddamar da wani aikace-aikacen da ke ba wa 'yan ƙasa damar bincika idan sun taɓa haɗuwa da mutanen da ke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. A Singapore, ana amfani da wani app da ake kira TraceTogether.
Wannan manhajar da wata babbar kungiya ta masana fasahar sadarwa ta IT ta samar, an fitar da ita ne a matsayin wata hanyar samun bayanai ga kowa da kowa kuma za a ba da ita ga gwamnati. Arewacin Macedonia ta fitar da "StopKorona!", wani manhajar da ke amfani da Bluetooth don gano cewa kana kusa da mutanen da ke da mummunar kamuwa da cutar kuma ta ba da amsa mai sauri ga hukumomin kiwon lafiya.
An kirkiro wannan manhajar ne daga Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
Daga ranar 14 ga Afrilu, 2020, ana jiran karɓar aikace-aikacen a cikin Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, Gwamnati ta ce an kammala aikin gano hanyoyin sadarwa kuma ya kamata a samu don a fara shi a cikin makonni masu zuwa. Ana shirin yin irin wannan shirin a Ireland, da Faransa ("StopCovid").
Ostiraliya da New Zealand suna tunanin kirkirar manhajojin wayar hannu na zamani kamar su TraceTogether na Singapore da BlueTrace na Rasha. Rasha na shirin kaddamar da wani tsarin kula da lafiyar COVID-19 a Moscow, wanda zai tabbatar da cewa ba su fita daga gida ba.
Ross Anderson, Farfesa a fannin aiwatar da tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli da tsarin da ke amfani da manhajojin wayar salula ke fuskanta, ciki har da rashin lafiyar da ke nuna cewa suna da lafiya da kuma rashin yin abin da aka tsara idan amfani da manhajojin ya iyakance ga ƙananan mutane.
Don magance damuwar da ke tattare da yaduwar wadannan aikace-aikacen da ke gano cutar coronavirus, Apple ya kafa iyakantaccen matakin kamfanoni da ke shigar da aikace-aikacen da ke gano cutar coronavirus a cikin App Store, wanda ke ba da izinin "a hukumance" ko kuma a wasu kalmomin, kungiyoyi masu aminci.
Google da Amazon sun kafa irin wannan dokar.
Mutane sun nuna damuwa game da sa ido kan mutane da yawa ta hanyar fasahar wayar hannu, musamman idan za a iya kawar da kayan aikin da aka kafa don kula da cutar ta coronavirus lokacin da annobar ta ƙare.
Kungiyar kare hakkin dan Adam ta Amnesty International da kuma kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a rage amfani da irin wannan tsarin na sa ido.
Kungiyoyin sun bayyana ka'idoji takwas da gwamnati ke bukata don gudanar da ayyukan su:
Dole ne a yi bincike bisa doka, dole ne kuma a kan matakin da ya dace da manufar sa ".
tsawaita lokacin da za a yi nazari da kuma duba ya kamata ya ƙunshi sharuddan lokacin da za a ƙare;
ya kamata a yi amfani da bayanai ne kawai don dalilai masu alaƙa da COVID-19;
tsaro da sirrin bayanai da za a kiyaye da kuma tabbatar da cewa an kiyaye su bisa ga shaidar;
dole ne a yi amfani da fasaha wajen yin bincike ba tare da nuna bambanci ko rashin daidaito ba;
kowane watsa labarai dole ne ya kasance bisa doka;
ya kamata a sami hanyar da za ta hana cin zarafi da kuma taimaka wa al'umma su guje shi;
"Ana buƙatar haɗin kai na kowane mai buƙata, gami da ƙwararrun likitocin jama'a da ƙungiyoyin waɗanda aka bari" Cibiyar Fasaha ta Jamus (CCC) da kuma 'Yan Jarida Ba tare da Kan iyakoki ba (RSF) sun ba da jerin abubuwan da za a kula da su.
Shirin da Google/Apple suka kafa na nuna rashin daidaito na yau da kullum ya yanke shawarar cire fasalin gano mutane da suka kamu da cutar daga na'urorin su lokacin da ba a bukatar wannan fasalin.
Wasu ƙasashe sun yi amfani da hanyar ganowa ta hanyar wayar salula maimakon wayar salula, suna kawar da buƙatar shigar da wannan fasaha a cikin wayar salula da kuma yiwuwar guje wa ganowa.
A Isra'ila, an tabbatar da tsarin gano wadanda suka kamu da cutar ta hanyar kwayar cutar.
Tsarin gano wanda ya kamu da cutar wanda ya dogara da mai bincike yana da damar samun damar bayanan mutum game da inda mutum yake da matukar damuwa game da sirrin mutum.
Duk da haka, ba duk hanyoyin adana bayanai na zamani ba ne amma suna buƙatar samun damar yin amfani da bayanan sirri na mutum game da wurin da yake; an kafa hanyoyin da yawa don kiyaye bayanan sirri na mutum wanda ke amfani da bayanan sirri kawai lokacin da ake buƙatar watsa bayanai.
A Koriya ta Kudu, an yi amfani da hanyar sadarwa ta zamani don gano wadanda suka kamu da cutar.
Maimakon amfani da fasahar zamani da aka saka a cikin wayar, an tattara bayanai ta hanyoyi daban-daban da suka hada da amfani da wayar salula, ayyukan katin SIM da kuma sanar da mutane masu kamuwa da cutar ta hanyar saƙon rubutu a wayoyinsu.
Baya ga amfani da wannan bayanin don tabbatar da cutar, gwamnati ta kuma samar da hanyar samun damar yin amfani da bayanan yanki, saboda canje-canje a cikin dokokin sirri bayan barkewar cutar MERS.
Kowa na iya samun wannan bayanin ta hanyar fasahohin wayar salula da kuma shafukan yanar gizo daban-daban. Kasashe kamar Jamus sun yi amfani da duka hanyoyin na kasa duk da cewa suna ba da bayanan sirri na mutum.
Tun daga ranar 6 ga Afrilu, 2020, ba a sake fitar da bayani ba.
Tsarin ganowa na sirri na sirri ya kasance mai inganci, bisa ga bayanan sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri na sirri.
Duk da haka, PEPP-PT na da karfi sosai wajen hada tsarin kasa da na jama'a kuma ba ya aiki daidai. Tsarin jama'a ya hada da tsarin gano mutum (DP-PPT), lambar sadarwa ta wucin gadi (TCN), lambar sadarwa ta hutu (CEN), tsarin bayanan sirri na mutum (PACT) da sauransu.
Ta wannan hanyar, bayanan sirri na mutanen da aka gano ba su fita ba, kuma ana gano su ta hanyar fasaha.
Kungiyar masu zaman kansu a MIT Media Lab na ci gaba da neman ingantaccen tsarin shiga ba tare da izini ba, da kuma amfani da hanyar ganowa ta asali don ganowa game da yaduwar COVID-19.
Wannan ya dogara ne akan binciken Apps Gone Rogue: Tsare Sirrin Mutum da aka fitar a watan Maris na shekarar 2020. Wani sabon bayani da aka bayar shine gano wadanda suka kamu da cutar ta hanyar Enigma MPC, wani kamfanin kera fasahar sarrafa bayanan sirri, wanda kuma MIT Media Laboratory ya kirkiro.
Tabbatar da ganowa na amfani da na'urorin zamani don taimakawa masu amfani da su don musayar bayanan wuri da kuma bayanan kiwon lafiya tare da masu kula ba tare da yin watsi da sirrin mutane ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi masu ra'ayi ɗaya waɗanda galibi suna fuskantar matsala game da ƙa'idodi sun kafa TCN International Forum, wanda ke da niyyar haɗuwa da haɓaka haɗin gwiwa na duniya game da fasahar wayar hannu don gano waɗanda suka kamu da cutar, wanda ke haifar da ingantaccen tsarin aiki.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta kafa tsarin gano cutar ta hanyar fasahar gwamnati.
A ranar 10 ga Afrilu, 2020, manyan kamfanonin wayar hannu na Android da iOS, Google da Apple, sun sanar da cewa suna da tsarin bin diddigin kamuwa da cuta, wanda kamfanonin ke ikirarin sun bi ka'idodin tsare sirri, wanda ya dogara ne akan haɗin fasahar Bluetooth Low Energy da sauran tsarin kwamfuta wanda ke ba da damar ɓoye bayanan sirri.
An kuma bayyana yadda wannan fasaha za ta yi aiki a wannan shirin.
Google da Apple sun bayyana cewa ana amfani da wannan hanyar a matakai uku:
tattara kayan aiki don taimakawa gwamnati wajen samar da fasahar kiyaye sirrin mutane da ke biye da masu kamuwa da cutar.
Google da Apple suna shirin ƙaddamar da wannan hanyar don magance matsalolin da ke tattare da ƙwarewar farko ta hanyar faɗaɗa wannan hanyar zuwa wasu fasahohin da ke akwai, sannan kuma a cire ta lokacin da annobar ta ƙare.
Yin amfani da magunguna a cikin magungunan da ba a tsara su ba, wanda aka sani da drug repurposing, re-profiling, re-tasking ko therapeutic switching a Turanci, shine hanyar ɗaukar magani da aka yarda da shi don magance wata cuta da ta bambanta ko kuma ta bambanta da cutar da aka tsara don magance ta.
Wannan shine matakin da ake ɗauka don samar da ingantaccen magani don maganin COVID-19.
Sauran binciken da ake yi na samar da allurar rigakafin COVID-19 da kuma maganin jini. SARS-CoV-2 yana da kwayoyi 66 da ake gwadawa a wurare daban-daban.
Binciken da aka yi a wurin ya samar da wani tsari na maganin da zai iya magance kwayar cutar COVID-19.
Wasu daga cikin manyan kwayoyin SARS-CoV-2 da ake bincike akan su sune masu kama da kwayoyin da ake samu a cikin kwayar fure, wadanda suke da alaƙa da RNA, helicase, S protein, da ADP ribophosphatase.
Hussein A A, da abokan aikinsa, sun gudanar da binciken magungunan da suka nuna cewa suna da kamanceceniya da magungunan gargajiya na asibiti don hanzarta samar da maganin da zai iya magance SARS-CoV-2 a cikin binciken farko na su don sanya shi cikin jerin magungunan da za a yi nazari.
Chloroquine magani ne na cutar zazzabin cizon sauro amma kuma yana iya magance wasu cututtukan da ke haifar da rigakafin jiki.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine na iya shiga cikin jerin magungunan bincike guda hudu da kamfanin gwajin magunguna mai suna Solidarity ke gudanarwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydroxychloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate idan babu wani magani da aka sani da ake kira Izin Amfani da Gaggawa (EUA) a Turanci.
Ba a tabbatar da maganin ba ta hanyar gwajin FDA, ana amfani da shi ne kawai a matsayin EUA, magani da ake ci gaba da bincike don amfani dashi a asibiti amma ba a iya warkar da shi ba maimakon gwajin magani.
CDC ta ce ba a bayyana amfani, adadin, ko tsawon lokacin da za a iya shan maganin hydroxychloroquine don rigakafi ko maganin SARS-CoV-2 ba.
Likitoci sun bayyana cewa ana amfani da maganin ne idan "babu sauran zabi".
Wata ƙungiyar masu bincike a Turkiyya a Istanbul suna gudanar da karamin bincike kan amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a jami'o'in Duke da Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da gwajin lafiya da kuma ingancin maganin hydroxychloroquine a cikin mutane.
Wani gwaji na kasar Sin a lardunan Wuhan da Shenzhen ya bayyana cewa maganin favipiravir yana da "tabbataccen tasiri" wajen magance cutar.
Marasa lafiya 35 a Shenzhen sun nuna cewa sun warke cikin kwanaki 4, yayin da marasa lafiya 45 da ba a ba su maganin sun dauki kwanaki 11 kafin su warke.
A wani bincike da aka gudanar a Wuhan kan marasa lafiya 240 da ke fama da matsalar numfashi, rabi sun sha maganin  favipiravir kuma rabi sun sha umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da cewa ba za a yi la'akari da tushen da aka ba da shawarar maganin ba kuma har yanzu ana kan binciken farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta iya sayen maganin daga China kuma ta ajiye shi a cikin kantin sayar da kayayyaki sannan ta yi amfani da sojoji don isar da shi zuwa asibitin jami'a inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya shawarci gwamnatin Trump kan sayan maganin, wanda zai iya nuna rashin inganci a kan cutar a yankunan da ke da yawan masu kamuwa da cutar.
ba a ba da shawarar yin amfani da wannan magani ga mata masu juna biyu ko kuma waɗanda ke shirin yin ciki ba.
Binciken da aka yi kan lopinavir/ritonavir (Kaletra), hada lopinavir da ritonavir, ya kammala da cewa "ba su da tasiri".
An tsara wannan maganin ne don hana kwayar cutar HIV.
Wani rukunin masu bincike a Jami'ar Colorado na kokarin inganta maganin ne domin samar da maganin da zai hana kwayar cutar SARS-CoV-2 haifuwa.
WHO ta saka lopinavir/ritonavir a jerin magungunan da za a yi gwajin su a duniya
Remdesivir da aka kirkira da Gilead Sciences, an tsara shi ne don maganin annoba na Ebola da Marburg. Gilead Sciences kuma ya gano cewa Remdesivir na iya yaki da kwayar cutar da ba ta shiga cikin jiki, wadanda suka hada da kwayar cutar da ke iya haifuwa, na numfashi, na rigakafi, da kuma na coronaviruses.
Matsalar da ake samu a maganin cututtukan ƙwayoyin cuta ita ce yadda suke ƙin maganin saboda sauye-sauye da ke haifar da ƙaruwar cutar da kuma kamuwa da cuta.
Binciken da aka yi kwanan nan ya nuna cewa remdesivir na iya samun ingantattun abubuwan da ke hana shi kamuwa da cuta. Akwai wasu bincike da yawa da ake gudanarwa, ciki har da biyu a asibitin Jami'ar Cleveland; daya a cikin marasa lafiya da kuma wani a cikin gaggawa.
Akwai gwaji guda uku na maganin da ake ci gaba da samarwa na bitamin C wanda za a iya shafarsa ta hanyar jini, wanda ake gudanarwa a kan mutanen da ke kwance a asibiti da ke fama da cutar COVID-19; na farko ana gudanar da shi (China, Kanada) kuma na biyu ba a gudanar da shi ba (Italiya).
A ranar 24 ga Maris, jihar New York ta soma gwajin maganin kashe ƙwari mai suna azithromycin.
Hukumar Kula da Lafiya ta Japan (NCGM) tana shirin gwada maganin asma mai suna Teijin's Alvesco (ciclesonide) a kan marasa lafiya masu cutar coronavirus.
Ana gudanar da gwajin kwayar cutar ta 2 a kan marasa lafiya 200 da za a zaba a asibitocin da ke Denmark, Jamus, da Austria domin nuna ingancin maganin.
Masu bincike a Kwalejin Zuciya ta Montreal a Kanada suna nazarin maganin colchicine don rage zazzabi da cututtukan numfashi a cikin marasa lafiya da ke fama da alamun cutar COVID-19.
Binciken, wanda ake kira COLCORONA, yana neman mutane 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da cutar COVID-19 kuma suna nuna alamun rashin lafiya amma ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma wadanda ba sa amfani da maganin hana haihuwa ba a hada su a wannan binciken.
Ana gwada wasu magunguna da ke hana jini yin jini a ƙasar Italiya.
Ana amfani da maganin hana jini, Low-molecular-weight heparin a cikin magungunan marasa lafiya, wanda ke haifar da matsin lamba ga cibiyoyin kiwon lafiya a Italiya don fitar da jagororin amfani da maganin.
A ranar 14 ga Afrilu, an sanar da binciken asibiti na asibiti na marasa lafiya 300 a Italiya game da amfani da maganin sodium enoxaparin a matsayin maganin rigakafi da maganin da ya dace a bi da cutar.
Tun bayan sanarwar cutar SARS-CoV-2, yawancin bincike ya ci gaba da mai da hankali kan magungunan da aka amince da su don magance cututtukan da ke haifar da kwayar cutar da aka samar kafin barkewar cutar kamar MERS, SARS, da West Nile.
Ribavirin: ribavirin a cikin takardar shaidar kasar Sin ta 7 da aka ba da shawarar a matsayin magani na COVID-19
Umifenovir: an gabatar da umfenovir a cikin takardar shaidar 7 na kasar Sin don maganin COVID-19.
An bayar da rahoton cewa ana iya amfani da wasu maganin rigakafi don magance COVID-19:
Tocilizumab (Anti-IL-6 receptor): An amince da shi a China.
Har ma da gwajin Italiya. Duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 wata shawara ce ta samar da maganin rigakafin cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu maganin rigakafi, ana gudanar da gwaje-gwaje masu yawa da ke nuna yadda maganin zai iya aiki.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta sanar da cewa babu wani allurar rigakafin cutar SARS-CoV-2, wanda ke haifar da cutar, da za a iya yi a cikin watanni 18.
An yi gwajin allurar rigakafi guda biyar a cikin kashi na I a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Ya fara yaduwa a duniya a cikin 2020, wanda ya haifar da saka hannun jari mai yawa da kuma fara aikin bincike don gano rigakafi.
Yawancin kamfanoni suna amfani da magungunan da aka riga aka samar don samar da rigakafin SARS-CoV-2.
Tun daga watan Afrilu, CEPI ta fi mayar da hankali kan samar da allurar rigakafi a kan saurin, samarwa, samar da ma'aikata, da kuma isar da ita ga duniya.
A watan Afrilu, masana na CEPI sun sanar da cewa ana gudanar da bincike kan fasahohi daban daban guda 10 da za a samar a farkon 2020 don samar da rigakafin COVID-19.
A halin yanzu ana gudanar da bincike a kan wannan batu a matakin farko, wanda ya hada da:
Kwayoyin jini (DNA da RNA) na matakin I na binciken rigakafin sune: Moderna, mRNA-1273)
Kwayoyin cutar (Nazarin rigakafin mataki na 1: CanSino Biologics, adenovirus type 5 vector)
A cewar masana na CEPI a watan Afrilu, kimanin gwaji 115 na riga sun fara, ciki har da 78 da aka tabbatar da cewa an fara su (79 bisa ga Milken Institute), kuma 37 da aka sanar, amma ba a bayyana su ba (wanda ake tsammanin ana shirin ko ana ci gaba).
Gwajin matakin I-II yana tantance inganci da inganci, ana gudanar da shi gaba ɗaya, ana lura da shi sosai, ana gudanar da shi a wurare da yawa, yayin da ake guje wa kuskure, da kuma gano adadin da zai iya amfani da shi.
Matakin III na gwaji ya ƙunshi mutane da yawa, ciki har da ƙungiyar kulawa, da kuma kimanta tasirin rigakafin a cikin rigakafin, yayin da aka bincika ko za a iya rage tasirin rigakafin zuwa matakin da za a iya jurewa.
Daga cikin alluran rigakafi 79 da ake ci gaba da aiwatarwa (wanda aka amince da shi a farkon watan Afrilu 2020), 74 ba su fara gwajin mutum ba (har yanzu suna cikin matakin farko).
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Quensland ta sanar da cewa tana nazarin allurar rigakafin da za ta iya canza tsarin kwayar cutar ta hanyar taimakawa tsarin garkuwar jiki.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Kula da Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa an fara aikin samar da allurar rigakafin, wanda za a fara gwajin ɗan adam a cikin 2021.
An sanar da shirin samar da rigakafin ne a Cibiyar Kula da Cututtuka da Rigakafin Cutar ta kasar Sin a ranar 26 ga watan Janairun 2020, kuma an sanar da shirin a Jami'ar Hong Kong a ranar 28 ga watan Janairu.
A ranar 29 ga watan Janairun 2020, Kamfanonin Pharmaceutical da Hanneke Schuitemaker ke jagoranta sun sanar da cewa sun fara aikin samar da allurar rigakafi.
Janssen kuma tare da abokin aikinta Vaxart, suna kan aikin samar da maganin da za a iya sha.
A ranar 18 ga watan Fabrairun 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don samar da allurar rigakafi.
A ranar 8 ga watan Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya fitar da wani bincike kan tsarin maganin da ke da fasahar kama da maganin cutar kansa.
A ranar 25 ga watan Maris ne shugaban cibiyar binciken ya sanar da cewa ya kammala manyan matakan allurar rigakafin kuma yana gab da fara gwajin.
A ranar 27 ga Fabrairu, 2020, kamfanin NuGenerex Immuno-Oncology, wanda ke da alaƙa da Generex, ya sanar da cewa yana shirin fara aikin samar da allurar rigakafi don samar da allurar rigakafin kwayar cutar COVID-19.
Manufarsu ita ce samar da allurar rigakafin da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 25 ga watan Maris na shekarar 2020, Jami'ar Washington da ke St. Louis ta sanar da shirin samar da allurar rigakafi.
A ranar 5 ga watan Maris na shekarar 2020, Cibiyar Nazarin Kiwon Lafiya da Kayan Aikin Sojoji ta Amurka a Fort Detrick da Cibiyar Nazarin Makamai ta Sojoji ta Walter Reed, dukansu a yammacin Maryland, sun sanar da cewa suna kan aikin samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta fara hulɗa da Novavax Inc.
a cikin aikin samar da allurar rigakafi.
Abokan hulɗa sun kuma sanar da cewa suna da shirin fara gwajin rigakafin da gwajin sa na farko a watan Yuli na 2020.
A ranar 5 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana kan aikin samar da alluran rigakafi 11 kuma cewa a farko zai dauki akalla shekara daya zuwa shekara daya da rabi zuwa shekaru biyu don samar da allurar.
A ranar 5 ga Maris, 2020, Medicago, wani kamfanin kiwon lafiya da ke Quebec City, Quebec, ya sanar da samar da maganin rigakafin cutar coronavirus wanda Cibiyar Binciken Lafiya ta Kanada ta tallafawa.
Ana ci gaba da yin gwajin rigakafin a cikin dakin gwaje-gwaje, tare da shirin yin gwajin ɗan adam a watan Yuli ko Agusta 2020.
A farkon wannan makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da gudummawa mai yawa ga ayyukan samar da allurar rigakafin COVID-19, wanda gwamnatin Jamus ta yi watsi da shi.
A ranar 5 ga Maris, 2020, kamfanin magunguna na Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin da aka dogara da kwayar mRNA.
Ana ci gaba da gwajin allurar rigakafin da aka yi amfani da kwayar mRNA mai suna BNT162, wanda aka shirya fara a watan Afrilu na 2020.
A ranar 17 ga watan Maris na shekarar 2020, kamfanin kiwon lafiya na Italiya, Takis Biotech, ya sanar da cewa zai samu sakamakon gwajin da aka yi a watan Afrilu na shekarar 2020 sannan kuma a fara gwajin allurar a kan mutane nan take.
A ranar 19 ga Maris, 2020, Cibiyar Kula da Cututtuka ta Faransa (CEPI) ta sanar da kashe dala miliyan 4.9 a kan binciken rigakafin COVID-19 da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh ke gudanarwa, wanda ya kai dala miliyan 29 na CEPI a kan binciken rigakafin COVID-19.
Sauran abokan CEPI da suka saka hannun jari a cikin allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A watan Maris na shekarar 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana sun fara gwajin allurar rigakafin a kan dabbobi.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da allurar rigakafin COVID-19 bisa ƙwayoyin jini.
An yi allurar rigakafin ne cikin kwanaki 14 bayan da kasar Sin ta kawo kayan.
A karshen watan Maris, gwamnatin Kanada ta sanar da dala miliyan 275 don tallafawa ayyukan COVID-96, ciki har da ayyukan rigakafi a cibiyoyi da jami'o'i a Kanada, kamar waɗanda Medicago da Jami'ar Saskatchewan ke gudanarwa.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da cewa an ware dala miliyan 192 na C don samar da allurar rigakafin COVID-19 kawai, da nufin samar da "tushen rigakafi" wanda ke da tarin alluran rigakafi da za a iya amfani da su idan akwai wata annobar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Kiwon Lafiya ta Jami'ar Pittsburgh sun sanar da cewa suna yin gwaji a kan beraye tare da allurar PittCoVacc, wanda zai iya haifar da rigakafin COVID-19, suna ba da sanarwar cewa SARS-CoV-2 S1 kwayoyin halitta daga ƙwayoyin da aka ba da MNA sun nuna ikon samar da rigakafin [a cikin beraye], wanda ya fara bayyana tun farkon makonni 2 bayan amfani. "
A ranar 16 ga Afrilu, 2020, Kwalejin Magunguna ta Jami'ar Waterloo ta sanar da cewa suna kan aikin samar da rigakafin DNA wanda za a iya sakawa a hanci.
Ta hanyar maganin kashe ƙwayoyin cuta, za a yi amfani da DNA don shigar da shi cikin kwayar cutar don samar da kwayoyin cutar da ba su da matsala, wanda zai haifar da tsarin rigakafi da kuma samar da kwayoyin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun tattara bayanai don samun damar amfani da na'urorin kwamfuta na IBM, da kuma wasu kayayyakin fasaha na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako iri-iri, wanda ake kira da ba a san abin da ke faruwa ba.
Wannan yana nufin cewa suna iya samun sakamako mai kyau a kan cututtukan da suke hanawa.
Wani gwaji a Ostareliya yana neman likitoci 4,170 su yi amfani da shi.
A wasu lokuta, alluran rigakafin da ake samarwa ba su da inganci ko kuma ba su da inganci.
Binciken da aka yi kwanan nan na kimanta ingancin allurar rigakafi ta amfani da samfurori na COVID-19, kamar ACE2 da kuma bera, ya nuna cewa ana buƙatar matakan kiyaye matakin 3, don magance cutar, da haɗin kai na duniya don bin ƙa'idodin tsabta.
An gwada alluran rigakafin SARS da MERS a kan dabbobi.
Ya zuwa yanzu a shekarar 2020, babu magani ko allurar rigakafin SARS da MERS da aka tabbatar da inganci da inganci a jikin mutum.
Kamar yadda aka bayyana a cikin binciken 2005 da 2006, ganowa da samar da allurar rigakafi da magungunan SARS ya kasance babban abin gaggawa a cikin shirin gwamnati da na ma'aikatun kiwon lafiya a duk duniya. Babu wani rigakafin MERS da aka tabbatar.
A lokacin da cutar ta MERS ta bulla, ana tsammanin cewa binciken da ake yi zai samar da ingantaccen tsarin samar da allurar rigakafi da magunguna don hana kamuwa da cutar MERS-CoV.
Ya zuwa Maris 2020, allurar rigakafin MERS (DNA) ta kammala gwajin gwaji na Phase I a kan mutane, kuma ana kan aiwatar da wasu uku, dukansu masu yaduwar kwayar cutar, biyu daga kwayar cutar Adenoviridae (ChAdOx1-MERS, BVRS-GamVac), da kuma guda daga kwayar cutar MVA (MVA-MERS-S).
Kafofin watsa labarun sun yada jita-jita cewa COVID-19 sananne ne kuma riga-kafin riga-kafin riga-kafin.
Taron kafofin watsa labarun ya mayar da hankali ne kan kasancewar kwayoyin halitta da kuma alluran rigakafi na wasu cututtukan coronavirus kamar SARS.
Cutar kwayar cutar korona ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da kwayar cutar SARS-CoV-2 (SARS-CoV-2).
Alamun da ke nuna cewa yana ciwo sosai su ne zazzaɓi, ƙaiƙayi, da kuma rashin numfashi.
Sauran alamun cutar sun hada da gajiya, ciwon jijiya, tari, ciwon wuya, rashin jin ƙanshi da ciwon ciki.
Mutumin da ya kamu da cutar yakan nuna alamun cutar a cikin kwanaki biyar amma zai iya ɗaukar kwanaki 2 zuwa 14.
Yayin da yawancin masu kamuwa da cutar ke nuna alamun rashin lafiya, wasu suna fuskantar matsalar numfashi da rashin jin magana da kuma raunana gaɓoɓin jiki da yawa.
Ya zuwa ranar 17 ga Afrilu, 2020, sama da mutane miliyan 2.24 sun kamu da cutar a kasashe 210 da yankuna, wanda ya yi sanadiyar mutuwar mutane 153,000.
Fiye da mutane 568,000 sun warke. Cutar tana yaduwa ta hanyar hulɗa, galibi ta hanyar narkewar narkewar da ke fitowa daga tari, tari, ko magana.
Idan wannan ruwan ya fito daga numfashi, yakan sauka a ƙasa ko kuma a kan wani abu maimakon ya yaɗa cutar a nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓawa da cutar ta hanyar taɓawa fuska, hanci, ko baki.
Kwayar cutar na iya rayuwa a waje har tsawon sa'o'i 72.
Yana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma lokacin da cutar ba ta da tsanani. Hanyar da aka fi sani da shi shine  real-time reverse transcription polymerase chain reaction (rRT-PCR)  wanda aka yi ta amfani da gwajin hanci.
Yana da mahimmanci cewa mai kula da mai cutar ya sanya abin rufe fuska.
Ka'idojin sanya abin rufe fuska ga kowa ya bambanta, tare da wasu hukumomi suna ba da shawarar kada a yi amfani da shi, wasu kuma suna buƙatar mutane su yi.
A halin yanzu, babu wani rigakafi ko magani na musamman don maganin COVID-19.
An samu kamuwa da cutar tsakanin mutane a duk yankuna shida na WHO.
Wadanda suka kamu da kwayar cutar na iya zama marasa alamun ko kuma suna iya nuna alamun kama da mura kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamun da suka fi tsanani sun hada da wahalar numfashi, ciwon kirji mai ci gaba ko nauyi, jin zafi a fuska, rashin iya tafiya, fuska ko lebe sun yi ja; wanda ya kamata a nemi taimakon likita nan da nan idan aka nuna alamun.
Ba za ka iya samun alamun rashin lafiya na numfashi kamar tari, tari ko ciwon hanci ba.
Alamar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan da cututtukan da cututtukan da cututtuktuktukan da cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Marasa lafiya a China sun fara nuna alamun rashin karfin zuciya da kuma bugun zuciya.
A wasu mutane, cutar za ta iya zama mai tsanani har ta kai ga rashin numfashi, gaɓoɓin jiki da yawa sun daina aiki, har ma da mutuwa.
Wannan shi ake kira lokacin bayyanar cututtuka.
Lokacin bayyanar cutar COVID-19 yawanci kwanaki shida ne amma yana iya zuwa tsakanin 2 zuwa 14.
97.5% na mutane suna nuna alamun cutar a cikin kwanaki 11.5 da suka gabata. Rahotanni sun nuna cewa ba kowane mutum da ya kamu da cutar ne ke nuna alamun cutar ba.
Ba a san matsayin wadanda ba su da alamun cutar ba; duk da haka, bayanin farko shi ne cewa suna iya cutar da wasu.
Ba a san adadin mutanen da ba su da alamun cutar ba amma ana ci gaba da nazarin su, bisa ga bayanan da Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC) ta bayar cewa kashi 20% na duk waɗanda suka kamu da cutar ba su da alamun cutar.
Hukumar Lafiya ta kasar Sin ta fara lissafin wadanda suka kamu da cutar a ranar 1 ga watan Afrilu; daga cikin mutane 166 da aka samu a ranar, 130 (78%) ba su da alamun cutar a lokacin da aka gwada su.
Ciki da tari na iya ɗaukar adadin ƙwayoyin cuta.
Yin magana da ƙarfi yana sa a yi ruwa fiye da yin magana a hankali.
Wani bincike da aka yi a Singapore ya nuna cewa yin tari ba tare da rufe fuska ba zai iya sa ruwa ya kai tsawon mita 4.5 (15 feet).
Kodayake cutar tana yaduwa ta iska, Cibiyar Kimiyya ta Kasa ta ce yana yiwuwa kuma an gano cutar a cikin iska da aka fitar daga ɗakunan keɓewa.
Hanyoyin kiwon lafiya kamar su yin allurar hanci da kuma karin numfashi (CPR) na iya haifar da fitar da iska wanda zai iya haifar da kamuwa da cutar.
yayin da ake tambaya ko uwa zata iya cutar da jaririn da ke cikin ciki, babu tabbacin da ya nuna hakan. Kwayar cutar tana iya yaduwa lokacin da mutane suka nuna alamun cutar; yayin da akwai karancin damar kamuwa da cutar kafin bayyanar alamun cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, mutum na iya cutar da mutane biyu zuwa uku.
Musamman, kwayar cutar ta shafe kwana ɗaya a kan allon, kusan kwanaki uku a kan filastik (polypropylene) da ƙarfe mai ƙarfi ((AISI 304), da awanni huɗu a kan ƙarfe mai sassauci 99%.
Wannan zai iya canzawa ta hanyar sanyi da zafi.
Sabulu da magungunan kashe ƙwayoyin cuta, idan aka yi amfani da su yadda ya kamata, na iya kashe kwayar cutar; sabulu yana lalata kwayar cutar, yana hana ta aiki, kuma yana kawar da ita daga jiki ko kuma daga wurin da kwayar cutar take.
Sauran abubuwan da aka yi amfani da su sun hada da benzalkonium chloride da chlorhexidine gluconate (mai kashe kwari), amma ba su da tasiri sosai. A cikin binciken Hong Kong, an dauki samfurin hanci na tsawon kwanaki biyu bayan an shigar da shi asibiti.
Biyar cikin marasa lafiya shida, gwajin farko ya nuna yawan kwayar cutar, sannan na shida ya nuna yawan kwayar cutar a gwajin rana ta biyu.
Cutar coronavirus mai suna SARS-CoV-2 wani sabon kwayar cutar ne da ke kamuwa da cutar numfashi, wanda aka fara ganowa a Wuhan a cikin mutane uku da ke fama da matsalar numfashi da ke da nasaba da cutar numfashi.
Dukkanin abubuwan da ke nuna cutar SARS-CoV-2 ana iya gano su a cikin kwayar cutar coronavirus.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke kashe kwayar cutar. SARS-CoV-2 yana da kusanci da SARS-CoV na farko.
COVID-19 ya fi shafar huhu, saboda kwayar cutar tana wucewa ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda aka bayyana a cikin huhu.
Kwayar cutar tana amfani da wani bangare na baya da ake kira spike (mai ƙaho) don haɗuwa da ACE2 sannan kuma ya shiga cikin kwayar halitta.
Kashi 12% na waɗanda suka kamu da cutar kuma aka kwantar da su a asibiti a Wuhan, China, sun sami ciwon zuciya mai tsanani kuma wannan ya zama ruwan dare a cikin manyan cututtuka.
Matsayin bayyanar cututtukan zuciya yana da yawa, saboda kumburi da lalacewar rigakafi wanda ke faruwa a hankali yayin da cutar ke ci gaba, amma matsalolin lalacewar jijiyoyin zuciya na iya kasancewa tare da cutar zuciya ta masu karɓar ACE2.
Kwayar cutar ACE2 tana kaiwa ga zuciya kuma tana da tasiri a cikin aikin zuciya.
Marasa lafiya na ICU da ke dauke da COVID-19 sun nuna matsaloli na rashin karfin jini (31%) da kuma lalacewar hanyoyin jini (25%), wanda ke da alaƙa da rashin yiwuwar warkewa. Gwaje-gwajen da aka yi a kan mutanen da suka mutu daga COVID-19 sun nuna lalacewar tsarin numfashi (DAD), da kuma kumburi na huhu.
Duk da cewa SARS-COV-2 na iya zama ACE2-a cikin jiki da kuma a cikin kwayoyin numfashi, marasa lafiya da ke fama da COVID-19 sun nuna alamun kumburi mai tsanani.
Musamman, kwayoyin T da ke haifar da cutar GM-CSF sun nuna cewa suna aiki tare da IL-6-mai haifar da kumburi a cikin marasa lafiya na COVID-19.
Gwajin ya nuna cewa akwai kwayoyin garkuwar jiki a jikin wanda cutar ta kashe.
Hukumar Lafiya ta Duniya WHO ta gabatar da wasu hanyoyin da za a iya gano cutar.
Hanyar da aka fi amfani da ita wajen tantance cutar ita ce real-time reverse transcription polymerase chain reaction (rRT-PCR) .
Ana yin samfurori a kan gwaje-gwaje da aka ɗauka daga numfashi ta hanyar hanci; duk da haka, ana iya amfani da kayan shafawa da kuma kayan shafawa.
Ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma ana buƙatar gwaje-gwaje biyu na jini a cikin makonni biyu daban kuma sakamakon ba shi da mahimmanci nan take.
Masana kimiyya a China sun sami damar ware kwayar cutar coronavirus sannan kuma su fitar da sakamakon binciken a duniya don samar da kwayar cutar PCR da za a iya amfani da ita wajen tantance kwayar cutar.
Har zuwa 4 ga Afrilu 2020, ana gudanar da gwaje-gwaje kan rigakafin jiki (wanda zai iya nuna cutar a jiki ko kuma ta baya) amma ba a shirya yin amfani da shi a wurare da yawa ba.
Kwarewar gwajin na kasar Sin ya nuna inganci tsakanin kashi 60 zuwa 70 cikin dari.
Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da cibiyoyin gwajin a ranar 21 ga Maris, 2020 wanda ya kamata a fara amfani da shi a ƙarshen watan. Jagororin gwajin da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun ba da shawarar yadda za a gwada kamuwa da cuta bisa ga bayanan likita na yau da kullun game da tasirin cutar.
A farkon kamuwa da cuta, kwayar cutar tana iya ɓoyewa, ta tara kanta, ta ware kanta daga jikin da ta shiga, sannan ta yadu ko'ina.
Yayin da cutar ke girma, tana shiga cikin tsarin numfashi, tana yin hanya (ta hanyar rufe hanyoyin numfashi ta hanyar toshe hanyoyin numfashi) kuma tana mannewa.
Akwai ɗan bayani game da hoton microscopic da kuma yanayin COVID-19.
An yi bincike kan kwayar cutar a jikin gawa kamar haka:
Bayyanar ido: kumburi a cikin jijiyoyin numfashi, kumburi a cikin jijiyoyin zuciya, toshewar jijiyoyin numfashi
An gano nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Rashin numfashi mai sauƙi: ƙwayoyin ruwa a cikin huhu, ƙwayoyin ƙwayoyin cuta na numfashi, ƙwayoyin cuta na numfashi, fashewar ƙwayoyin cuta da kuma ƙwayoyin cuta da yawa
matsanancin ciwon hauka: yaduwar lalacewar tasoshin numfashi (DAD) da kuma yaduwar ƙwayoyin cuta.
DAD ita ce sanadin cututtukan numfashi masu tsanani (ARDS) da kuma toshewar jijiyoyin jini.
Cutar numfashi ta fara sauƙaƙe: tarin ƙwayoyin cuta a cikin numfashi da huhu
Jini: zubar jini (DIC); samar da sababbin ƙwayoyin jini
Matakan rage yaduwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren taruwa, wanke hannu sau da yawa da sabulu da ruwa kuma aƙalla na tsawon dakika 20, tsabtace hanyoyin numfashi, da kuma guje wa taɓa idanu, hanci, ko baki ba tare da wanke hannaye ba.
CDC ta ba da shawarar cewa mutane su rufe bakinsu da tawul mai tsabta lokacin da suke tari ko yin tari ko kuma su rufe bakinsu da hannunsu a gaban wuyan hannu idan babu tawul.
Yana da muhimmanci a wanke hannu bayan duk wani tari ko fitsari.
CDC ta ba da shawarar sanya abin rufe fuska a waje, don hana yaduwar kamuwa da cutar ta hanyar mutanen da ba su da alamun cutar. Tsarin nesa yana nufin rage haɗuwa tsakanin masu lafiya da masu cutar ta hanyar rufe makarantu, wuraren aiki, hana tafiye-tafiye da hana mutane taruwa.
Dokokin sun ce mutane su kasance nesa da juna na tsawon kafa shida da kafa 1.8.
Babu wani magani da aka sani na COVID-19. Tunda ana sa ran samun allurar rigakafin a 2021 mafi kyawun hanyar magance cutar ita ce samar da hanyoyin da za su rage kamuwa da cutar COVID-19 wanda aka sani da "flattening the curve" a Turanci.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa kuma aƙalla na tsawon dakika 20, musamman bayan sun fita daga bayan gida ko kuma lokacin da aka nuna cewa hannayensu sun gurɓata, kafin cin abinci, bayan yin fitsari, tari, ko fitsari.
CDC ta kuma ba da shawarar yin amfani da magungunan kashe ƙwari na musamman tare da ƙwayoyin cuta na 60%, wanda za a yi amfani da su lokacin da babu ruwa ko sabulu. A yankunan da ke da matsala samun maganin, WHO ta ba da shawarar wasu nau'ikan magunguna guda biyu.
a cikin wannan rukunin maganin akwai maganin kashe ƙwari da ake kira ethanol ko isopropanol.
Maganin hydrogen peroxide yana kawar da kwari; ba "maganin cututtukan hannu" bane.
An kuma ƙara Glycerol a cikin magungunan taimako.
Ana kula da mutane ta hanyoyi daban-daban, ciki har da maganin rigakafi, ƙarin iska, da kuma ƙarfafa sauran sassan da suka kamu da cutar.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa duk wanda ke da cutar ya sanya abin rufe fuska.
An ci gaba da amfani da maganin hana samun iska mai guba (ECMO) kuma har yanzu ana yaba masa.
Ana ƙarfafa mutane su kasance masu tsabta, su kula da lafiyarsu, kuma su ci abinci mai gina jiki don inganta garkuwar jiki.
Za a iya amfani da wasu hanyoyin da za a bi wajen kula da marasa lafiya da ke da alamun kamuwa da cutar. WHO da Hukumar Lafiya ta China sun sanar da yadda za a kula da marasa lafiya da ke kwance a asibiti da cutar COVID-19.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta tattara bayanai kan maganin cutar daga cibiyoyin bincike da bincike (IBCC) kuma ta buga su.
Har zuwa watan Afrilu 2020, babu maganin COVID-19 da aka sani.
Don magance alamun cutar, masana kiwon lafiya sun ba da shawarar yin amfani da paracetamol (acetaminophen) a maimakon ibuprofen a farkon lokacin cutar.
Ya kamata a dauki matakan da suka dace don rage yaduwar kamuwa da cutar, musamman a asibitoci lokacin da ake gudanar da ayyukan da ke iya haifar da numfashi, kamar su sanya bututun numfashi ko kuma numfashi na hannu.
CDC ta ba da shawarar cewa likitocin da ke kula da marasa lafiya na COVID-19 su sanya su a cikin wani daki na musamman wanda aka sani da Airborne Infection Isolation Room (AIIR) inda za a ci gaba da bin umarnin, guje wa hulɗa da kuma sanya abin rufe fuska. CDC ta ba da jerin umarnin da za a bi don amfani da kayan kariya na mutum (PPE) don rigakafin cutar.
Irin waɗannan tufafin sune: rigar PPE, abin numfashi ko abin rufe fuska , jakunkuna, har ma da safofin hannu. Zai fi kyau a yi amfani da kayan numfashi, idan akwai, maimakon sanya abin rufe fuska.
An amince da kayan numfashi na N95 don amfani da masana'antu, amma FDA ta amince da abin rufe fuska don amfani da shi (EUA).
An tsara shi don kare mai sakawa daga gurɓataccen iska kamar ƙura amma ba a tabbatar da ingancinsa ba wajen hana kamuwa da kwayar cutar.
Idan ba a samun abin rufe fuska, CDC ta ba da shawarar mutane su yi amfani da abin rufe fuska, ko kuma, a wasu lokuta, abin rufe fuska da aka yi da kansu.
Yawancin marasa lafiya na COVID-19 ba za su iya shan iska mai yawa ba kuma za a ba su maganin numfashi ko kuma wasu hanyoyin numfashi amma wasu na bukatar hakan.
Ana gudanar da bincike a asibitoci kan nau'ikan kayan aikin numfashi na COVID-19, tare da samar da hanyoyin da za su iya hana amfani da bututu ko wasu kayan numfashi.
Ba a san ko waɗannan hanyoyin biyu suna ba da sakamako iri ɗaya ba.
Wasu likitoci sun fi son ci gaba da amfani da na'urar motsa jiki idan akwai saboda wannan hanyar tana rage fitar da iska fiye da na'urar numfashi. Wannan cutar ta fi yawa a cikin tsofaffi (sama da shekaru 60 kuma musamman sama da shekaru 80).
Yawancin ƙasashe masu tasowa suna da matsalar rashin isasshen gadaje, wanda ke haifar da ƙalubalen magance ƙaruwar adadin mutanen da ke fama da cutar COVID-19 da ke buƙatar asibiti.
Wani bincike a China ya nuna cewa kashi 5 cikin 100 ne aka kai su sashen kula da gaggawa, kashi 2.3 cikin 100 suna bukatar maganin oxygen, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30 cikin dari na waɗanda ke da cutar COVID-19 a asibiti suna samun kulawa daga ICU.
Ana ci gaba da amfani da na'urorin motsa jiki saboda matsalar rashin iska da COVID-19 ke kara kawowa.
Ana buƙatar ƙarin kayan aikin PEEP don taimakawa masu fama da cutar ta hanyar rage raunin da ke faruwa da kuma hana numfashi.
Ba a samun irin wannan tsarin na PEEP a cikin tsofaffin na'urori.
Binciken maganin da zai iya magance cutar ya fara ne a watan Janairun 2020, kuma an fara gwajin magunguna da yawa.
Remdesivir magani ne mai bada bege.
Duk da cewa ana iya jiran zuwa 2021 don samun sabbin magunguna, ana gwada magunguna da yawa waɗanda aka saba amfani da su don magance wasu cututtuka ko kuma waɗanda aka riga aka yi bincike a kansu.
Ana iya gwada maganin rigakafi a kan marasa lafiya.
Hukumar ta WHO ta nemi masu sa kai su shiga cikin binciken da ke nuna inganci da amincin magungunan gwaji. FDA ta ba da shawarar yin amfani da magungunan kara kuzari na ɗan lokaci ga marasa lafiya idan akwai wata barazana ga lafiyarsu.
Hukumar ta FDA ba ta gudanar da wani bincike ba don tabbatar da inganci ko rashin lahani na wannan magani.
A watan Fabrairun 2020, kasar Sin ta kaddamar da fasahar wayar salula ta zamani domin magance yaduwar cutar.
Ana buƙatar masu amfani da wannan hanyar su shigar da sunayensu da lambar shaidarsu.
Wannan fasaha tana iya gano ko akwai cutar a wurin da kake amfani da ita, ta hanyar bayanan da aka samu daga bincike, wanda zai iya haifar da kamuwa da cuta.
Kowane mai amfani da wannan na'urar zai iya ganin yadda wasu masu amfani uku suke tsaye.
Singapore Idan aka gano cewa akwai kamuwa, ban da bayar da shawarar keɓewa, wannan hanyar sadarwa tana sanar da hukumomin kiwon lafiya na gida. Koriya ta Kudu da Taiwan suna amfani da fasahar tantance bayanan wayar hannu, na'urorin sa ido na fuska, bincike ta wayar hannu da kuma na'urorin kama-da-wane, a cikin tsarin gano mutanen da suka sami kamuwa da cutar.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba kamfanonin fasaha damar yin amfani da wayoyin salula na mutanen da ake zargi da kamuwa da cutar.
An yanke wannan shawarar ne domin aiwatar da tsarin keɓewa da kuma kare waɗanda ke iya kasancewa tare da waɗanda ke da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta samar da tsarin sa ido kan bayanan wayar salula tare da taimakon cibiyar Robert Koch ta gwamnatin Jamus, don gudanar da bincike da kuma hana yaduwar cutar.
Rasha ta tura fasahar gano fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya Giulo Gallera ya shaidawa masu kamfanonin sadarwa cewa " kusan kashi 40% na mutane sun ci gaba da tafiya kamar yadda suka gani. "
Gwamnatin Jamus ta yi taron awanni 48 da masana kimiyyar kwamfuta sama da 42,000.
Shugaban Estonia Kersti Kaljulaid ya yi kira ga al'ummar duniya da su nemi hanyoyin da za su magance yaduwar cutar coronavirus.
Mutane na iya fuskantar matsaloli masu yawa na damuwa saboda keɓewa, hana tafiya, tasirin magunguna, ko kuma tsoron cutar kanta.
BBC ta ruwaito Rory O'Connor, inda ta ce "rashin zaman lafiya, kadaici, rashin lafiya, damuwa da talauci suna da tasiri sosai a kan lafiyar kwakwalwa da kuma zaman lafiyar mutane".
Cutar na iya nuna alamun rashin lafiya ko kuma rashin alamun cutar, wanda ke nuna alamun cututtukan numfashi ko mura.
Mutane masu rashin lafiya na iya warkewa cikin kwanaki biyu, yayin da masu rashin lafiya na iya ɗaukar makonni uku zuwa shida.
Mata masu juna biyu suna iya kamuwa da COVID-19 bisa ga bayanan da aka samu game da wasu ƙwayoyin cuta, kamar SARS da MERS, amma ba a san ainihin cutar COVID-19 a cikin mata masu juna biyu ba. COVID-19 na iya haifar da cututtukan numfashi a cikin wasu mutane.
Wasu mutane da suka kamu da cutar COVID-19 na iya samun matsalar numfashi mai tsanani (ARDS) wanda zai iya haifar da rashin numfashi, rashin motsin rai da kuma rauni a wasu sassan jiki.
Matsalar COVID-19 ta hada da ciwon jiki da kuma ciwon zuciya, koda da kuma jijiyoyin jini.
An gano cutar hauka, musamman a cikin duhu, a cikin kashi 6% na marasa lafiya na COVID-19 da aka kwantar da su, yayin da cutar koda ta bayyana a cikin kashi 4%.
Kimanin kashi 20-30% na mutanen da ke da cutar COVID-19 sun nuna karuwar ƙwayar transaminases.
Rahoton ya kuma nuna cewa, tsawon lokaci tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, tare da shigar da mutane biyar asibiti.
Duk da haka, marasa lafiya da aka kai ICU sun yi kwanaki bakwai a asibiti kafin su mutu.
A cikin binciken da aka yi a kan waɗanda suka kamu da cutar kwanan nan, ana ƙididdige lokaci tsakanin bayyanar cututtuka da mutuwa a cikin kwanaki 14, a matsakaita tsakanin kwanaki 6 zuwa 41.
Wani bincike da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta gudanar ya nuna cewa, mace mace na mutuwa ne a kashi 2.8 cikin dari, maza kuma a kashi 1.7 cikin dari.
An yi gwaje-gwaje a kan mutanen da suka mutu daga cututtukan huhu wanda ya nuna lalacewar ƙwayar cuta ta huhu da ke faruwa a cikin ƙwayoyin cuta.
Matsalar numfashi ta nuna cewa kwayar cutar tana canzawa.
Hoton da aka yi na huhu ya nuna cewa na kamu da matsalar numfashi mai tsanani.
A cikin kashi 11.8 na mutuwar da Hukumar Lafiya ta kasar Sin ta ruwaito, an samu ciwon jijiya ko kuma bugun zuciya.
Bayanai na watan Maris na Amurka sun nuna cewa kashi 89% na waɗanda aka kwantar da su a asibiti suna da wasu matsaloli. Matsalolin kiwon lafiya da zamantakewa da tattalin arziki na iya ba da gudummawa ga mutuwar.
Adadin mutuwar cutar na iya bambanta daga yanki zuwa yanki, amma kuma saboda matsalolin da ke tattare da hanyoyin da ake amfani da su.
Rashin kula da yanayin rashin alamun cutar na iya haifar da karuwar yawan mutuwar.
Amma, yawan mutuwar da ake yi a wasu lokatai zai iya sa a ƙi yin la'akari da yawan adadin gawa.
Masu shan sigari sun fi kamuwa da cutar COVID-19 sau 1.4 kuma sun fi kamuwa da cutar ko mutuwa sau 2.4 fiye da wadanda ba sa shan sigari.
Hukumar kula da asibitocin Hong Kong ta gano cewa ruwa ya yi tari a cikin huhu tsakanin kashi 20 zuwa 30 cikin dari na mutanen da suka warke daga cutar, kuma hotunan da aka yi ta hanyar na'urar daukar hoto sun nuna cewa huhu sun lalace.
Wannan kuma yana nufin cewa suna bukatar ci gaba da kulawa bayan an sallame su daga asibiti na gaggawa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar ta haifar da gagarumar rigakafin jiki na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Wannan na iya zama kamar na sauran kwayar cutar, amma akwai mutanen da suka sake kamuwa da COVID-19 bayan an sanar da su sun warke daga cutar.
An yi hasashen cewa wadannan mutane za su fi jin dadin sauran kwayoyin da ke jikin su fiye da yadda za su ji dadin cutar ta biyu.
An yi zaton cewa cutar ta samo asali ne daga dabbobi, kuma za a iya yaɗawa daga halittu masu rai.
Ba a san asalin asalin cutar ba, amma har zuwa watan Disamba na 2019 cutar tana yaduwa daga mutum zuwa mutum.
Binciken 41 na COVID-19, wanda aka buga a cikin Janairu 2020 a cikin Lancet, ya nuna alamun cutar da suka fara bayyana a ranar 1 ga Disamba, 2019.
Hukumar ta WHO ta bayyana bayyanar cututtukan cutar a ranar 8 ga watan Disamba, 2019.
An dauki matakai da dama don kidaya adadin wadanda suka mutu.
Wannan adadin yana canzawa ta hanyar yanki, lokaci da yawan gwaje-gwajen da aka yi, ikon ma'aikatun kiwon lafiya, hanyoyin da ake bi, lokacin da cutar ta fara bayyana da kuma yanayin jama'a da suka hada da shekaru, jinsi da kuma lafiyar jama'a.
A ƙarshen 2019, WHO ta ba da lambar U07.1 ga cutar ICD-10 ga marasa lafiya da aka tabbatar da cewa sun mutu daga SARS-CoV-2 da lambar U07.2 ga marasa lafiya da aka tabbatar da cutar ta COVID-19 amma ba a tabbatar da cewa suna da cutar SARS-CoV-2 ba.
Bisa ga bayanan da Jami'ar Johns Hopkins ta bayar, yawan mutuwar mutane a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Ƙididdigar sun bambanta daga yanki zuwa yanki. Sauran matakan sun haɗa da ƙididdigar CFR, wanda ya yi daidai da rabo tsakanin mutanen da suka kamu da cutar da suka mutu daga cutar, da kuma CFR, wanda ya yi daidai da rabo tsakanin mutanen da suka kamu da cutar (waɗanda aka gwada da waɗanda ba a gwada su ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su dogara da lokaci ba kuma suna da alaƙa da ƙididdigar yawan mutanen da ke kamuwa da cutar dangane da yadda ake kula da su.
Idan ba duka mutane masu kamuwa da cutar ba ne suka fara samar da kwayoyin cutar nan take, bayyanar kwayoyin cutar na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A cikin cibiyar cutar da ta fara kaiwa Italiya, Castiglione d'Adda, wani karamin yanki mai yawan mutane 4,600, 80 (1.7%) sun mutu.
A Gangelt, annobar ta bazu ne a lokacin bukukuwan Carnival, wanda matasa ke yadawa, wanda ya rage yawan masu zanga-zanga, amma ba a ba da rahoton duk mutuwar COVID-19 ba.
Bugu da ƙari, ba a taɓa yin sanyin gwiwa ba ga ma'aikatan kiwon lafiya na Jamus.
A Netherlands, kusan kashi 3% na mutane na iya samun tsarin garkuwar jiki, kamar yadda aka gano a cikin masu ba da jini.
An bayar da rahoton mutuwar COVID-19 a kashi 69 (0.004% na yawan jama'a).
Sakamakon annoba da yawan mutuwa sun bambanta ga maza da mata.
Yawan mutuwar maza ya yi yawa; kamar yadda bincike da aka yi a China da Italiya ya nuna.
Maza masu shekaru 50 suna da haɗari sosai, da bambanci tsakanin maza da mata waɗanda shekarunsu sun kai 90 kawai.
A ƙasar Sin, adadin mutanen da suke mutuwa ya kai kashi 2.8 na maza da kuma kashi 1.7 na mata.
Ba a san dalilan da ke haifar da bambancin jinsi ba, amma yana iya kasancewa saboda yanayin jiki da halayyarsu.
Bambancin tsarin garkuwar jiki tsakanin maza da mata, rashin shan taba da yawa na mata da kuma cututtukan da suka fi shafar maza da suka hada da bugun zuciya da wuri fiye da mata na iya taimakawa wajen karuwar mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu 2020, gwamnatin Amurka ba ta fara tattara bayanan jinsi game da kamuwa da cutar COVID-19 ba.
Binciken cututtukan da ke haifar da kwayar cuta kamar Ebola, HIV, mura da SARS sun shafi maza da mata daban.
Mafi yawan likitoci, musamman ma likitoci, mata ne, kuma suna da babban haɗarin kamuwa da kwayar cutar.
A ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta sanar da cewa cutar ta COVID-19 ce.
Daraktan WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, kwayar cutar VI, cutar D, kuma 19 na nufin lokacin da cutar ta fara bayyana: 31 ga Disamba, 2019.
An zaɓi sunan ne don kaucewa sanya sunan wani yanki (misali China), nau'in dabba ko rukuni na mutane, bisa ga ƙa'idodin ƙasashen duniya na suna don yaƙi da rashin fahimta ko rashin fahimta. Kwayar cutar da ke haifar da COVID-19 ita ce kwayar cutar coronavirus mai saurin numfashi ta 2 (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar COVID-19" da "kwayar da ke haifar da COVID-19" a cikin sadarwa ta hukuma.
Dukkanin cututtuka da ƙwayoyin cuta ana kiransu "coronavirus".
A Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da kuma "Wuhan coronavirus".
A watan Janairun 2020, WHO ta sanar da 2019-nCov da 2019-nCoV a matsayin sunayen da aka sanya na wucin gadi na ƙwayoyin cuta da cututtuka a cikin bin ƙa'idar 2015 da ta hana amfani da sunayen yanki a cikin sunayen ƙwayoyin cuta da cututtuka.
An sanar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda rashin wadatar kasuwa, wasu masana'antu na zamani suna samar da kayan aikin kiwon lafiya kamar su kayan aikin daukar hanci, da kuma na'urorin kara iska.
Alal misali, sa'ad da asibitoci a Italiya suka bukaci na'urorin sarrafa iska da gaggawa kuma mai ba su ya kasa zuwa a kan lokaci, sai wani kamfanin da ke yankin ya yi na'urori 100 a dare ɗaya.
Bayan kamuwa da cutar COVID-19 ta farko, jita-jita, yaudara, da kuma bayanan da ba daidai ba game da asalin cutar, yadda ta samo asali, yadda za a hana ta, yadda za a bi da ita, da sauran abubuwan da suka shafi cutar sun fara bayyana kuma sun yadu cikin sauri a cikin Intanet.
Mutane na iya yada kwayar cutar daga wasu dabbobi.
Bincike bai nuna yadda za a iya kwace kwayar cutar a aladu, dabbobin daji da kaji ba.
Babu magani ko rigakafi da aka tabbatar da cewa zai warkar da cutar.
Akwai bincike na duniya kan alluran rigakafin COVID-19 da magunguna da hukumomin gwamnati, kungiyoyin malamai da masana masana'antu ke gudanarwa.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da gwajin "SOLIDARITY Trial" domin tantance tasirin magungunan gargajiya guda hudu da ake ganin za su iya magance cutar.
Babu riga-kafi, amma cibiyoyi daban-daban suna gwadawa a kan wasu alluran rigakafi.
Ana amfani da binciken farko na SARS-CoV SARS-CoV da SARS-CoV-2 saboda dukansu suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin jikin mutum.
Akwai hanyoyin rigakafi guda uku da ake bincike a kansu.
Da farko, masu bincike suna son yin cikakken rigakafin cutar.
Amfani da kwayar cutar, ko ta mutu ko ta kashe, shine don tayar da tsarin garkuwar jikin mutum don gano sabon kamuwa da cutar COVID-19.
Mataki na biyu shine amfani da ƙananan ƙwayoyin cuta, wanda shine tsarin da ke haifar da rigakafin jiki wanda ke gano cewa ƙananan ƙwayoyin cuta suna nan.
A cikin SARS-CoV-2, binciken ya mai da hankali kan kwayar cutar da ke kama da ƙaho wanda ke taimakawa kwayar cutar ta shiga cikin abubuwan da ke cikin ACE2.
Hanyar ta uku ita ce ta DNA ko RNA, wato sabon tsarin yin rigakafi.
A ranar 16 ga Maris, 2020, masu ba da agaji huɗu a Seattle sun fara gwajin rigakafin.
An ba da shawarar ƙara yawan rigakafin jiki a matsayin mafi kyawun hanyar yin allurar rigakafin SARS-COV-2, amma har yanzu akwai matsala.
A watan Afrilu na shekarar 2020, an gudanar da gwajin rigakafi sama da 300.
An gudanar da gwaje-gwaje guda bakwai kan magungunan da aka amince da su don maganin zazzabin cizon sauro, ciki har da guda hudu na hydroxychloroquine ko chloroquine.
Binciken da ake yi a kasar Sin ya fi mayar da hankali kan maganin rigakafin cutar, tare da gwajin kashi na uku na gwajin remdesivir a kasashe da dama, wanda za a fitar da rahoto a karshen watan Afrilu.
Ya zuwa Afrilu 2020, akwai ci gaba da gwajin gwaji na COVID-19. Ana nazarin magungunan da aka saba amfani da su don maganin COVID-19, waɗanda suka haɗa da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir tare da interferon beta.
Ya zuwa watan Afrilu 2020, akwai wasu shaidu da ke nuna cewa remdesivir yana da tasiri.
Marasa lafiya da aka yi musu maganin remdesivir sun nuna cewa sun sami sauƙi.
Ana gudanar da gwajin mataki na III a Amurka, Kanada da Italiya. Chloroquine, wanda aka yi amfani da shi a baya don maganin zazzabin cizon sauro, an gudanar da binciken a watan Fabrairu na 2020, tare da samun sakamako na farko.
Duk da haka, ana kira ga ƙarin bincike.
Ma'aikatar lafiya ta Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kula da Cututtukan Kwayar cuta ta Wuhan, yayin da take ba da shawarar amfani da gram ɗaya a rana, ta ba da shawarar cewa ninka wannan adadin na iya haifar da manyan matsaloli da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin wucin gadi ga likitocin da ke kula da marasa lafiya na COVID-19 don amfani da hydroxychloroquine da chloroquine a ɓoye.
Bayanai na farko sun nuna cewa ana buƙatar ribavirin mai yawa don magance SARS-CoV-2 wanda ba a shigar da shi cikin jiki.
Ana iya amfani da nitasoxanide a kan kwayar cutar da ta shiga jiki bayan an gano ƙananan ƙwayoyin SARS-CoV-2. Nazarin ya nuna cewa ana buƙatar kwayar halitta ta farko ta hanyar shigar da kwayar halitta ta 2 (TMPRSS2) don SARS-CoV-2 ta shiga ta hanyar mai karɓar ACE2.
Nazarin da aka yi kan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba ya nuna manyan abubuwan da ke hana likitoci amfani da waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir ba ya kawar da SARS-CoV-2 ba tare da shiga jiki ba kuma ba shi da wani muhimmin aiki a cikin maganin COVID-19.
Cytokine na iya haifar da matsala yayin da COVID-19 ke ci gaba da zama mai tsanani.
Akwai wasu alamomi da ke nuna cewa hydroxychloroquine na iya cutar da cytokines. Hukumar Lafiya ta China ta sanya Tocilizumab a cikin jerin magunguna bayan an yi karamin bincike.
A Italiya ana gudanar da gwajin matakin 2 tare da gwajin ƙasa bayan samun sakamako mai kyau a cikin mutanen da suka kamu da cutar.
An yi amfani da gwajin jini na kifi don gano kwayoyin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut.
A shekara ta 2017, FDA ta amince da amfani da maganin cututtukan jini mai hana kamuwa da cuta mai suna interleukin-6 a kan binciken da aka yi game da maganin cututtukan steroid da ke haifar da wani abu, wanda ake kira CAR T-cell therapy.
Ya zuwa yanzu, babu wata hujja da ta nuna cewa tocilizumab yana da tasiri wajen maganin CRS.
Ana gudanar da bincike kan samar da kwayoyin cuta masu tsabta da yawa da aka samar daga kwayoyin cuta na mutanen da suka warke daga COVID-19 ga mutanen da ke bukatar su a matsayin hanyar da ba ta amfani da rigakafin da aka samu daga wani mutum.
An gwada wannan hanyar a kan SARS amma ba ta yi tasiri ba.
Tsarin hana kwayar cutar wani tsari ne da aka yi tunanin cewa za a iya hada kwayoyin cutar SARS-CoV-2 da aka samu daga wani mutum.
Amma kuma ana iya amfani da wasu hanyoyi, kamar su kara yawan kwayoyin cutar.
Ana kuma samar da wasu hanyoyin maganin da za a iya amfani da rigakafin da aka samo daga wani mutum, kamar su yin amfani da rigakafin da aka samar a dakin gwaje-gwaje.
Ya kamata a kara yawan hanyoyin bayar da jini, da kuma samun jini daga mutanen da suka warke da kuma wadanda ke dauke da maganin cutar, domin samun saurin shiga jiki.
Cutar coronavirus, rukuni ne na cututtuka da ke da alamomi tara kawai.
Li Wenliang, likita a babban asibitin Wuhan, ya kamu da cutar COVID-19 kuma ya mutu bayan ya sanar da cewa cutar ta bulla.
